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ABSTRACT
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OLDER ADULTS
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Murad Taani
The University of Wisconsin Milwaukee, 2017
Under the Supervision of Dr. Christine Kovach

Objectives: To describe the muscle mass, strength, and function of older adults living in
residential care apartment complexes (RCACs) and examine the association between selfefficacy for exercise, depressive symptoms, social support and sarcopenia. The convergent
validity of Muscle Mechanography (MM) when compared to the traditional muscle function and
strength tests was also tested.
Design: Secondary data analysis of baseline data from a clinical trial.
Setting: One RCAC in the Midwestern United States.
Participants: Thirty-one older adults living in one RCAC.
Measurement: Muscle mass was measured by bioelectrical impedance spectroscopy. Muscle
function was evaluated by the Short Physical Performance Battery test, Timed Up and Go test,
and MM. Grip strength was measured by a Jamar® hand dynamometer. Self-efficacy for
exercise was measured by the Self-efficacy for Exercise Scale. Depressive symptoms were
measured by the Geriatric Depression Scale. Social support was measured by the Lubben Social
Network Scale.
Results: Participants had lower values of muscle mass, strength, and function compared to
values obtained in previous research. A sex difference exists for muscle mass, strength, and
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function. The findings showed a trend for individuals with high self-efficacy, without depressive
symptoms, and with strong social support to present greater muscle mass, strength, and function.
The findings also demonstrated convergent validity across all the examined measures of muscle
function and strength.
Conclusion: This study is only one of a few to describe the muscle outcomes and evaluate the
relationship between selected cognitive and psychosocial factors and sarcopenia among older
adults living in RCACs. The preliminary findings of this study warrant further investigation of
an intervention aimed at maintaining or improving the muscle outcomes of RCAC residents.
While the interpretation of findings should be presented with caution and replicated with other
samples, this study may provide a new understanding about the muscle outcomes and the
relationship between self-efficacy for exercise, depressive symptoms, and social support and
sarcopenia. Improved understanding of muscle outcomes and the relationship between cognitive
and psychosocial factors and sarcopenia is crucial. The findings also provided a new evidence
about MM as a new technology to quantitively assess muscle function in older adults, potentially
making this a valuable research tool.
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CHAPTER 1
This chapter introduces the problem of decreased muscle mass, strength, and function in
older adults living in residential care apartment complexes (RCACs). This problem is commonly
referred to as sarcopenia. The terms, decreased muscle mass, strength, and function and
sarcopenia will be used interchangeably in this study. In this study the term RCACs refers to
facilities licensed by the state at a non-nursing home level of care, which provide room, board,
24-hour oversight, and minimal hours of assistance with activities of daily living. This study will
fill gaps in the literature in three areas that are introduced in this chapter; it will a) describe the
characteristics of muscle mass, strength, and function in older adults living in RCACs; b)
describe the relationship of select cognitive and psychosocial factors to sarcopenia; and c)
examine the convergent validity of Muscle Mechanography (MM) method with traditional
muscle function tests. This chapter describes prevalence and significance as well as an
introduction to the potential risk factors associated with decreased muscle mass, strength, and
function among older adults. Gaps in the literature and the purpose of this study are given. The
Individual and Family Self-management Theory (IFSMT) is described, conceptual definitions
are provided, and the application of this theory to the study is discussed.
Introduction to the Problem
The reduction of muscle mass, strength, and function is one of the most consistent
changes that occurs with aging and is considered one of the main causes of disability in older
adults (Bruyère et al., 2016; Fielding et al., 2011; Morley, 2012). Recent estimates indicate that
up to 45% of older adults in the United States suffer from sarcopenia (Janssen, Shepard,
Katzmarzyk, & Roubenoff, 2004). Older adults with sarcopenia are at great risk for disastrous
health outcomes such as premature death and disability caused by falls, fractures, head injuries,

1

limited mobility, and impaired daily functioning (Bruyère et al., 2016; Buehring, Krueger, &
Binkley, 2010; Janssen et al., 2004; Morley, 2012). Sarcopenia also leads to an increased use of
nursing homes, long-term care (LTC) facilities, and hospital inpatient treatment (Janssen et al.,
2004). These negative health outcomes are costly to the individual, the healthcare system, and
society as a whole (Bruyère et al., 2016; Morley, 2012).
Several medical explanations for sarcopenia have been proposed related to genetic
factors, endocrine issues, hormonal changes, protein synthesis, proteolysis, and inflammatory
processes (Fielding et al., 2011; Henwood, Keogh, Reid, Jordan, & Senior, 2014). While many
of these mechanisms and their relationship to the onset and progression of sarcopenia are wellunderstood, the cognitive and psychosocial risk factors for developing sarcopenia are poorly
understood (Brady, Straight, & Evans, 2014; Campbell & Vallis, 2014; Henwood et al., 2014). A
greater understanding of the factors contributing to sarcopenia in older adults is needed
(Henwood et al., 2014). As sarcopenia is highly prevalent, identifying the treatable risk factors of
sarcopenia is considered to be a crucial step to prevent decline in muscle mass, strength, and
function in older adults (Fielding et al., 2011). Exploring these factors may enable the
development of interventions to prevent or decrease potential consequences of sarcopenia in
older adults.
Prevalence and Significance
Researchers estimated that more than 50% of older adults suffer from sarcopenia around
the world (Cruz-Jentoft, Landi, Topinkova, & Michel, 2010). In the United States, researchers
estimate that 45% of the elderly population is sarcopenic and 64% of adults over 65 years of age
reported limitations in at least one domain of physical function including walking, climbing,
standing, and sitting (Janssen et al., 2004, McAuley, Szabo, Gothe, & Olson, 2011). Morley
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(2012) reported that there are 3.6 million older adults in the United States who are sarcopenic. In
the New Mexico Elder Health Survey study, the prevalence of sarcopenia was determined to be
over 50% in individuals older than 80 years (Baumgartner et al., 1998). In a systematic review
by Cruz-Jentoft et al. (2014), the prevalence of sarcopenia in older adults was 1–33% across
multiple populations and communities. Cruz-Jentoft et al. (2014) reported that the rates of
sarcopenia vary across settings, such as in the community (1-29%), LTC facilities (14–33%), and
among patients (10%) in acute care hospitals. A second systematic review revealed that the
prevalence of sarcopenia in the older adults ranged from 0.0% to 85.4% in men and 0.1% to
33.6% in women (Pagotto & Silveira, 2014).
Sarcopenia is a public health problem, and preventing disability in older adults is a
national priority (Bruyère et al., 2016; Ferrucci et al., 2004). The reduction of muscle mass,
strength, and function leads to a cascade of negative health outcomes including the loss of
physical function, which represents the major prognostic indicator for the development of
physical disability (Bruyère et al., 2016; Janssen, Heymsfield, & Ross, 2002). This loss begins
with weakness of the lower extremities which contributes to difficulties in rising from a chair
and getting out of bed, slow gait speed, balance problem, and falls (Barbat-Artigas et al., 2013;
Kamel, 2003; Mijnarends et al., 2015).
With advancing age, sarcopenia-related impairment in physical function becomes severe
and leads to increased risk for falls, reduced ability to perform activities of daily living, increased
use of LTC facilities and nursing homes, hospitalization, and morbidity and mortality (Bruyère et
al., 2016; Clark & Manini, 2010; Cruz-Jentoft et al., 2010; Hirani et al., 2015; Janssen, 2010;
Morley, 2012; Newman et al., 2006). These negative consequences decrease the quality of life of
older adults and result in a substantial increase in healthcare costs (Bruyère et al., 2016; Morley,
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2012). Sarcopenia has been estimated to cost the United States health system around $18.5
billion a year (Bruyère et al., 2016). As the aging population increases, the negative impact of
sarcopenia on the elderly and the healthcare system is projected to rise (Bruyère et al., 2016;
Janssen et al., 2004).
According to the Administration on Aging (2012), older adults 65 years of age and older
are expected to increase from 43.1 million in 2012 to 79.7 million by 2040 and older adults over
the age of 85 years will triple from 5.9 million in 2012 to 14.1 million by 2040. Once sarcopeniarelated functional decline becomes apparent in this population, older adults will have difficulty
recovering from it (Cruz-Jentoff, et al., 2010). Thus, nurses and other healthcare professionals
have a pivotal role to play in improving muscle mass, strength, and function and preventing
disability in older adults. Knowledge about the risk factors for muscle weakness and impaired
muscle function is important to develop tailored intervention programs that ameliorate the
antecedents and muscle strength and function themselves. This knowledge can also consequently
prevent disability and improve mobility in older adults and decrease healthcare costs.
Assessment of Muscle Function in Older Adults: Measurement Issues
Increased dependency and impairments are considered a major reason for transfer from
RCACs to more restrictive living environments such as LTC and nursing homes. Researchers
suggested that increased impairments may be related to a lack of appropriate assessment and
treatment (Giuliani et al., 2008; Roberts et al., 2013). Most studies on RCACs residents only
report general functional ability such as Activities of Daily Living (ADL), and there are no
benchmarks for functional data (Giuliani et al., 2008; Kerse, Butler, Robinson, Todd, 2004;
Roberts et al., 2013; Zimmerman et al., 2005). Although measures of ADL are valuable for
identifying disability level, they are not useful for detecting modifiable muscle function
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impairments and functional limitations that lead to disability (Gibson et al., 2010; Giuliani et al.,
2008). Therefore, performing more sophisticated assessment of muscle function is needed to
identify limitations, understand the predictive value of specific impairments, and to target
intervention modalities in older adults living in RCACs (Giuliani et al., 2008; Guralnik et al.,
1994). Measures that provide more specific information regarding the muscular function include
Muscle Mechanography (MM), the Short Physical Performance Battery (SPPB), and the Timed
Up and Go (TUG) (Buehring et al., 2010; Guralnik et al., 1994; Minneci et al., 2015).
Understanding with precision the muscle function of older adults living in RCACs is
important. It provides the ability to distinguish older adults at risk for placement into LTC
facilities or nursing homes due to sarcopenia and the sequelae of sarcopenia from those who are
more likely to successfully age in their home environment. Knowledge of this at-risk group may
also assist in developing interventions to improve or maintain functional status and prevent or
delay transfer to more restrictive living environments. Maintaining or improving functional
status is associated with enhanced quality life and decreased use of expensive healthcare services
(Fielding et al., 2011; Giuliani et al., 2008).
A new technology such as MM provides the possibility to obtain precise measures of
muscle function and benchmarks for functional data (Buehring et al., 2010; Siglinsky et al.,
2015). MM was developed to overcome some shortcomings of the traditional muscle function
tests and to provide an objective quantification of muscle function (power and force) by using
maximal two-leg maximal countermovement jumps, serial hopping, or heel raises performed on
a ground reaction force platform. MM has been used in research and clinical settings (Buehring
et al., 2010; Siglinsky et al., 2015). However, data comparing MM with traditional muscle
function tests is limited and more research is needed to validate MM with other widely used
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muscle function tests in older adults (Buehring et al., 2015; Rittweger, Schiessl, Felsenberg, &
Runge, 2004; Siglinsky et al., 2015). This study will examine the relationship between MM and
other traditional muscle function tests including SPPB, TUG, and grip strength.
The Individual and Family Self-management Theory
The selection of a theoretical framework is critical to quantitative research as it provides
the rationale for investigating a particular research problem. This study will use the theoretical
foundation provided by the individual and family self-management theory (IFSMT) (Ryan &
Sawin, 2009; Ryan & Sawin, 2013). According to the IFSMT, self-management is a process by
which individuals and families use knowledge and beliefs, self-regulation skills and abilities, and
social facilitation to achieve health-related outcomes (Ryan & Sawin, 2009). The IFSMT can
potentially provide greater insight into the self-management behaviors in older adults to prevent
sarcopenia and improve muscle outcomes. The IFSMT can provide a framework for assessing,
planning, and implementing a theory based approach to the care of older adults and facilitate
optimal health outcomes, particularly muscle mass, strength, and function. The IFSMT is
depicted in Figure 1.
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Figure 1. The Individual and Family Self-Management Theory.

The premise of the IFMST is that self-management is a complex dynamic phenomenon
consisting of three dimensions: context, process, and outcomes (Ryan & Sawin, 2013). The
theory incorporates cognitive and psychosocial concepts, such as self-efficacy, depression, and
social support, which are relevant to identifying potential risk factors that contribute to
sarcopenia in older adults. Ryan and Sawin (2013) postulate that contextual and process factors
influence individual and family engagement in the process of self-management and these factors
are antecedent to proximal and distal outcomes. Enhancing the individuals’ and families’ selfmanagement processes leads to more positive health outcomes (Ryan & Sawin, 2013).
Contextual factors include risks, protective, and individual factors such as depression and social
support. The process factors (or the process of self-management) is influenced by concepts that
7

affect individuals’ knowledge and beliefs in their abilities such as the level of self-efficacy. The
self-management behaviors are noted as a proximal outcome such as engaging in physical
activity, managing depression, and developing a strong social network. Distal outcomes include
health status (e.g., muscle mass, strength, and function), quality of life, and direct and indirect
healthcare costs (Ryan & Sawin, 2013). Self-efficacy, depression, and social support concepts
are selected for inclusion in the theoretical framework and are identified in the next section.
Introduction to Potential Risk Factors for Sarcopenia
The IFSMT model has been used to explain the self-management of calcium and vitamin
D intake in women with osteoporosis (Ryan, Maierle, Csuka, Thomson, & Szabo, 2013). The
model was also used to describe the self-management of medications in frail older adults
receiving home healthcare services (Marek et al., 2013). However, the IFSMT model has not
been used to study the potential risk factors for sarcopenia in older adults. The IFSMT has been
modified to provide the foundational concepts for this research and to focus on concepts that
might be relevant to the development of sarcopenia in older adults (Figure 2).
The decline in muscle mass, strength, and function has a complex and multifactorial
etiology, which contributes to the phenomenon of sarcopenia (Cruz-Jentoft et al., 2010; Fielding
et al., 2011; Morley, 2012). Although evidence has shown that malnutrition and physical
inactivity are associated factors for sarcopenia, limited evidence was found about other potential
factors including self-efficacy for exercise, depression, and social support. These factors have
received less attention in this area of research and require further study (Brady et al., 2014;
Campbell & Vallis, 2014; Goisser et al., 2015; Henwood et al., 2014; Kim et al., 2011). If the
relationship between self-efficacy for exercise, depression, and social support to sarcopenia
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could be better understood and addressed, it could positively impact muscle outcomes and
functional status in older adults.

Context

Outcome

Process

Risks and Protective The Self- Management
Factors
Process

Individual and Family
Factors

Knowledge &
Beliefs

• Depression
• Pain
Physical & Social
Environment Factors

• Self-efficacy
for exercise

• Social support

Proximal

Distal

Individual & Family
SM Behaviors

Health Status

• Engaging in
physical activity
• Managing
depression
• Developing a
strong social
network

• Muscle mass
• Muscle strength
• Muscle function

Figure 2. Application of Individual & Family Self-management Theory on Sarcopenia.

Physical activity. There is considerable evidence that exercise and physical activity are
effective approaches to decrease the decline in muscle mass, strength, and function (Cruz-Jentoft
et al., 2014; Cruz-Jentoft et al., 2010; Morley, Anker, & Haehling, 2014). Physical activity
causes the muscles to contract, and that contraction stimulates the release of muscle growth
factors (insulin growth and mechanogrowth factors). Release of muscle growth factors activates
satellite cells and enables protein synthesis, which in turn, leads to muscle regeneration (CruzJentoft et al., 2010, Kamel, 2003; Morley, 2012). People who are physically inactive or lead a
sedentary lifestyle are less likely to stimulate the muscle regeneration process, making them
more susceptible to developing sarcopenia (Gianoudis, Bailey, & Daly, 2014; Morley, 2012).
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New research shows that sarcopenia is less likely to be present among individuals with high
levels of physical activity and that physical inactivity is predictive of sarcopenia in older adults
(Figueiredo et al., 2014; Landi et al., 2012; Lee et al., 2007). In addition, sarcopenia was less
likely to be present among participants with high levels of physical activity. Gianoudis et al.
(2014) reported that greater overall sitting time is associated with an increased risk of sarcopenia.
Therefore, researchers need to further explore which factors might underlie any effects of
physical activity on muscle outcome and physical function in older adults to guide and
implement tailored intervention programs designed for this population.
Self-efficacy. The concept of self-efficacy was first introduced by Albert Bandura as a
result of his psychological research in 1977. Self-efficacy is defined as people’s judgments of
their capabilities to carry out courses of action required to attain designated types of
performances (Bandura, 1977). Self-efficacy has been considered a strong predictor for the level
of physical activity and consistently associated with physical activity and well-being of older
adults (Goisser et al., 2015; McAuley et al., 2011). Self-efficacy can enhance or impede the
motivation to exercise and be active. Older adults with a high level of self-efficacy are able to set
and achieve specific physical activity goals. These individuals have the commitment to engage in
routine physical activity regimens for a sustained period of time. In contrast, low self-efficacy
among older adults is associated with failure to engage in specific physical activity regimens for
a sustained period of time leading to physical inactivity and sedentary lifestyle (McAuley et al.,
2011).
Older adults may not have a high level of self-efficacy that is required to engage in
routine physical activity regimens. Likewise, if older adults do not believe that engaging in
physical activities will make difference in their mobility and muscle outcomes, they may lack
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outcome expectancy and have low levels of self-efficacy (McAuley et al., 2011). Additionally,
falls are considered a major public health problem and a main cause of morbidity and immobility
in older adults, particularly among RCACs and nursing homes residents (Berry & Miller, 2008).
Falls may increase fear of injury, which leads to low self-efficacy and self-imposed limitation of
activity (Berry & Miller, 2008), and consequently negatively influences muscle outcome and
physical function in older adults.
Depression. Depression, which is both prevalent and undertreated in older adults, has
deleterious consequences among older adults. Depression can negatively influence mobility,
cognitive function, perceived self-efficacy, and self-management behaviors (Cramm et al., 2012;
Fiske, Wetherell, & Gatz, 2009). Evidence shows that depression is a significant risk factor for
development of sedentary lifestyle and decreased level of physical activity due to low motivation
(Fiske et al., 2009; Roshanaei-Moghaddam, Katon, & Russo, 2009). As depression is strongly
associated with physical inactivity and immobility, there may be an association between
depression and sarcopenia.
Depression also compromises the nutritional status of older adults (Fiske et al., 2009),
and consequently triggers substantial muscle loss. Recent studies demonstrated that malnutrition
is significantly associated with sarcopenia in community-dwelling older adults (Landi et al.,
2012; Santos et al., 2015; Volpato et al., 2014). Studies have shown that proper body mass index
(BMI) and adequate protein intake are important for proper muscle mass and function and these
are also key components of prevention and management of sarcopenia (Bauer et al., 2013;
Beaudart et al., 2014; Cruz-Jenoft et al., 2010; Morley et al., 2010; Muir & Montero-Odasso,
2011).
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Additionally, the literature indicates that depression and malnutrition can activate the
immune system, which increases the production of inflammatory cytokines and C-reactive
protein. Activating the inflammatory processes amplifies chronic catabolic conditions and
reduces muscle mass in older adults (Alexandre, Duarte, Santos, Wong, & Lebrão, 2014; Cesari
et al., 2004). Hence, because depression shares a relationship with known risk factors associated
with sarcopenia (physical inactivity, malnutrition, and inflammatory processes), there may also
be an association between depression and sarcopenia. Depression, when in combination with
other factors, such as increasing old age, co-morbidities, and inadequate social support, can serve
to compound and accelerate difficulties experienced with muscle mass, strength, and function.
Social support. Social support has captured the attention of gerontology researchers who
seek to understand how this multi-dimensional concept influences the aging process of older
adults. Social support can be defined as “information leading the subject to believe that he is
cared for and loved, esteemed, and a member of a network of mutual obligations” (Cobb, 1976).
One of the primary dimensions of social support is the structural dimension, which refers to
individuals’ degree of social involvement or embeddedness and the composition and size of their
social network (Chen & Silverstein, 2000). Family and friends are an important source of support
for older adults with chronic conditions that leads to greater adherence to self-management
(Chen & Wang, 2007). Social support system functions as an environmental resource that
facilitates self-management by meeting social interaction needs and enhancing an individual’s
motivation.
Social support is considered one of most important factors that impacts the relationship
between self-efficacy and self-management behaviors and predicts the physical health in older
adults (Gallant, 2003). Being in a supportive social network leads to beneficial effects on
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motivation, coping, psychological well-being, and self-management (Chen & Wang, 2007;
Gallant, 2003). People experience different life-course exposures and daily life events that
threaten their ability to perform the activities of daily living in a normal manner or engage in
physical activity/exercise regimens (Yeom, Fleury, & Keller, 2008). While older adults who
have strong social support are less likely to lead inactive lifestyles and be depressed, individuals
with poor social support systems are prone to be isolated, depressed, and inactive (Wallace,
Theou, Pena, Rockwood, & Andrew, 2015; Yeom et al., 2008). These negative consequences of
poor social support may negatively impact physical function and muscle outcome in older adults.
Strong and effective social support systems for older adults are related to a reduced risk for
mobility deficits and depression, suggesting that strong social support may reduce or prevent
disability in older adults (Wallace et al., 2015; Yeom et al., 2008).
Pain. While pain is not a normal part of aging, it is experienced daily by a majority of
older adults due to chronic conditions such as osteoarthritis, rheumatoid arthritis, and
neuropathic disorders. Undertreated pain in older adults has significant functional, cognitive, and
emotional consequences (Kovach, 2013). Pain was also found to be a factor that reduces physical
activity and directly contributes to the progression of sarcopenia in older adults (Scott, Blizzard,
Fell, & Jones, 2012). Since pain is associated with sarcopenia, pain must be considered in this
study and there is a need to control for the influence of pain when examining the relationship
between self-efficacy for exercise, depression, and social support in regards to sarcopenia.
In summary, the adapted theoretical framework based on the IFSMT is a dynamic
framework that shows the interactive relationship between self-efficacy for exercise, depression,
and social support in regards to sarcopenia. The framework shows that self-efficacy for exercise,
depression, and social support may contribute to sarcopenia in older adults. This adapted
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framework also reveals how these factors may influence muscle mass, strength, and function in
older adults. Accordingly, the adapted theoretical framework represents a logical and dynamic
design that could be useful to describe and explain the phenomenon of sarcopenia and its
associated risk factors in older adults living in RCACs. Ultimately, this framework will also
inform the research design, data collection and analysis, and discussion of the implications.
Other Terms/Definitions
Bioimpedance spectroscopy (BIS). A device used to measure the body composition of
lean body mass (Yamada et al., 2013).
Convergent validity. The extent to which different tools that are designed to measure the
same construct correlate with each other (Polit & Beck, 2012).
Muscle function. The basic function of a muscle in generating power and force. Muscle
power is the product of force production and the velocity at which the force is produced. Muscle
force is the total force required of muscles to move the body (Buehring et al., 2010).
Muscle mechanography (MM). A novel method that provides an objective
quantification of muscle function parameters including muscle power and muscle force (Taani,
Kovach, & Buehring, 2010).
Muscle mass. The body composition of lean body mass (Buehring et al., 2010).
Muscle strength. The ability of a muscle or muscle group to exert a maximal force or
torque at a specific velocity during a muscle contraction (Verbrugge & Jette, 1994). Muscle
strength in this study refers to handgrip strength, which is the maximal amount of force the
dominant hand can produce isometrically. Handgrip strength is measured by using a hand
dynamometer.
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Residential care apartment complexes (RCACs). Facilities licensed by the state at a
non-nursing home level of care, which provide room, board, 24-hour oversight, and minimal
hours of assistance with activities of daily living (Giuliani et al., 2008).
Sarcopenia. The reduction in muscle mass, strength, and function in older adults
(Morley, 2012).
Short physical performance battery (SPPB). A traditional muscle function test that
consists of: gait speed as determined by a four-meter walk, timed repeated chair rises, and
standing balance tests (Guralnik et al., 1994).
Timed up and go (TUG). A timed assessment of muscle function and mobility. It
measures the time that an individual takes to rise from a chair, walk three meters, turn around,
walk back to the chair, and sit down (Podsiadlo & Richardson, 1991).
Gaps in Nursing Knowledge
The relationship of self-efficacy for exercise, depression, and social support on muscle
mass, strength, and function in older adults, particularly among RCACs residents, cannot be
reasonably inferred from the existing literature. Although some risk factors such as nutrition and
physical activity have been examined in several studies (Alexandre et al., 2014; Figueiredo et al.,
2014; Kim et al., 2011; Landi et al., 2012; Lau, Lynn, Woo, Kwok, & Melton, 2005; Lee et al.,
2007; Santos et al., 2015; Senior, Henwood, Beller, Mitchell, & Keogh, 2015; Tasar et al., 2015;
Volpato et al., 2014; Yalcin et al., 2015), other potential risk factors have received less attention,
particularly self-efficacy for exercise, depression, and social support. Limited studies have been
previously conducted at nursing homes (Landi et al., 2012; Senior et al., 2015; Tasar et al.,
2015); however, it is not clear whether the results of these studies can be generalized to RCACs
residents. To the best knowledge of the author, there is no nursing study that has yet examined
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the relationship between the aforementioned cognitive and psychosocial factors and sarcopenia
in older adults living in RCACs. In addition, although the most current literature explores the
relationship between a few potential risk factors and sarcopenia in older adults, previous studies
have lacked a theoretical framework or conceptual model to guide their research design and
methodology.
Furthermore, measures of ADL are not useful to identify the modifiable functional
impairments and limitations that contribute to disability (Gibson et al., 2010; Giuliani et al.,
2008). One study found that most of the RCACs residents who were reportedly independent in
ADL they had substantial mobility problems based on actual functional performance (Giuliani et
al., 2008). However, most studies on RCACs residents in the United States still report general
data about functional ability such as ADL without reporting benchmarks for functional data of
this population (Giuliani et al., 2008; Roberts et al., 2013). There is limited knowledge about the
muscle function characteristics of RCACs residents that based on muscle function measures. In
addition, using a new technology such as MM to obtain precise measure of muscle function and
benchmarks for functional data in older adults is important (Buehring et al., 2010; Rittweger et
al., 2004). However, there is paucity of data comparing MM with other widely used traditional
muscle function tests in older adults (Buehring et al., 2015; Rittweger et al., 2004; Siglinsky et
al., 2015). This study will fill these gaps.
Study Purpose
The purpose of this dissertation study is threefold: 1) to describe the characteristics of
muscle mass, strength, and function in older adults living in RCACs; 2) to determine, after
controlling for pain, whether there is a difference in muscle mass, strength, and function among
older living in RCACs based on self-efficacy for exercise, depression, and social support levels;
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and 3) examine the convergent validity of MM parameters with widely used traditional muscle
function tests (SPPB, TUG, and grip strength).
Research Questions and Hypotheses
The research questions that will be addressed in this study include:
1) What are the self-efficacy for exercise, depression, social support of older adults living in
RCACs?
2) What are the muscle mass, strength, and function of older adults living in RCACs?
The hypotheses for this study include:
1) Participants with high self-efficacy for exercise will have greater muscle mass, strength,
and function than participants with low self-efficacy for exercise.
2) Participants who do not have depression will have greater muscle mass, strength, and
function than participants who have depression.
3) Participants with high social support will have greater muscle mass, strength, and
function than participants with low social support.
4) Weight corrected jump power obtained by MM correlates well with other traditional
muscle function and strength tests, including SPPB, TUG, and grip strength.

The findings of this study could contribute to the design of a tailored, nurse-driven,
multicomponent intervention that could minimize sarcopenia, prolong independent mobility, and
delay LTC placement among RCACs residents.
Contributions to Nursing and Innovation
This study will add to the nursing knowledge by examining potential risk factors for
sarcopenia that have not been studies in previous research among older adults living in RCACs.
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It will also provide a better understanding of muscle mass, strength, and function characteristics
in older adults by using sophisticated technology including MM and BIS. MM and BIS tools,
along with other traditional measures, will be used to assess muscle function and muscle mass,
respectively. This study is among the first to focus on using highly innovative technology to
quantitatively measure health outcomes in nursing research. The National Institute of Nursing
Research has emphasized extending nursing science through the integration of biological
sciences and supporting and employing new innovative technologies for research questions and
methods (National Institute of Nursing Research [NINR], 2011). New technology generates
opportunities to nursing researchers to move the nursing field forward and optimize patients’
health outcomes.
The preliminary findings of this study could help on how best to further expand our
current understanding of factors associated with sarcopenia and unsuccessful aging. The finding
could also inform researchers and policy makers on how to best develop, test, and implement a
multi-component nurse-driven intervention that could improve muscle function, prevent
disability, and delay LTC placement among RCACs residents, and subsequently decrease
healthcare costs.
Study Setting and Sample
This study is a secondary data analysis using a cross-sectional design from a randomized,
crossover design study that investigated the effect of semi-recumbent vibration therapy on
muscle mass, strength, and function in older adults age 70 and older. Participants were recruited
from a RCAC located in the Midwestern United States. Participants completed several
questionnaires and tests including Self-Efficacy for Exercise (SEE) Scale, Geriatric Depression
Scale (GDS), Lubben Social Network Scale (LSNS), muscle mass (body composition), two-leg
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maximal countermovement jump, SPPB, TUG, and grip strength tests. This secondary data
analysis provides further analyses, interpretations, conclusions, and knowledge from the primary
study. The author of this dissertation was the primary coordinator for the primary randomized
controlled trial study. He was responsible for all aspects of study conduct to include recruitment,
consent, scheduling exercise sessions, and coordinating testing visits.
Chapter Summary
This chapter introduced the importance of identifying the associated factors for
sarcopenia and understanding the functional characteristics of older adults living in RCACs. The
Individual & Family Self-management Theory (Ryan & Sawin, 2009) was adapted as a
theoretical framework for this dissertation study. Self-efficacy for exercise, depression, and
social support are factors that could influence the development and progression of sarcopenia
and disability in RCACs residents. This dissertation study will provide new knowledge about the
relationship between these factors and sarcopenia, muscle function characteristics, and new
technology to assess muscle function in older adults living in RCACs. This knowledge is
important to develop new intervention to improve muscle outcome and functional status, and to
delay long-term placement of older adults living in RCACs.
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CHAPTER 2
Introduction to the Chapter
In this chapter of this non-traditional dissertation, two manuscripts are presented. The
first manuscript is a literature review that discuss the current state of knowledge regarding the
associated risk factors for sarcopenia in older adults. Several studies that explore the risk factors
for sarcopenia in older adults are examined. The second manuscript presents Muscle
Mechanography (MM) as a novel method that can be used to quantitatively assess muscle
function in older adults. MM is presented as a safe and useful method that appears to have more
precision and reliability than more commonly used muscle function tests.

Section 2.1-Manuscript 1
Risk Factors for Sarcopenia in Older Adults: A Review of Literature
Introduction
Sarcopenia is an important geriatric syndrome characterized by generalized and
progressive reduction in muscle mass, strength, and function that is associated with aging (CruzJentoft et al., 2010). The reduction in muscle mass typically starts at the age of 40 years, where
approximately 8% of muscle mass is lost per decade until the age of 70 years. The loss
accelerates to reach 15% per decade after age 70 and this reduction negatively affects muscle
strength and function (Grimby & Saltin, 1983). The reduction in muscle mass, strength, and
function is one of the most common causes of declines in mobility and increases dependency in
older adults. This reduction also significantly reduces the ability of older adults to perform
activities of daily living (ADL) and increases the risk of fall, loss of bone mineral density, and
fractures (Cruz-Jentoft et al., 2010).
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The implications of sarcopenia in the older adults have been reported extensively in the
literature. Due to the changes in muscle mass, strength, and function that accompany aging and
that are related to many interrelated factors, older adults are at increased risk for accelerated
muscle loss and weakness, which contributes to functional decline, physical disability, and loss
of independence. This consequently leads to increased healthcare services utilization,
institutionalization, and healthcare costs (Cruz-Jentoft et al., 2010; Janssen et al., 2004).
Sarcopenia is highly prevalent among older adults in both genders worldwide (CruzJentoft et al., 2014; Janssen et al., 2004; Pagotto & Silveira, 2014). Estimates based on the
prevalence of sarcopenia and on the World Health Organization population data suggest that
more than 50 million of older adults are affected by sarcopenia, and the number is expected to
increase to more than 200 million over the next 40 years (Bruyère et al., 2016). In 2000, the
World Health Organization reported that the number of people around the world aged 60 years
and older was around 600 million and the number is expected to rise to 1.2 billion by 2025 and 2
billion by 2050 (Bruyère et al., 2016). In the United States, the number of individuals over 65
years old is predicted to increase to over 70 million by 2030 due to two factors: longer life spans
and aging baby boomers (Administration on Aging, 2012). Hence, the prevalence of sarcopenia
and its negative outcomes among older adults and the healthcare system is expected to increase,
which underscores the importance of sarcopenia diagnosis and prevention in older adults.
Sarcopenia has many causes and can be observed in both young and older adults (CruzJentoft et al., 2010; Pagotto & Silveira, 2014). Sarcopenia can be classified into two categories:
primary and secondary sarcopenia. Sarcopenia can be considered primary or age-related when no
other causes are evident but aging itself. Secondary sarcopenia is the term used when one or
more causes for changes in muscle mass and function are identified such as chronic illnesses,
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malnutrition, cachexia, chronic inflammation, muscle disuse, and physical inactivity (CruzJentoft et al., 2014). The cause of sarcopenia in many older adults is multifactorial so that it may
not be possible to describe each individual as having a primary or secondary sarcopenia. This
situation is consistent with recognizing sarcopenia as a multi-faceted geriatric syndrome (CruzJentoft et al., 2010; Cruz-Jentoft et al. 2014; Landi et al. 2012).
Whereas several mechanisms for the development of sarcopenia are well understood
(e.g., hormonal alterations, protein synthesis, proteolysis, and endocrine issues), the role of
cognitive factors (e.g., self-efficacy) and psychosocial factors (e.g., depression and social
support) on the onset and progression of sarcopenia are currently poorly understood (Brady et al.,
2014; Campbell & Vallis, 2014; Goisser et al., 2015; Henwood et al., 2014). Understanding risk
factors and mechanisms of action can potentially assist in identifying early markers for
sarcopenia prevention. Identifying the modifiable risk factors for sarcopenia is pivotal to
developing and implementing therapeutic interventions to reduce the negative consequences of
sarcopenia including disability, institutionalization, falls, fractures, and death. While knowledge
gaps remain, there is some evidence that several factors may contribute to the phenomenon of
sarcopenia in older adults (Brady et al., 2014; Fielding et al., 2011; Goisser et al., 2015;
Henwood et al., 2014).
The purpose of this manuscript is to review the literature that describes the factors
associated with sarcopenia in older adults. A search for relevant literature was conducted using
the Cumulative Index to Nursing and Allied Health Literature (CINAHL), PubMed, and
PsychInfo using keywords ‘sarcopenia’, ‘muscle mass’, ‘muscle strength’, ‘muscle function’,
‘older adults’, ‘elderly’, ‘residential care apartment complexes (RCACs)’, ‘nursing homes’, ‘risk
factors’, ‘psychosocial factors’, ‘cognitive factors’, ‘self-efficacy’, ‘depression’, and ‘social
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support’. A total of 172 articles were retrieved. Inclusion criteria consisted of relevant, full-text
English language research studies in older adults aged 60 years and older, resulting in 21 articles
to be reviewed.
Methods
The databases searched for relevant literature were CINAHL, PubMed, and PsychInfo.
Keywords for this preliminary search included ‘sarcopenia’, ‘muscle mass’, ‘muscle strength’,
‘muscle function’, ‘older adults’, ‘elderly’, ‘residential care apartment complexes (RCACs)’, and
‘nursing homes’. Over 3,400 articles were identified. Additional terms were used to refine the
search including keywords ‘risk factors’, ‘psychosocial factors’, ‘cognitive factors’, ‘selfefficacy’, ‘depression’, and ‘social support’. The search was limited to relevant, English
language papers published between 2000 and 2016. Due to the paucity of studies among older
adults living in RCACs, the criteria for considering studies were broadened to include studies
that identified associated factors for sarcopenia in community-dwelling older adults, assisted
living facility residents, and nursing home residents aged 60 years and older. This refined search
resulted in 172 articles of which the titles and abstracts were screened for inclusion criteria.
Reference lists of relevant articles were screened for other potentially eligible studies. A total of
21 studies met the inclusion criteria and were extracted for review. The outcomes obtained from
a review of the literature are illustrated in Appendix A.
Results
Physical Activity
Several correlational, cross-sectional studies explored the relationship between physical
activity and sarcopenia in community-dwelling older adults (Alexandre et al., 2014; Castillo et
al., 2003; Figueiredo et al., 2014; Gianoudis et al., 2014; Lee et al., 2007; Senior et al., 2015;
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Volpato et al., 2014), and nursing home residents (Landi et al., 2012; Senior et al., 2015; Tasar et
al., 2015; Yalcin et al., 2015). The International Physical Activity Questionnaire-Short Form,
Barthel Index of Activities of Daily Living, and Physical Activity Scale of the Elderly were used
as tools to assess physical activity level.
Most of these studies show a negative association between physical activity and
sarcopenia and that sarcopenia is less likely to be present among older adults with high levels of
physical activity. The presence of sarcopenia was also inversely associated with involvement in
daily leisure physical activities. In addition, Hsu and colleagues conducted a correlational, crosssectional study in a veterans retirement community and found that low level of ADL and
physical dependence were significantly associated with sarcopenia in older men (Hsu et al.,
2014). One correlational, cohort, longitudinal study also revealed that low physical activity is
significantly associated with the development of sarcopenia in community-dwelling older adults.
The results of the protective effect of physical activity indicate a need for intervention and that
increasing physical activity could be beneficial in preventing sarcopenia (Yu et al., 2014).
However, only a few studies showed no significant association between physical activity
level and sarcopenia among community-dwelling older adults (Volpato et al., 2014; Alexandre et
al., 2014), and nursing home residents (Tasar et al., 2015; Yalcin et al., 2015). However, the
results of these studies have some limitations including selective healthy individuals and limited
number of individuals with sarcopenia which may led to small statistical power and increased the
probability of type II error.
Although resistance exercise and weight training are effective countermeasures to
sarcopenia in older adults, vigorous exercise is not always required and moderate physical
activity carried out as part of everyday activities and regular leisure activities (e.g., walking,
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gardening, and dancing) seem to be enough to reach considerable benefits among older adults
(Figueiredo et al., 2014; Landi et al., 2010). In their correlational, cross-sectional study, Lee and
colleagues reported that the Physical Activity Scale for the Elderly (PASE) score — a detailed
record about physical activity involved in recreational, household, and social/voluntary work in a
week time period — showed a significant association between physical inactivity and low
appendicular muscle mass, which is an essential component of sarcopenia (Lee et al., 2007). In
addition, a correlational, cross-sectional study examined the relationship between sedentary
behaviors and musculoskeletal health and function in community-dwelling older adults found
that greater overall sitting time is associated with an increased risk of sarcopenia (Gianoudis et
al., 2014). Likewise, Senior and colleagues in their correlational, cross-sectional study found that
setting time was predictive of sarcopenia in nursing home residents (Senior et al., 2015).
Self-efficacy. Although physical activity recommendations for older adults include both
aerobic exercise and resistance-training, estimates indicate that only 51.1% and 21.9% of older
adults meet the aerobic and resistance-training guidelines, respectively (Brady & Straight, 2014).
Yet, most of older adults do not meet the recommended physical activity guidelines and engage
in a sufficient volume of physical activity to promote health outcomes. Researchers assert that an
important aspect very rarely addressed so far in sarcopenia research is the influence of selfefficacy (Brady et al., 2014; Goisser et al., 2015). An older adult with or without sarcopenia
might not be easily integrated into a group-based exercise program and maybe prone to a
sedentary lifestyle due to lack of self-efficacy. As research has demonstrated in behavioral
change interventions, the role of self-efficacy is an important factor and is considered one of the
strong predictors for the level of physical activity in older adults (Goisser et al., 2015). However,
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no studies found that examined the association between self-efficacy and sarcopenia in older
adults.
Nutritional Status
Multiple correctional, cross-sectional studies have explored the association between
nutritional status and sarcopenia in community-dwelling older adults (Alexandre et al., 2014;
Figueiredo et al., 2014; Gariballa & Alessa, 2013; Kim et al., 2011; Lau et al., 2005; Lee et al.,
2007; Santos et al., 2015; Volpato et al., 2014) and nursing home residents (Landi et al., 2012;
Senior et al., 2015; Tasar et al., 2015; Yalcin et al., 2015). Body mass index (BMI) and the Mini
Nutritional Assessment (MNA) tool were the two main methods used to evaluate nutritional
status.
Most of the studies reported a negative association between malnutrition/BMI and
sarcopenia (Alexandre et al., 2014; Figueiredo et al., 2014; Kim et al., 2011; Landi et al., 2012;
Lau et al., 2005; Lee et al., 2007; Santos et al., 2015; Tasar et al., 2015; Yalcin et al., 2015). Hsu
et al. (2014) also reported that low BMI was significantly associated with sarcopenia in older
men living in a veterans retirement community. One correlational, retrospective, longitudinal
study showed that malnutrition is significantly associated with sarcopenia in communitydwelling older adults and that high BMI is a predictor of sarcopenia (Murphy et al., 2013). Yu
and colleagues conducted a correlational, cohort, longitudinal study and reported that low BMI is
significantly associated with sarcopenia in community-dwelling older adults (Yu et al., 2014).
This review shows that sarcopenia is less likely to be present among participants who
have a normal BMI, as well as an appropriate BMI is associated with higher muscle mass,
muscle strength, and physical performance. In addition, older adults with sarcopenia are demonstrated to have a significantly lower BMI and poorer nutritional status than those without
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sarcopenia. A low BMI serves as an independent predictor of sarcopenia in both communitydwelling older adults and nursing home residents (Alexandre et al., 2014; Landi et al., 2012;
Murphy et al., 2013; Yu et al., 2014). These results may have implications for development of
interventions to improve nutritional status and improve muscle outcomes.
Depression
Several cross-sectional studies explored the association between depression and
sarcopenia in community-dwelling older adults (Alexandre et al., 2014; Byeon, Kang, Kang,
Kim, & Bae, 2016; Gariballa & Alessa, 2013; Han et al., 2016; Kim et al., 2011; Lee et al., 2007;
Volpato et al., 2014), nursing home residents (Senior et al., 2015), and older men living in a
veterans retirement community (Hsu et al., 2014). The GDS and the Center for Epidemiologic
Studies Depression (CESD) scale were used to evaluate depression among the participants.
A positive association has been found between depression and sarcopenia in older adults,
and depression was less likely to be present among older adults who have higher skeletal muscle
mass (Gariballa & Alessa, 2013; Hsu et al., 2014; Kim et al., 2011). In a correctional, crosssectional study among older men and women, individuals with self-reported depression or those
taking antidepressants had lower muscle mass than those free of depression or antidepressant
medications use (4.2 % lower in men and 3.7 % lower in women) (Kim et al., 2011). In another
correlational, cross-sectional study included hospitalized patients aged 65 years and older, those
identified with sarcopenia were more likely to be older, suffer from depression, and have a
longer length of hospital stay (Gariballa & Alessa, 2013).
In contrast, the association between depression and sarcopenia was not detected in other
studies. For instance, in a recent study included multiple age groups (20-39, 40-59, and ≥60
years) (N= 7,364), sarcopenia group did not have a higher prevalence of depression or depressive
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symptoms compared to the non-sarcopenia group, and all age groups showed no significant
association between depression and sarcopenia (Byeon et al., 2016). Another correlational, crosssectional study included 1,149 Brazilian community-dwelling older adults found no association
between depression and sarcopenia (Alexandre et al., 2014). Other correlational, cross-sectional
studies reported no association between depression and sarcopenia in community-dwelling older
adults (Han et al., 2016; Lee et al., 2007; Volpato et al., 2014). Only one correlational, crosssectional study conducted in a nursing home and found no relationship between depression and
sarcopenia (Senior et al., 2015). Therefore, the literature has shown inconsistent results and
conflicting reports about the association between depression and sarcopenia. Further studies are
needed to assess the relationship between depression and sarcopenia among older adults.
Cognitive Impairment
Cognitive impairment has been linked to poor functional status and sarcopenia in older
adults. Cognitive impairment commonly leads to sedentary lifestyle, bed rest, and malnutrition,
which could trigger excessive muscle loss in older adults (Hsu et al., 2014). Cognitive
impairment also causes neuronal changes in the central nervous system which alters the levels
and activity of neurotransmitters, and consequently leads to a decrease in the motor units and the
ability to maintain muscle activation (Walston et al., 2006).
Several correlational, cross-sectional studies explored the association between cognitive
function and sarcopenia in community-dwelling older adults (Alexandre et al., 2014; Volpato et
al., 2014), nursing home residents (Landi et al., 2012; Senior et al., 2015; Yalcin et al., 2015),
and in older men living in a veterans retirement community (Hsu et al., 2014). The Mini-Mental
State Examination and Cognitive Performance Scale were the most common methods used to
evaluate the cognitive function among the participants. Two studies showed that cognitive
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impairment is associated with sarcopenia in older adults (Alexandre et al., 2014; Hsu et al.,
2014). However, other studies showed no association between cognitive function and sarcopenia
(Landi et al., 2012; Senior et al., 2015; Volpato et al., 2014; Yalcin et al., 2015). Yu and
colleagues also found no significant associations between cognitive impairment and incident
sarcopenia (Yu et al., 2014). Therefore, supporting data are still scarce and controversial, and the
association between cognitive function and sarcopenia needs further investigation.
Social Support
Strong social support and high social participation are often considered in discussions
about healthy aging. Researchers underscore the importance of understanding these factors and
to identify means through which social support and social participation might be maintained,
particularly among older adults (Cruz-Jentoft et al., 2010; Wallace et al., 2015; Yeom et al.,
2008). Social support is a common risk factor associated with quality of life among older adults.
Poor social support has negative impacts on physical, cognitive, and mental wellness, as well as
on morbidity and mortality (Cruz-Jentoft et al., 2010; Wallace et al., 2015). Nonetheless, no
studies were found that explore the relationship between social support and sarcopenia in older
adults.
Only one study was found that examined the association between social participation and
lower extremity muscle strength and gait speed in Americans aged 50 years and older (Warren,
Ganley, & Pohl, 2016). The study revealed a significant association between social participation
and gait speed among older adults who aged 65 years and older. Older adults with low social
participation had three times higher odds of slower walking speed compared with those without a
reported limitation with social participation (OR = 3.1; 99% CI [1.5–6.2]). The social
participation was also significant with lower extremity strength and self-reported limitation in
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those 65 and older. These older adults had a significantly three times higher odds of being weak
compared with strong (OR = 3.5, 99% CI [1.3–9.9]) (Warren et al., 2016).
Smoking and Alcohol Consumption
Multiple correlational, cross-sectional studies explored the relationship between smoking
status and sarcopenia in community-dwelling older adults (Alexandre et al., 2014; Castillo et al.,
2003; Figueiredo et al., 2014; Gabrilla & Alessa, 2013; Han et al., 2016; Lau et al., 2005; Lee et
al., 2007; Martins, Bôas, & McLellan, 2016), and nursing home residents (Tasar et al., 2015).
Self-reported questionnaires were used to assess smoking status among the participants. Smoking
was reported as a risk factor for sarcopenia (Alexandre et al., 2014; Castillo et al., 2003;
Figueiredo et al., 2014; Lee et al., 2007; Martins et al., 2016; Tasar et al., 2015). Alexandre et al.
(2014) stated that smoking may reduce the ability of the already suffering system to obtain
muscular energy, which may cause muscle fatigue and subsequently increase the protein
catabolism that can reduce muscle mass and function (Alexandre et al., 2014). One correlational,
longitudinal study showed no significant association between smoking status and sarcopenia in
community-dwelling older adults (Murphy et al., 2013).
Other studies examined the association between alcohol consumption and sarcopenia
using self-reported questionnaire in community-dwelling older adults (Castillo et al., 2003;
Gabrilla & Alessa, 2013; Lau et al., 2005; Lee et al., 2007; Han et al., 2016), and nursing home
residents (Tasar et al., 2015). The results did not support alcohol consumption as a risk factor for
sarcopenia. However, only one study showed a significant association between daily drinking
and sarcopenia in women, suggesting that chronic consumption may promote loss of muscle
mass and strength in old age (Han et al., 2016).
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Other Factors
A few correlational, cross-sectional studies explored the relationship between chronic
illnesses and pain and sarcopenia. Several studies revealed that cerebrovascular disease,
hypertension, osteoarthritis, and diabetes are factors associated with sarcopenia in older adults
(Han et al., 2016; Landi et al., 2012; Lee et al., 2007). A correlational, longitudinal study also
showed that stroke is associated with sarcopenia (Yu et al., 2014). Pain was also found to be a
risk factor for sarcopenia in older adults. Murphy et al. (2013) assessed muscle mass, gait speed,
and grip strength seven times over 9 years and found that pain is a predictor of transition from
the normal state toward sarcopenia in older adults. The result may reflect avoidance of physical
activity due to pain-related fear, as well as pain may indicate inflammation that contributes to
muscle loss.
Critique of the Literature
The examined literature showed that the majority of the studies were conducted among
community-dwelling older adults, whereas only a few studies focused on older adults living in
nursing homes. Only one study conducted among older men living in a veterans retirement
community and no studies found among assisted living facilities residents. Most of the studies
were correlational with a cross-sectional design, which limits the ability to clarify any causeeffect relationships between sarcopenia and its associated factors. Detailed descriptions of the
participants including sample size, age, gender, and demographic location from which the
participants were recruited were discussed. However, many studies did not report how the effect
size was justified.
The inclusion and exclusion criteria were clearly presented in most of the studies.
However, several studies potentially introduced selection bias by excluding older adults living in
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institutions and those with mobility difficulties (e.g., individuals using walker), and representing
only healthier, more physically active, and more educated individuals from the general
population (Alexandre et al., 2014; Gariballa & Alessa, 2013; Lee et al., 2007; Murphy et al.,
2013; Tasar et al., 2015; Volpato et la., 2014; Yalcin et al., 2015; Yu et al, 2014). Thus, it cannot
be said that the sampling is necessarily representative of the overall older adult population. These
limitations may also hinder the ability to detect associations between potential risk factors and
sarcopenia. Interestingly, most of the studies were found on sarcopenia and its associated factors
were current and published in the past 5 years, which indicates that interest in sarcopenia among
older adults is growing among members of the scientific community and more research is needed
in this area.
The majority of the measures and data collection procedures were clearly defined and
described in the reviewed studies. However, the studies have several methodological issues.
First, most of the studies have used traditional muscle function tests (e.g., gait speed, timed-upand-go (TUG), and chair rise tests) to assess muscle function. These traditional measures have

important limitations. These limitations include pass/fail determinations and timing variability
resulting from examiner subjectivity. Older adults with significant disability may not be able to
perform chair-rise or TUG test. Another limitation is that the traditional chair-rise test requires
maximal power (watts) but is reported in seconds (Taani et al., 2017).
Second, the use of bioelectrical impedance spectroscopy (BIS) to measure muscle mass
may lead to measurement errors because of the dehydration problems that can be observed in
older adults. Decreasing the total body water may result in an underestimation of body fat and an
overestimation of fat-free mass (Yamada et al., 2013). However, BIS is inexpensive, easy to use,
reproducible, and considered a portable alternative to dual-energy X-ray absorptiometry (DXA)
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(Yamada et al., 2013). Measure muscle mass in older adults using DXA is not feasible and BIA is
a more practical method to use in large samples. Finally, one study did not find an association
between physical activity and nutritional status and sarcopenia (Volpato et al., 2014). This
unexpected result may due to misclassification in the self-report assessment of physical activity
level and nutritional intake.
Discussion
Sarcopenia is considered a main cause for impaired physical function, dependency, and
decreased quality of life (Morley, 2012). This underscores the importance of identifying the risk
factors associated with sarcopenia and developing effective preventative interventions. This
review shows that physical inactivity and malnutrition are risk factors for sarcopenia in older
adults. These two factors were common across most of the studies. Although self-efficacy for
exercise is considered one of the strong predictors for the level of physical activity in older adults
(Goisser et al., 2015; Brady et al., 2014), the impact of self-efficacy has been rarely addressed in
relation to sarcopenia and none of the studies examined the existence of such relationship.
Several studies showed that older adults with sarcopenia were more frequently diagnosed
as malnourished than older adults without sarcopenia. Maintaining proper nutrition status and
BMI along with adequate protein intake play a major role in preventing and managing sarcopenia
in older adults (Alexandre et al., 2014; Landi et al., 2012; Yu et al., 2014). These results can be
significantly important for conducting further research and designing effective interventions to
improve nutritional status and prevent sarcopenia.
Studies shows that depression and cognitive impairment are inconsistently associated
with sarcopenia. Limited studies reported a significant relationship between these two factors
and sarcopenia (Alexandre et al., 2014; Hsu et al., 2014; Gariballa & Alessa, 2013; Kim et al.,
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2011). Depression and cognitive impairment may lead to malnutrition and sedentary lifestyle,
which may contribute to muscle loss and development of sarcopenia (Hsu et al., 2014; Kim et al.,
2011). However, evidence showed that the relationship between depression and cognitive
impairment and sarcopenia is still poorly understood and further research is needed in this area.
Although researchers emphasized the importance of social support in the context of aging
(Cruz-Jentoft et al., 2010; Wallace et al., 2015; Warren et al., 2016; Yeom et al., 2008), no
studies explored the relationship between social support and sarcopenia. Furthermore, limited
evidence was reported about the relationship between smoking status, alcohol consumption, pain,
and chronic illnesses and sarcopenia. While limited studies in this review showed a significant
association between smoking status and pain and sarcopenia, none of the studies showed a
significant association between alcohol consumption and sarcopenia.
Conclusion and Gaps in Knowledge
This review revealed that the relationship of self-efficacy for exercise, depression, and
social support on muscle mass, strength, and function in RCACs residents is poorly understood.
Many studies have focused on common factors including physical activity and nutrition status
and limited or no studies were found that addressed other potential factors including selfefficacy, depression, and social support. Several studies have also focused on identifying the risk
factors for sarcopenia in community-dwelling older adults and no studies indicate that attention
has been focused on RCACs residents.
To gain better understanding of the risk factors for sarcopenia among older adults living
in RCACs, more studies need to be conducted in this at-risk group. Knowledge of this at-risk
group is important to develop tailored interventions to prevent sarcopenia and its negative health
consequences. Such interventions may also assist in improving or maintaining functional status
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and preventing or delaying transfer to more restrictive living environments, and consequently
enhancing quality life of older adults and decreasing use of expensive healthcare services.
In addition, most the studies have used traditional muscle functions tests to assess muscle
function among the participants. These tests have several limitations and more precise
measurements of muscle function in older adults are needed. More research is need to address
these gaps in the literature; to gain better understanding of the risk factors for sarcopenia in
RCACs residents and provide knowledge about the muscle function characteristics of this at-risk
group of older adults.
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Section 2.2-Manuscript 2
Manuscript 2: Muscle Mechanography: A Novel Method to Measure Muscle Function in
Older Adults
Introduction
Assessing muscle function in older adults has become an important topic in the field of
geriatric research. Aging is associated with changes in body composition and functional
capability, including a reduction in muscle mass and muscle function (Morley, 2012). These agerelated reductions have been named sarcopenia (Fielding et al., 2011). Recent estimates indicate
that up to 45% of older adults in the United States experience sarcopenia, depending on which
population is studied and which definition is used (Janssen et al., 2004). Older adults with
sarcopenia are at greater risk for falls, fractures, and head injuries (Buehring et al., 2010; Morley,
2012). Compromised muscle function in older adults was found to be an independent predictor
of increased use of long-term care facilities, hospitalization, disability, and mortality (Clark &
Manini, 2010; Hirani et al., 2015; Landi et al., 2013).
Assessment of sarcopenia requires measurement of muscle function. Key physical units
necessary to quantify muscle function include: force (Newtons [N]), velocity (m/s), and power
(watts [W]). Muscle force relates to the force exerted to get the body moving, or the direct
muscle forces imparted to the skeleton during movement. Common tests assessing muscle force
are grip strength or knee extensor strength. These tests require a maximal muscle contraction to
create a peak force. Muscle force is one of the primary regulators of bone mass and an important
determinant of bone and joint health in older adults. Muscle force is strongly correlated with
bone strength, bone size, total bone area, and femoral neck bone mineral density (Hardcastle et
al., 2014; Pojednic et al., 2012; Rantalainen et al., 2009; Runge & Hunter, 2006). Muscle
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velocity (or movement velocity) is the rate of motion (speed) in a specific direction. The best
example of a test measuring velocity is the 4-m walk to assess gait speed. Velocity (e.g., gait
speed) slows with aging and is a key component in the onset of functional impairments in older
adults.
Muscle force and velocity are significant determinates of power production and
functional task performance in older adults (Pojednic et al., 2012). Muscle power is defined as
the ability to generate as much force as possible and as quickly as possible. It is calculated as the
product of force and velocity. Thus, altered neural or muscular ability affecting either factor
(force or velocity) will contribute to declines in power and potentially physical function
(Pojednic et al., 2012). Examples of tests measuring power are the chair-rise test and two-leg
maximal countermovement jumps. Muscle power is a valuable measure for identifying agerelated physical impairments and strongly correlates with physical capability, mobility, the risk
of falling, and sarcopenia (Caserotti, Aagaard, Simonsen, & Puggaard, 2001; Runge & Hunter,
2006; Rittweger et al., 2004; Siglinsky et al., 2015; Singh et al., 2014). Leg power is often
corrected for body weight (W/kg).
Several traditional muscle function measures have been developed, validated, and used to
assess muscle function in older adults (Siglinsky et al., 2015). Among these, gait speed is one of
the most frequently used methods. It is measured as the time taken to walk 4 m or another
distance achieved during a 2-minute timeframe. Gait speed is a predictor for falls, fractures,
hospitalization, caregiver need, and mortality among older adults (Montero-Odasso et al., 2005;
Studenski et al., 2011). The chair-rise test is measured by the time required to rise from a chair
five times without using its arms. After first assessing if the individual is able to rise once
successfully, he/she will be asked to rise from a chair five times and time to complete the five
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chair rises will be recorded. Repeated chair-rise performance is strongly related to fall and hip
fracture risk among older adults (Cawthon et al., 2008). The grip strength test assesses muscle
strength using a hand-grip dynamometer. Grip strength is associated with important clinical
measures, including disability, length of hospital stay, postoperative complications, and mortality
in older adults (Bohannon, 2015). Low grip strength is also associated with various causes of
death, including myocardial infarction, stroke, fall, and fracture (Leong et al., 2015).
However, many of the traditional tests have limitations: they often cannot be used over a
wide range of performance levels and have drawbacks for testing older adults who have very
high or low functional ability. For example, self-selected usual gait speed has a ceiling effect
because at some point the individual is walking at a faster pace than his/her usual pace or even
jogging/running. The chair-rise test has a floor effect because individuals who cannot rise from
the chair cannot be measured. Often these measures only examine particular aspects of muscle
function (e.g., balance, power, force) and few provide a quantitative measure (e.g., force,
velocity, power). For example, the traditional chair-rise test requires maximal power (W) but is
reported in seconds (Buehring et al., 2013; Puthoff, 2008; Siglinsky et al., 2015). Other
limitations of these tests include dichotomous (pass/fail) determinations and being prone to
human errors as the final results depend on the times taken by individual examiners (Buehring et
al., 2013; Siglinsky et al., 2015).
Therefore, quantitative methods for the precise measurement of muscle function in older
adults over a broad range of performance is desirable. The National Institute of Nursing
Research has emphasized extending nursing science through the integration of biological
sciences and supporting and employing new innovative technologies for research questions and
methods (NINR, 2011). These technologies should include methods to optimally assess muscle
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function in older adults. Muscle mechanography is an innovative technology that quantitatively
assesses muscle function parameters in older adults using a ground reaction force platform
(GRFP). The purpose of the current article is to introduce muscle mechanography as a method to
assess muscle function in older adults. The review covers the mechanism of muscle
mechanography, different types of tests, parameters that can be obtained by using muscle
mechanography, measurement procedures, reproducibility, and safety.
Muscle Mechanography
Muscle mechanography can quantitatively assess muscle function (force, velocity, power,
center of gravity/sway) using a GRFP. Movements that can be measured include heel rise, chair
rise, hopping, jumping, and static balance positions (e.g., semi-tandem or tandem stance). A
variety of GRFP systems have been used in research settings (Buehring et al., 2010; Matheson et
al., 2013; Rantalainen et al., 2010; Rittweger et al., 2004; Singh et al., 2014). One of the most
commonly used systems is the Leonardo Mechanograph®.
Principle of Measurement
The Leonardo Mechanograph GRFP comprises two symmetrical left- and right-sided
force plates, which measure and quantify any asymmetries in individuals' physiological
movements. A mass (e.g., body weight) creates a vertical ground reaction force on the plates,
which elicits changes in electrical resistance in the GRFP's sensors that are proportional to the
exerted force. The voltage changes are measured at a frequency of 800 Hz by four strain gauge
force detectors located in each force plate (eight total force sensors). The collected voltage
reading is transferred via a USB 2.0 connection to a personal computer running the Leonardo
Mechanography software (Binkley & Specker, 2008; Matheson et al., 2013; Rittweger et al.,
2004; Veilleux & Rauch, 2010). From the measured voltage and changes in voltage over time,
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the software can calculate other muscle function parameters, such as velocity and power. Several
software versions are available and the most recent includes reference data for individuals ages 3
to 99 years.
Muscle Function Parameters Obtained Using Muscle Mechanography
Unlike traditional muscle function tests, muscle mechanography directly measures the
applied force vector and calculates measures of force, velocity, power, jump height, and sway
(i.e., the change of the center of gravity during a balance test) (Buehring et al., 2010; Matheson
et al., 2013; Rittweger et al., 2004). The Leonardo system also reports the Esslinger Fitness
Index, an age- and sex-adjusted measure of power assessed during countermovement jumps.
Operational definitions of the variables available through Leonardo mechanography are
presented in the Table 1.

Table 1
Operational Definitions of the Variables Available Through Muscle Mechanography
Variable
Force

Definition
The total force exerted on the platform to get the body moving, which
also causes acceleration. Force is exerted by movements. Force is
calculated by multiplying body’s mass with its acceleration. Force
(Newton) = mass (kg) x acceleration (m/s).

Velocity

Velocity is the rate of motion (speed) in a specific direction. It is
calculated by integrating acceleration over time.

Power

Power is a necessary parameter to measure movement. Movement is the
action of force along a specific distance in a certain time, which is
measured as power. Power is also used to describe the rate at which
energy is used. It is calculated by multiplying force and velocity.
Power=force x distance/ time = force (N) x velocity (m/s).

Esslinger Fitness
Index (EFI)

This is the performance of the movement. The EFI represents the
maximum jump power relative to body weight for one’s age (ages 3 to
99 years) and gender-matched reference population.

Jump height
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Jump height is defined as the displacement of the body’s center of
gravity. Integration of velocity over time results in displacement of
center of gravity/jump height.

Measurement Procedures
Platform Quality Assurance
Although no standardized procedure exists, it is the current authors' recommendation that
the platform should be calibrated at least weekly to assure accuracy and precision of the static
properties before performing any tests. In addition, it should be calibrated every time it is moved
from one location to another. Three 20-kg Troemner cast iron grip handle weights were used for
calibration in the current authors' studies. These weights are stacked in one corner of the platform
and the measurement of the weight is recorded. This process is repeated for each of the other
three corners. In addition, two weights are placed side by side in the middle of the platform with
a third weight placed on top to obtain a central measurement. If any measurements are outside of
the ±0.5-kg limit, recalibration is needed.
Test Procedures
Several tests and movements can be performed on the GRFP. All tests are generally easy
to understand as they are natural movements that most individuals have performed throughout
their lives (e.g., rising on the toes, rising from a chair, hopping/jumping). However, it is
recommended that participants receive standardized instructions and that the tests be
demonstrated by a trained staff member. In addition, older adults should wear a gait belt while
performing tests and at least two staff members should be present to ensure the individual's
safety. Staff should be ready to assist the participant who is wearing a gait belt in case he/she
loses balance (Figure 3).
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Figure 3. Example of Older Adult Performing a Countermovement Jump under supervision of
two trained staff members.

Heel-rise test. The main outcomes of this test are velocity and power. The test comprises
heel rises with the goal of achieving the maximum speed of their upward movement. After
standing still on the force platform, participants should be instructed to rise on their tiptoes by
lifting their heels from the force platform as quickly as possible after hearing a single-tone beep
(Veilleux & Rauch, 2010). A double-audible tone indicates the end of the test. Participants are
asked to perform three heel raises and the heel raise with the greatest height is used for analysis.
This test is useful for older adults who have a degree of functional disability that limits their
ability to participate in the jump and chair-rise tests.
Chair-rise test. The major outcomes of this test are force, velocity, and power. In
addition, this test evaluates a movement that is highly relevant in everyday life (Veilleux &
Rauch, 2010). A specific bench is installed on the force plate for the purpose of this test. After
sitting on the bench with feet on the ground, participants are instructed to cross their arms over
their chest, then stand up straight and sit down again as fast as possible. If participants rise
successfully, they are instructed to repeat this five times as quickly as possible. These are exactly
the same instructions as for the traditional chair-rise test, but muscle power is reported instead of
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time. The rise with the highest maximum power, or an average of several rises (three to five), is
analyzed.
Single two-legged countermovement jump. This test has been extensively used among
older adults in research settings (Buehring et al., 2010; Matheson et al., 2013; Rittweger et al.,
2004; Runge et al., 2004; Siglinsky et al., 2015; Singh et al., 2014). The main outcome of this
test is power (usually body weight corrected power [W/kg] is reported), but velocity and force
can also be examined. To perform the test, participants stand on a platform, with a foot on each
side, as still as possible. After standing still on the platform for at least 2 seconds, participants'
body weight is recorded. Participants should be instructed to perform the jump as quickly and as
high as possible, using both legs after hearing a single-tone beep. Participants should stand up
straight and remain still after landing on the platform for at least 2 seconds until a double-tone
beep indicates the end of the test (Buehring et al., 2010; Veilleux & Rauch, 2010). Participants
can jump freely, without any arm movement restrictions (Figure 4). This procedure is repeated
several times, with the goal to get three countermovement jumps deemed valid by the software.
Participants should be given time to rest and recover between jumps. Depending on the
participant's ability to lift off the platform completely and stand still before and after the jump, it
might not always be possible to record three valid jumps. The jump with the greatest height is
selected for analysis.
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Figure 4. Sequence of A Countermovement Jump. (A) Before the jump, the participant stands in
an upright position on the force platform as still as possible; (B) The participant squats as quickly
as possible before the jump; (C) The participant jumps as high as possible; (D) The participant
begins the smooth landing stage; and (E) The participant stands up straight and as still as
possible.
Serial one- or two-legged jumps (hopping). Although this type of test measures force,
velocity, and power, it is used to assess maximal jump force, which is correlated with bone
strength, bone size, bone strength indices, total bone area, and tibial strength strain index
(Hardcastle et al., 2014; Rantalainen et al., 2009; Runge & Hunter, 2006). Participants are
instructed to hop on one forefoot or both forefeet with their knee almost straight and without
touching the ground with their heel. Participants should hop 10 times. The software detects and
eliminates hops if heels hit the ground; the hop with the highest force is used for analysis
(Veilleux & Rauch, 2010).
Balance assessment/measurement of sway. This test can be used to assess balance,
coordination, and fall-risk assessment in older adults. Participants try to stand as still as possible
in a comfortable upright position with both arms hanging free and a foot on each side of the
platform for a specific period of time (e.g., 10 seconds). Various feet positions and open or
closed eyes, such as used by the Romberg, semi-tandem, and tandem stands, can be chosen to
increase difficulty. Instructions for these foot positions are identical to the ones used in validated
test batteries, such as the short physical performance battery (Guralnik et al., 1994). During these
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tests, the position of the center of pressure (COP) on the platform is recorded. In addition to the
traditional scoring of these balance tests, outcome parameters (e.g., total COP path length [m],
sway area [m2], mean velocity [m/s]) can be measured. These parameters can be used to describe
the direction and extent of postural sway. The smaller the COP path length or sway area, the
better the stability. The velocity (i.e., COP path length divided by trial duration) represents the
amount of activity required to maintain stability; the smaller the COP velocity, the better the
postural control (Treffel et al., 2016).
Safety of Muscle Mechanography
Muscle mechanography has been used in many research studies across various
populations, including young and older adults (Buehring et al., 2015; Dietzel, Felsenberg, &
Armbrecht, 2015; Hardcastle et al., 2014; Matheson et al., 2013; Rittweger et al., 2004; Runge et
al., 2004; Siglinsky et al., 2015; Singh et al., 2014), athletes (including master athletes) (Ireland
et al., 2015; Michaelis et al., 2008), as well as children and adolescents (Binkley & Specker,
2008; Fricke, Weidler, Tutlewski, & Schoenau, 2006; Veilleux & Rauch, 2010). None of these
studies reported pain, falls, or fractures while using muscle mechanography. Furthermore, in the
current authors' unpublished data of more than 300 older adults, all participants were able to
complete most tests on the platform (<5% were not able to perform countermovement jumps).
Mild joint pain was the only complaint, but there were no lasting adverse events.
Buehring et al. (2015) conducted a study to examine the safety of jumping
mechanography (using countermovement jumps) in an older population including individuals
with osteoporosis and prior vertebral fracture. Jumping mechanography was determined to be a
safe and useful method. Self-reported pain did not change after countermovement jumps and no
injuries or new vertebral fractures were sustained, even in individuals with low bone mass
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density and previous vertebral fractures (Buehring et al., 2015). Individuals older than 90 with
moderate control of balance, who were unable to perform the repeated chair-rise test, were able
to complete other tests, including countermovement jumps, without any complaints or adverse
events (Rittweger et al., 2004). Very frail individuals may ask for more assistance to complete
countermovement jumps and some may only be able to perform heel rises. Evidence supports the
safety of muscle mechanography in older adults.
Reproducibility of Muscle Mechanography
The reproducibility of muscle mechanography has been examined in several studies
(Fricke et al., 2006; Matheson et al., 2013; Rittweger et al., 2004; Veilleux & Rauch, 2010).
Buehring et al. (2015) have recently found that jumping mechanography (i.e., using
countermovement jumps) has excellent test–retest reliability compared to other traditional
muscle function tests in 97 adults age 70 and older. Jumping mechanography and grip strength
had the highest intraclass correlation coefficients (ICC) (0.93 and 0.95, respectively), whereas
traditional chair rises and gait speeds had lower ICCs (0.81 and 0.76, respectively).
Other literature supports the finding that jumping mechanography and gait speed perform
better than Timed Up and Go, 10-m gait speed, and chair-rise tests (Rittweger et al., 2004).
Jumping mechanography has good test–retest reliability, with low intra-subject, short-term error
(3.6%); large inter-subject coefficient of variation (45.4%); and a high test–retest correlation
coefficient (r = 0.99) (Rittweger et al., 2004). Good reproducibility results of muscle
mechanography are further supported in samples of children and middle-aged adults (Matheson
et al., 2013; Veilleux & Rauch, 2010). Interrater coefficients of variation were <0.6% for the
two-leg countermovement jumps and intrarater coefficients of variation were <5.3% for all
variables (Matheson et al., 2013). Veilleux and Rauch (2010) reported coefficients of variation
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ranged from 3.4% to 7.5% for multiple one- and two-legged jumps, single two-legged jumps,
and heel-rise tests.
Muscle mechanography is a method that has well-documented reliability, reproducibility,
and promises to be a sensitive test to detect even small functional changes in older adults. In
addition, it has less test variability than other traditional muscle function tests (e.g., gait speed,
chair rise).
Implementing Muscle Mechanography in Nursing Research
Most nursing research studies involve the collection of data through traditional methods,
such as self-reporting or observation tools. Using innovative and advanced methodology in
nursing research is highly recommended (NINR, 2011). A growing body of evidence indicates
that identifying muscle power, with specific attention to the contribution of force and velocity, is
a critical component in the design of intervention strategies aimed at ameliorating muscle
function and physical ability in older adults (Pojednic et al., 2012). Muscle mechanography
provides in-depth knowledge of the individual contributions of force and velocity to muscle
power so interventions can be tailored to optimize the most influential component. Muscle
mechanography can also be used to evaluate the potential of nursing therapeutic interventions in
older adults (Caserotti et al., 2001; Dietzel et al., 2015; Rantalainen et al., 2010; Runge et al.,
2004; Singh et al., 2014; Tsubaki et al., 2016).
The current review highlights potential advantages of muscle mechanography, including
(a) that it is computerized (making it less prone to human error and variation), (b) being able to
report actual physical units of interest for particular tests, (c) assessing a wide range of physical
ability (less ceiling or floor effects), and (d) that it is reproducible and safe in older adults.
Muscle mechanography can assist nursing researchers toward building a comprehensive picture
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of the muscle function in older adults, predicting the onset of physical decline, and identifying
the changes in muscle function parameters potentially more precisely than traditional methods
(Buehring et al., 2015; Fricke et al., 2006; Matheson et al., 2013; Pojednic et al., 2012; Rittweger
et al., 2004; Veilleux & Rauch, 2010). Because of these advantages, muscle mechanography has
the potential to reduce the sample size, duration, and total cost of research studies.
Despite all these advantages, muscle mechanography has some limitations. First,
although the method can be performed by most older adults, some may be unable to perform
some tests due to severe frailty or significant physical impairments. However, even very frail
older adults can perform at least one or two of the available tests. Second, studies are lacking to
determine whether muscle mechanography results can be used to predict outcomes such as
fractures, hospitalizations, and mortality. As researchers become familiar with muscle
mechanography and begin incorporating this technology into more studies, data will be available
to fill gaps in evidence. Muscle mechanography correlates well with measures of maximal force,
such as grip strength and muscle mass, and also traditional muscle tests (Siglinsky et al., 2015).
Many studies show that these muscle function parameters are associated with health outcomes
among older adults. For example, muscle force correlates with bone health in older adults
(Hardcastle et al., 2014; Rantalainen et al., 2009), and muscle power correlates with age
(Buehring et al., 2010; Rantalainen et al., 2010; Runge et al., 2004), fall risk (Caserotti et al.,
2001; Runge & Hunter, 2006; Runge et al., 2004), impaired physical performance and activities
of daily living (Caserotti et al., 2001; Dietzel et al., 2015; Runge et al., 2004; Tsubaki et al.,
2016), and sarcopenia (Siglinsky et al., 2015; Singh et al., 2014). As such, although no direct
evidence exists that muscle mechanography can predict health outcomes, the correlation of
muscle mechanography with traditional muscle function tests suggests that it could. Jumping
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mechanography has already been integrated into prospective studies and outcome results should
be available in the next few years.
Conclusion
Muscle mechanography is an innovative and safe research tool for measuring muscle
function in older adults that offers several advantages to currently used methods. Muscle
mechanography is consistent with the movement toward an increased use of highly innovative
technology to quantitatively measure health status and outcomes. More research is needed to
examine whether muscle mechanography can predict health outcomes such as falls, fractures,
loss of independence, hospitalizations, and mortality.
Chapter Summary
The first manuscript in this chapter introduced the phenomenon of sarcopenia in older
adults. Gaps in knowledge were discussed and recommendations for future studies were
addressed. The second manuscript in this chapter introduced muscle mechanography (MM) as a
novel method that can be used to quantitatively assess muscle function parameters in older
adults. The manuscript covered the mechanism of MM, the different types of tests, the
parameters that can be obtained by using MM, and the measurement procedures. The safety and
reproducibility of MM were also discussed.
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CHAPTER 3
Chapter Introduction
The purpose of this study is threefold: 1) to describe the characteristics of muscle mass,
strength, and function in older adults living in RCACs, 2) to determine, after controlling for pain,
whether there is a difference in muscle mass, strength, and function among RCACs residents
based on self-efficacy for exercise, depression, and social support levels, and 3) examine the
convergent validity of MM with widely used traditional muscle function tests (i.e., SPPB, TUG,
and grip strength). The overall goal of this study is to improve sarcopenia prevention research
and practices, as well as to improve the physical function and delay LTC placement among
RCACs residents.
Method
Research Design
This study is a secondary data analysis using a cross-sectional descriptive correlational
design. The descriptive correlational design is intended to describe the association between the
dependent and independent variables and provide information to generate future hypotheses and
research. Data for this study were collected for a randomized, crossover design study that
explored the effect of semi-recumbent vibration exercise on muscle mass, strength, and function
in older adults. This study only included data collected at baseline prior to the intervention and
control condition participation. Secondary data analysis is feasible as the data collection is
usually time consuming and expensive. Secondary data analysis is also an effective way for new
researchers with limited resources to begin to answer important research questions (Polit, &
Beck, 2012). It is important to acknowledge that the available data set provides a unique access
to vulnerable and understudied population.
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The author of this study was the primary coordinator for the primary study. He was
responsible for all aspects of study conduct such as recruiting, scheduling exercise sessions,
supervising the interventions, and coordinating the assessment visits.
Research Questions and Hypotheses
The research questions that were addressed in this study include:
1) What are the self-efficacy for exercise, depression, and social support of older adults
living in RCACs?
2) What are the muscle mass, strength, and function of older adults living in RCACs?
The hypotheses for this study include:
1) Participants with high self-efficacy for exercise will have greater muscle mass, strength,
and function than those with low self-efficacy for exercise.
2) Participants without depressive symptoms will have greater muscle mass, strength, and
function than those with depressive symptoms.
3) Participants with high social support will have greater muscle mass, strength, and
function than those with low social support
4) Weight corrected jump power obtained by MM correlates well with other traditional
muscle function and strength tests, including SPPB, TUG, and grip strength.
Sample and Setting
The participants of the original study were recruited from one RCAC located in a
Midwestern city that was chosen by convenience. Inclusion criteria for research participants in
the primary study included English-speaking older adults age 70 and older with no significant
cognitive impairment. Participants were able to stand without assistance and free of any major
illness such as end-stage organ disease. Excluded were older adults who could not speak English,
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had any injury or surgery in the last six months that limits ability to move around, or were not
able to stand without assistance. The participants of the original study were recruited through
flyers and community talks in the facility. The study coordinator explained the study to potential
participants and answered their questions and concerns.
A total of 63 residents were solicited for participation in the primary study. Only 31
residents participated in the primary study. The entire sample of 31 participants were included in
this secondary analysis. Many residents decided not to participate in the primary study. The most
common reason residents declined to participate is that their schedule was already very busy and
could not accommodate the exercise sessions. Other reasons include being not interested, having
a deteriorated health status and frequent doctors' appointments, and providing care for an ill
spouse. This study is underpowered, which will be discussed more thoroughly under Data
Analysis Plan and Limitation Sections.
Instruments
This section of the paper provides a description of the tools that were used in the original
study to measure the dependent and independent variables. The baseline measures of these
variables before any intervention was started were use in this secondary analysis.
Dependent variables. The dependent variables measured in the primary study are muscle
mass, muscle strength, and muscle function.
Muscle mass. A bioimpedance spectroscopy (ImpediMed SFB7) device was used to
measure body composition including skeletal muscle mass. The device scans 256 frequencies
between 4 kHz and 1000 kHz. The device utilizes Cole modelling with Hanai mixture theory to
determine total body water (TBW), extracellular fluid (ECF) and intracellular fluid (ICF) from
impedance data. Fat-free mass (FFM) and fat mass (FM) are then calculated on the device
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(Yamada et al., 2013). Skeletal muscle mass (SM) was calculated using the equation developed
by Janssen and colleagues where SM (kg) = [(height2 /R50 × 0.401) + (sex × 3.825) + (age × –
0.071)] + 5.102. Height was measured in centimeters, R50 was measured in ohms between the
right wrist and ankle in a supine position (men = 1 and women = 0), and age was measured in
years (Janssen, Heymsfield, Baumgartner, & Ross, 2000).
Compared to the existing methods for assessing body composition (e.g., magnetic
resonance imaging (MRI), computed tomography (CT), and dual-energy X-ray absorptiometry
[DXA]), BIS is an affordable, noninvasive, easy-to-operate, and portable method for assessing
lean mass in older adults (Yamada et al., 2013). BIS was found to be valid and reliable method to
assess body compositions in young and older adults (Janssen et al., 2000; Sun et al., 2005;
Yamada et al., 2013). Janssen and colleagues reported correlation coefficients between skeletal
muscle mass determined by BIS and skeletal muscle mass measured by MRI exceeding 0.88 and
standard errors of the estimate of 9% in a multiethnic sample of 158 women and 230 men
(Janssen et al., 2000). In another study, body fat estimates by BIA (18.6 +/- 9.2 kg) was not
significantly different from those obtained by DXA (18.2 +/- 7.9 kg). DXA showed a relatively
good agreement with BIA [-0.39 +/- 3.3 (-6.9 to 6.1) kg] in all patients (Sun et al., 2005).
Muscle strength. Muscle strength is related to hand grip strength. The purpose of grip
strength test is to measure the maximum isometric strength of the hand and forearm muscles.
Grip strength was measured using a JAMAR® hand dynamometer, which is the “gold standard”
for the measurement of grip strength (Mathiowetz, 2002). Each participant performed the test
three times using participant’s non-dominant hand and the greatest score was selected for
analysis.
Grip strength test has been widely used among older adults. Low grip strength is
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predictive of limited physical function, disability, longer hospitals stays, and mortality
(Bohannon, 2015). Grip strength is inversely associated with all-cause mortality, cardiovascular
mortality, non-cardiovascular mortality, myocardial infarction, stroke, fall, and fracture (Leong
et al., 2015). Grip strength has an excellent inter-instrument reliability, intraclass correlation
coefficients ranged from 0.90 to 0.97 (Mathiowetz, 2002). Another study examined the test–
retest reliability of grip strength measured using a JAMAR® hand dynamometer over a 12-week
period in older adults (Bohannon & Schaubert, 2005). Test and retest measurements did not
differ significantly over time on either side. Intraclass correlation coefficients were 0.95 and 0.91
for the left and right hands, respectively (Bohannon & Schaubert, 2005).
Muscle function. Muscle function was measured by three tools: SPPB, MM, and TUG.
SPPB. The SPPB test is a feasible, useful, and commonly used tool to assess muscle
function in older adults. SPPB test focuses primarily on lower extremity function and includes
three components: a) a 4 meter walk at a usual pace to measure gait speed, b) one chair rise
followed by 5 timed chair rises if the first is successfully completed, and c) balance stands with
the feel held in different positions for 10 seconds each (Appendix B). The total score is range
from 0 (worst performance) to 12 (best performance). Based on their SPPB scores, individuals
can be classified with mobility limitations (0-9), or without mobility limitations (10-12)
(Bernabeu-Mora et a., 2015; Guralnik, Ferrucci, Simonsick, Salive, & Wallace, 1995).
The SPPB test has been widely used among older adults and is predictive of nursing
home admission and mortality (Guralnik et al., 1994). A study showed that the test has a testretest reliability of 0.87 (CI 95%: 0.77-0.96) in older adults aged 65 to 74 years (Gómez, Curcio,
Alvarado, Zunzunegui, & Guralnik, 2013). Another study demonstrated evidence of validity and
reliability of the SPPB in two very different populations (Freire, Guerra, Alvarado, Guralnik, &
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Zunzunegui, 2012). The validity of the SPPB was demonstrated by the strong and consistent
association with health status measures, in spite of the socioeconomic and cultural differences
between the both groups. There was a graded decrease in mean SPPB scores with increasing
limitation of lower limbs, disability, and poor health. Using the test–retest reliability the authors
evaluated the intraclass correlation coefficient, which was high in both groups: 0.89 (95% CI:
0.83, 0.93) in the first group and 0.83 (95% CI: 0.73, 0.89) in the second group (Freire et al.,
2012).
MM. MM is a tool that provides an objective quantification of the muscle function
parameters of the lower limbs, including muscle power and force (Taani et al., 2017). Several
tests can be performed through MM including the two-leg maximal countermovement jump. The
countermovement jump was used to assess weight corrected jump power among the participants.
This test has good test-retest reliability with low intrasubject short-term error (3.6%), large
intersubject coefficient of variation (45.4%), and a high test-retest correlation coefficient (r=.99)
(Rittweger, et al., 2004).
In a study by Buehring and colleagues, the countermovement jump test had excellent
test–retest reliability compared to other traditional muscle function tests among older adults. The
test had the highest intraclass correlation coefficients (ICC) (0.93), whereas traditional chair rises
and gait speeds had lower ICCs (0.81 and 0.76, respectively) (Buehring et al., 2015). Detailed
description of MM is provided in chapter 2 of this dissertation.
TUG. The TUG test includes the measurement of the time in seconds for an individual to
rise from sitting from an armless chair, walk 3 meters, turn, walk back to the chair, and sit down
(Appendix C). The test is a commonly used measure of functional mobility due to its
requirement of performing multiple tasks such as standing up, walking, turning around 180
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degrees, and sitting down (Podsiadlo & Richardson, 1991). The test is quick and easy to
administer and requires no special equipment.
Although formal normal values are not available, a study found that older adults who
completed the TUG test in less than 20 seconds were independent for basic transfers (e.g., tub
and shower transfers) and ability of going outside alone while older adults who completed the
test in more than 30 seconds tend to be much more dependent (e.g., need help with chair and
toilet transfers, get in and out of the tub or shower) and were not able to go out alone (Podsiadlo
& Richardson, 1991). The TUG test correlates with balance, gait speed, and functional capacity.
The test also has a test-retest reliability of 0.99 (Podsiadlo & Richardson, 1991).
Independent variables. The independent variables measured in the primary study are
self-efficacy for exercise, depression, social support, and pain.
Self-efficacy for exercise. Self-efficacy for exercise scale (SEE) was used to assess
perceived self-efficacy and confidence to participate in exercise (Appendix D). The SEE scale
was particularly designed for older adults and developed from a continuing care retirement
community population (average age 85). The SEE scale is an 9-item scale with a possible range
of scores of 0 to 90. For each item, the individual uses the scale from 0 (Not Confident) to 10
(Very Confident) to describe his/her current confidence that he/she could exercise 3 times a week
for 20 minutes each time (Resnick & Jenkins, 2000). Total score is calculated by summing the
responses to each question. A higher score indicates higher self-efficacy for exercise.
Prior use of the SEE scale in older adults living in a continuing care retirement
community provided evidence of reliability and validity (Resnick & Jenkins, 2000). The scale
demonstrated internal consistency with an alpha coefficient of 0.92 and validity by finding a
significant correlation between scores on the SEE and exercise behavior (r = 0.56, P < .05)
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(Resnick & Jenkins, 2000).
Depression. Depression was measured using the short form of the Geriatric Depression
Scale (GDS) (Appendix E). Although there are many tools available to assess for depression, the
GDS was designed specifically for older adults and its items were developed after careful
consideration of unique characteristics of depression in older adults (Sheikh & Yesavage, 1986).
The scale assesses the symptoms of diminishing interest in activities, diminishing in social
activities, life satisfaction, feeling of worthlessness, cognitive impairment, and suicidality
(Sheikh & Yesavage, 1986). The short form of the GDS is more easily used by physically ill and
mildly to moderately demented patients who have short attention spans and/or feel easily
fatigued. The short form of the GDS is a self-report scale consists of 15 yes/no questions. Each
question is scored as either 0 or 1 points depending upon whether the item is worded positively
or negatively (Sheikh & Yesavage, 1986). Of the 15 items, 10 items indicate the presence of
depression when answered positively, while the rest of the items (1,5,7,11,13) indicate
depression when answered negatively. A score > 5 points is suggestive of depression and a score
≥ 10 points is almost always indicative of depression. The GDS was found to have Crohnbach’s
alpha of 0.94, and a 92% sensitivity and an 89% specificity when evaluated against diagnostic
criteria (Allen & Annells, 2009; Marc, Raue, & Bruce, 2008).
Social support. Social support was measured by the abbreviated version of the Lubben
Social Network Scale (LSNS-6) (Appendix F). The LSNS-6 is a six-item, self-reported scale to
assess social isolation in older adults aged 65 years and older by measuring perceived social
support received by family and friends (Lubben et al., 2006). The LSNS-6 assesses the size,
closeness, and frequency of contacts of a respondent’s social network including both kin/family
and nonrelated individuals. The LSNS-6 consists of two subscales: Family subscale which
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consists of three times that ask about relatives and Friends subscale which consists of three times
that ask about friends. The total scale score is the sum of the six items and ranges from 0 to 30,
where high scores indicate good informal social support. Individuals scoring < 12 indicate a
positive screen for social isolation and should be considered candidates for additional assessment
and referral (Lubben et al., 2006). Participants screening positive on the LSNS-6 are considered
socially isolated. Scores of less than 6 on the three-item LSNS-6 Family subscale are considered
to have marginal family ties and those with scores of less than 6 on the three-item LSNS-6
Friends subscale to have marginal friendship ties.
Low scores have been correlated with physical health problems (Mor-Borak, Miller, &
Syme 1991), all-cause hospitalization (Mistry, Rosansky, McQuire, McDermott, & Jarvik,
2001), depression (Dorfman et al., 1995), lack of adherence to good health practices (Potts,
Hurwicz, Goldstein, & Berkanovic, 1992), and mortality (Ceria et al., 2001). LSNS-6 is a
reliable and valid tool for the measurement of social support. Crohnbach’s alpha for the
subscales ranges from 0.80 to 0.89 (Lubben et al., 2006).
Pain. Pain was assessed by the Numeric Rating Scale (NRS), which is a useful tool to
assess pain in individuals who can point to or state the number that reflects their current pain
level (Appendix G). The NRS is a widely-used scale to assess pain among cognitively intact
young and older adults (Herr, Spratt, Mobily, & Richardson, 2004). The NRS is an 11-point
scale from 0 to 10 (0 = no pain, 1-3 = mild pain, 4-6 = moderate pain, 7-10 = sever pain).
Individuals verbally select a value that is most in line with the intensity of pain that they have
experienced in the last 24 hours.
The NRS has adequate test-retest reliability for a single pair of assessments (one
assessment during week 1, one assessment during week 2) (r = 0.63) and good test-retest
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reliability for ratings on 2 or more days during week 1 compared to 2 or more days during week
2 (r = 0.79 – 0.92) (Jensen & McFarland, 1993). The scale also has excellent interrater reliability
with 100% agreement between two raters and good internal consistency in participants aged 65
to 94 years (Cronbach’s alpha = 0.87) (Herr et al, 2004). The NPR has good sensitivity while
producing data that can be statistically analyzed (Williamson & Hoggar, 2005)
Other variables. Additional variables were measured to describe the sample, including
age, sex, and body mass index (BMI). Weight (in kilograms) and height (in centimeters) were
measured. BMI was calculated by using the formula, weight in kilograms divided by the square
of the height in meters. To assess the number of falls in the last year and the number of fractures
after age 50, the following questions were used: “How many times have you fallen in the last
year?” and “Have you ever broken a bone over age 50? If yes, how many times?”
Research Procedures
This section describes the data collection procedures conducted in the primary study. All
potential subjects were scheduled for a screening visit to collect information about eligibility. An
appointment was made to do the assessment session at the facility. Three subjects did not meet
the eligible criteria. One subject had a recent hip surgery, one subject had a back surgery, and
one subject had a severe end organ disease. All the collected information from these three
subjects who did not meet the inclusion criteria to participate was destroyed. Participants were
provided with a reminder call within 24 hours of the scheduled data collection session. In the
data collection session, the study questionnaires (SEE, GDS, LSNS, and NRS) were
administered and MM, BIS, SPPB, TUG, and grip strength tests were performed. The purpose of
each tool was explained to the participant.
Two strategies were used to reduce participant burden and potentially limit missing data:
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1) the data collectors administered the tools by interview; and 2) the participants were asked if
they are fatigued and want to finish the questionnaires or muscle function tests after a break. In
addition, participants were familiarized and instructed on the correct method to perform the
muscle function tests. All tests were demonstrated by the data collectors before the participants
performed any of the tests. Two data collectors were presented during performance of all muscle
function tests and all participants wore a gait belt to enhance safety. Testing was done in a
private and quiet location at the facility. The research team met regularly to assure that all
recruitment, consent, and data collection and measurement procedures were met.
Data Analysis Plan
After gaining access to the de-identified data, all data were entered into a password
protected database. Cases with missing data were included in the analysis where they had
complete data. Statistical analysis was performed using Statistical Package for Social Sciences
software (version 21, SPSS, Inc, Chicago, IL, USA). The study is underpowered due to the small
sample size. Therefore, descriptive analysis is reported. The descriptive results provide new
information about a vulnerable and difficult to access population. The findings provided
information regarding effect sizes between the independent and dependent variables. Inferential
analyses were performed with acknowledgement of the potential for Type II error. The data
analysis plan is documented in Appendix I.
Descriptive statistics of frequencies, means, standard deviations and ranges were used to
describe the sample and answer questions 1 and 2 (Appendix I). Assumptions for statistical tests
were examined. The distributions of all continuous variables were examined for skewness and
the skewness calculations showed no skewness. The correlation coefficient values between pain
and the dependent variables (i.e., muscle mass, strength, and function) indicated that pain was
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not a significant factor. After eliminating the covariate (pain), multiple t-tests were carried out to
answer the first three hypotheses (1, 2, and 3). T-test was used to determine the association
between the independent variables (i.e., self-efficacy for exercise, depression, and social support)
and dependent variables (i.e., muscle mass, strength, and function). Pearson's product moment
correlation coefficient values between traditional muscle function tests (i.e., gait speed, grip

strength, chair rise, SPPB, and TUG) and muscle power were reported to describe the convergent
validity of MM with other traditional muscle function tests (Hypothesis 4).
Strengths and Limitations
This study has several strengths. First, the results of this study contributed to the body of
knowledge on sarcopenia and its cognitive and psychosocial risk factors among vulnerable and
understudied population. Second, using sophisticated equipment to measure the outcome
variables provided precise measurements of muscle mass, strength, and function. Third, the study
allowed to examine the convergent validity of MM with widely used traditional muscle function
tests. However, this study has several limitations. A descriptive, correlational design is limited in
the results that can be reported and causality cannot be inferred. Only strength of relationships
between variables was reported. The small sample size was another limitation, which limits
generalizability. This is due to the fact that this analysis was secondary in nature and the sample
size was predetermined. However, the results were used to gain more information on effect sizes
between the independent and dependent variables. The small sample size and inferential analyses
planned may lead to a Type II error. Moreover, the original study recruited participants from one
facility as well as individuals with end-stage organ disease, cognitive impairment, recent injury
or surgery that limits ability to move around, and who were unable to stand without assistance
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were excluded. These limitations produce a homogenous sample and limit generalizability to a
broader population. Thus, findings will need to be viewed with caution.
Measurement error can be a significant threat to the internal validity of this study. The
SPPB and TUG tests have limitations including that older adults who have very low functional
ability may not be able to perform these tests. Other limitations of these tests include
dichotomous (yes/no) determinations and being prone to human errors as the final results depend
on the times taken by individual examiners. Although BIA is inexpensive, noninvasive, and well
correlate with MRI and DXA predictions, the use of BIA to assess muscle mass presents a
drawback because the dehydration problem that can be observed in older adults. Dehydration
causes an increase in the body's electrical resistance, which may result in an underestimation of
fat-free mass and an overestimation of body fat. A significant limitation in this study was that all
the potential confounding variables could not be controlled for, which may affect the results.
Finally, although self-efficacy, depression, and social support were measured using validated
scoring systems, the scores may not be robust due to only one time measurement. Future
longitudinal studies, including large-scale cohort studies, and repeated measures are necessary
and would improve accuracy by providing more robust findings.
Chapter Summary
The goal of this cross-sectional descriptive correlation study was to fill the gaps that
currently exist in the literature about the relationship between self-efficacy for exercise,
depression, and social support and sarcopenia in older adults. The study also examined the
convergent validity of MM with widely used traditional muscle function tests (i.e., SPPB, TUG,
and grip strength). This chapter provided an overview of the sample, procedures used in the
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primary study for data collection, and the instruments and data analysis methods used in this
study. Finally, this chapter discussed the limitations of this study.
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CHAPTER 4
Chapter Introduction
In this chapter the study design, setting, and sample are described. The measurement
methods and statistical analysis procedures used are described, and the study results are
discussed. Characteristics of self-efficacy for exercise, depression, social support, muscle
outcomes including muscle mass, strength, and function are reported and discussed. The findings
on the associations between these variables, as well as the convergent validity of MM are
discussed. Finally, limitations and potential implication of the study findings are addressed.
Introduction
Sarcopenia is a geriatric syndrome characterized by a reduction in muscle mass, strength,
and function in older adults (Cruz-Jentoft et al., 2010). This reduction leads to negative outcomes
including reduced mobility and independence, falls, and fractures (Bruyère et al., 2016).
Sarcopenia also increases usage of long-term care facilities and nursing homes, hospitalization,
morbidity, and mortality, which places a burden on individual, family, and healthcare system
(Bruyère et al., 2016; Clark & Manini, 2010; Hirani et al., 2015; Janssen, 2010). Estimates
indicate that sarcopenia costs the U.S. healthcare system around $18.5 billion annually (Janssen,
et al., 2004).
The etiology of sarcopenia is multifactorial, consisting of hormonal changes, endocrine
issues, protein synthesis, proteolysis, inflammatory processes, physical inactivity and
malnutrition (Fielding et al., 2011; Henwood et al., 2014). While these mechanisms and their
role on the onset and progression of sarcopenia are well understood, other factors including
cognitive and psychosocial factors are poorly understood. For example, physical activity and
exercise have shown promises in preventing sarcopenia and improving physical function (Cruz-
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Jentoft et al., 2014; Kamel, 2003; Morley, 2012). People who are physically inactive or lead a
sedentary lifestyle are less likely to stimulate the muscle regeneration process, making them
more susceptible to developing sarcopenia (Gianoudis et al., 2014; Morley, 2012). Only 51.1%
and 21.9% of older adults meet the recommended aerobic and resistance-training guidelines,
respectively (Brady & Straight, 2014). It is crucial to explore which factors might underlie any
effects of physical activity and exercise on physical function and muscle outcomes. Self-efficacy
is a major predictor of physical activity and exercise among older adults as it can enhance or
impede the motivation to exercise and be active (Goisser et al., 2015; McAuley et al., 2011).
However, the influence of self-efficacy is one of the major aspect that is rarely addressed so far
in sarcopenia research (Brady et al., 2014; Goisser et al., 2015), and yet no studies have been
conducted to addressed the association between self-efficacy and sarcopenia.
Sarcopenia and depression seem to share several common risk factors, such as physical
inactivity, malnutrition, hormonal dysregulation, and upregulation of inflammatory markers such
as cytokines (Bauer et al., 2013; Beaudart et al., 2014; Cruz-Jenoft et al., 2010; Fiske et al.,
2009; Morley et al., 2010; Muir & Montero-Odasso, 2011). However, recent studies showed
inconsistent results about the association between sarcopenia and depression. Hsu and colleagues
found that sarcopenia was associated with depressive symptoms (Hsu et al., 2014), whereas
Byeon and colleagues reported no association between depression and sarcopenia among older
adults (Byeon et al., 2016). Social support and sarcopenia also appear to share common risk
factors. Social support impacts the relationship between self-efficacy and self-management
behaviors and predicts the physical health in older adults (Gallant, 2003). While older adults who
have strong social support are less likely to lead inactive lifestyles and be depressed, individuals
with poor social support are prone to be isolated, depressed, and inactive (Wallace et al., 2015;
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Yeom et al., 2008). These outcomes negatively impact the physical function in older adults.
More research is needed to further examine the association between social support and
sarcopenia. A greater understanding of the factors contributing to sarcopenia is crucial to prevent
sarcopenia and design intervention to decrease its potential consequences.
In addition, it is suggested that the lack of appropriate assessment and treatment is a
critical factor for increased physical impairments (Giuliani et al., 2008; Roberts et al., 2013).
Many traditional methodologies exist to assess muscle function; however, all have important
limitations. These limitations include yes/no determinations (e.g., balance test) and floor effect
(e.g., chair rise test has). The traditional tests are also prone to tester subjectivity as the results
depend on the time taken by individual examiners (e.g. SPPB, gait speed, TUG) (Buehring et al.,
2010; Taani et al., 2017). Thus, performing more sophisticated assessment of muscle function is
needed to identify limitations, understand the predictive value of specific impairments, and target
intervention modalities (Giuliani et al., 2008; Guralnik et al., 1994; Taani et al., 2017).
Muscle Mechanography (MM) is a promising tool for assessing muscle function and
obtaining benchmarks for functional data (Taani et al., 2017). MM provides an objective
quantification of muscle function parameters including muscle power and force by using
maximal countermovement jumps, serial hopping, or heel raises performed on a ground reaction
force platform. However, data comparing MM with traditional muscle function tests is limited
and further research is needed to validate MM with other commonly used muscle function tests
(Buehring et al., 2015; Rittweger et al., 2004; Siglinsky et al., 2015).
This study aimed to describe the self-efficacy for exercise, depression, and social support
of the participants as well as their muscle characteristics including muscle mass, strength, and
function. In addition, four hypotheses were tested:
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1) Participants with high self-efficacy for exercise will have greater muscle mass, strength,
and function than those with low self-efficacy for exercise.
2) Participants without depressive symptoms will have greater muscle mass, strength, and
function than those with depressive symptoms.
3) Participants with high social support will have greater muscle mass, strength, and
function than those with low social support.
4) Weight corrected jump power obtained by MM correlates well with other traditional
muscle function and strength tests, including SPPB, TUG, and grip strength.
Methods
Study Design
This is a secondary data analysis using data collected for a randomized crossover design
study to investigate the effectiveness of semi-recumbent vibration exercise on muscle mass,
strength, and function in older adults. The study consisted of several visits; screening and
baseline visit followed by eight weeks of training three times a week, visit at eight weeks
followed by four weeks of washout, visit at 12 weeks followed by eight weeks of training three
times a week, and a final visit at 20 weeks. Each participant signed an IRB-approved, protocolspecific informed consent in accordance with the IRB of University of Wisconsin Madison.
At the screening visit, participants were asked information about their medical history
including fractures and falls within the last 12 months. At the baseline visit several
questionnaires were obtained and participants then were proceeded with muscle function tests
(SPPB, grip strength, TUG, and MM). Participants were then randomized into one of two
groups, the first group received vibration treatment for the first eight weeks and the second group
received sham treatment. After eight weeks both groups have gone through a 4-week wash-out
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period and then crossover occurred. The participants were trained for 10 minutes, three times a
week, during the active 16 total weeks.
Study Sample
In the primary study, 31 older adults were recruited from a Residential Care Apartment
Complex (RACA) located in the Midwestern United States. Study eligibility requirements
included English-speaking older adults age 70 and older with no significant cognitive
impairment. Participants were able to stand without assistance and free of any major illness such
as end-stage organ disease. Excluded were older adults who could not speak English, those had
any injury or surgery in the last six months that limits ability to move around, or those who were
not able to stand without assistance. The entire sample of 31 participants were included in this
secondary analysis and only baseline data collected from the participants were used.
Measures
Demographic data were obtained such as age, sex, and BMI. Weight (in kilograms) and
height (in centimeters) were measured. The formula used to calculate BMI is weight (Kg)/height
(cm2) (Jensen et al., 2013). To assess the number of falls and the number of fractures after age
50, the following questions were used: “How many times have you fallen in the last year?” and
“Have you ever broken a bone over age 50? If yes, how many times?”
Self-efficacy for exercise. The Self-Efficacy for Exercise Scale (SEE) was used to assess
participants' confidence in their ability to continue exercising despite barriers to exercise
(Resnick & Jenkins, 2000). The SEE scale is an 9-item scale with a possible range of scores of 0
to 90. The score of each item ranges from 0 (“not confident”) to 10 (“very confident”), with
lower values indicating lower self-efficacy. The reliability, validity, and internal consistency
(Cronbach α = 0.92) of the scale have been established (Resnick & Jenkins, 2000).
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Depression. The short form of the Geriatric Depression Scale (GDS-15) was used to
measure the depressive symptoms (Sheikh & Yesavage, 1986). The GDS-15 includes 15 yes/no
questions with one point for each depressive symptom. The total score ranges from 0 to 15, with
15 being most depressed. A cut-off point of > 5 points can be considered as indicating
depression. The scale was found to have Crohnbach’s alpha of 0.94, and a 92% sensitivity and an
89% specificity when evaluated against diagnostic criteria (Allen & Annells, 2009; Marc et al.,
2008).
Social support. The abbreviated version of the Lubben Social Network Scale (LSNS-6)
was used to measure perceived social support received by family and friends (Lubben et al.,
2006). The scale consists of 6 items and it has two subscales: family and friends. The total score
ranges from 0 to 30, higher scores indicating greater social support. Individuals scoring ≤ 11
indicate a positive screen for social isolation and should be considered candidates for additional
assessment and referral (Lubben et al., 2006). Participants screening positive are considered
socially isolated. Crohnbach’s alpha for the subscales ranges from 0.84 to 0.89 (Lubben et al.,
2006).
Pain. The Numeric Rating Scale (NRS) was used to assess the pain level. The NRS is an
11-point scale from 0 to 10 (0 = no pain, 1-3 = mild pain, 4-6 = moderate pain, 7-10 = sever
pain). The scale is a useful tool to assess pain in those who can state the number that reflects
their current pain level and widely-used among older adults (Herr et al., 2004). The NRS has
good test-retest reliability for ratings on 2 or more days during week 1 compared to 2 or more
days during week 2 (r = 0.79 – 0.92) (Jensen & McFarland, 1993). It has also excellent interrater
reliability with 100% agreement between two raters and good internal consistency in participants
aged 65 to 94 years (Cronbach’s alpha = 0.87) (Herr et al, 2004).
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Skeletal muscle mass. A bioimpedance spectroscopy (ImpediMed SFB7) device was
used to measure body composition. The details of BIS have previously been described (Kaysen
et al., 2005; Gudivaka, Schoeller, Spiegel, & Kushner, 1994). Skeletal muscle mass (SM) was
calculated using the equation developed by Janssen and colleagues where SM (kg) = [(height2
/R50 × 0.401) + (sex × 3.825) + (age × –0.071)] + 5.102. Height was measured in centimeters,
R50 was measured in ohms between the right wrist and ankle in a supine position, and age was
measured in years (Janssen et al., 2000). Compared to the existing methods (e.g., MRI and
DXA), BIS is a feasible, noninvasive, and portable tool for assessing body composition (Yamada
et al., 2013).
Muscle strength-hand grip. This was measured using a JAMAR® handgrip
dynamometer, which is the “gold standard” for the measurement of grip strength (Mathiowetz,
2002). Subjects used their dominant hand unless otherwise instructed. Three measurements were
taken and the highest score was recorded.
Muscle function. Muscle function was measured by three tools: SPPB, MM, and TUG.
SPPB test includes measures of standing balance (timing of tandem, semitandem, and side-byside stands), gait speed (4-m walking speed), and ability and the time needed to rise from a chair
five times (Guralnik et al., 1994). Each component has a possible score of 0–4 and the total
SPPB scores ranges from 0–12. Individuals can be classified with low performance (0-6),
intermediate performance (7-9), and high performance (10-12) (Guralnik et al., 2000). TUG test
includes the measurement of the time in seconds for an individual to rise from sitting from an
armless chair, walk three meters, turn and walk back to the chair, and sit down. The test has a
test-retest reliability of 0.99 (Podsiadlo & Richardson, 1991).
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MM provides an objective quantification of muscle function parameters of the lower
limbs, including muscle power (i.e., weight corrected jump power). The details of MM have
previously been described (Taani et al., 2017). Several tests can be performed by MM including
the two-leg maximal countermovement jump. Three jumps were performed on a force plate
(Leonardo, Novotec, Pforzheim, Germany) by each participant and the jump with the greatest
peak power was recorded. This test has good test-retest reliability with low intrasubject shortterm error (3.6%), large intersubject coefficient of variation (45.4%), and a high test-retest
correlation coefficient (r=.99) (Rittweger et al., 2004).
Statistical Analysis
SPSS® version 21 was used for data analysis. Assumptions for statistical tests were
examined. None of the continuous variables were skewed. Descriptive statistics were used to
describe the self-efficacy for exercise, depression, social support, and muscle outcomes including
muscle mass, strength, and function. Pain was tested for possible inclusion as a covariate but was
not significantly related to the dependent variables. T-tests for independent samples were
conducted to determine whether there is a difference in muscle outcomes (i.e., muscle mass,
strength, and function) based on self-efficacy for exercise, depression, and social support
(Hypothesis 1,2, and 3). Self-efficacy for exercise, depression, and social support variables were
grouped by sample mean for self-efficacy and established cut-off points for depression and social
support. Pearson's product moment correlation coefficients were used to examine the association
of muscle function tests (i.e., gait speed, grip strength, chair rise, SPPB, and TUG) with weight
corrected jump power obtained by MM (Hypothesis 4). This study is underpowered as the
sample size was predetermined. The study focused on descriptive analyses, which provided new
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information on a vulnerable and difficult to access population. Inferential analyses were
performed with acknowledgement of the potential for Type II error.
Results
Sample Characteristics
Thirty-one participants were included in the analysis. Participants’ ages ranged from 75
to 99 with a mean of 88 years (SD = 6). Participants were predominately female (n= 21, 71 %),
which is consistent with this population. Participants BMI ranged from 18.86 to 41.99 with a
mean of 27.7 kg/m2 (SD = 5.12). Forty-one percent (n=9) of the sample had an incidence of fall
in the past year. Five subjects reported more than one fall in the past year (16.2%) and 8 subjects
reported only one fall in the past year (25.8%). Twelve subjects reported a broken bone over age
50 years (38.7%). Only one subject reported three broken bones after age 50 years (3.2%), 5
subjects reported two broken bones after age 50 years (16.2%), and 6 subjects reported only one
broken bone after age 50 years (19.4%). These results are displayed in Table 2.
Table 2
Demographic Characteristics of Sample (n = 31)
Characteristic
Age in years
Body mass index (kg/m2)
Characteristic

M
88
27.70

SD
6
5.12

n

%

9
22

29
71

13
18

41.9
58.1

8
5

25.8
16.2

12
19

38.7
61.3

Gender
Male
Female
Fall
Yes
No
Number of falls
1
More than 1
Broken bone
Yes
No
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Range
75-99
18.86-41.99

Number of broken bone
1
6
19.4
2
5
16.2
3
1
3.2
Note: Fall: Incidence of fall in the past year, Number of falls: Number of falls in the past
year, Broken bones: Broken bones after age 50, Number of broken: Number of broken bone
after age 50.

Description of Self-efficacy, Depression, and Social Support
The SEE was used to measure self-efficacy for exercise. The SEE scores ranged from 3
to 89 with a mean of 50 (SD = 26.04). The GDS was used to screen for depression. Based on the
established cut-off points, subjects who scored greater than 5 were classified as depressed and
those who scored less than or equal 5 were classified as not depressed. The GDS scores ranged
from 0 to 13 with a mean of 2.97 (SD = 2.79). Only four (12.9%) individuals were depressed.
The LSNS results were categorized based on the established cut-off points as socially isolated (≤
11) and not socially isolated (> 11). The LSNS scores ranged from 2 to 25 with a mean of 14.71
(SD = 6.98). Ten individuals were categorized as socially isolated (32.3%). These results are
described in Table 3.

Table 3
Description of Self-efficacy, Depression, and Social Support (n = 31)
Classification
SEE
GDS

M
50

SD
26.04

Range
3 to 89

2.97

2.79

0 to 13

Not depressed
Depressed
LSNS

14.71

6.98

n
31

%

27
4

87.1
12.9

2 to 25

Not socially isolated
21
67.7
Socially isolated
10
32.3
Note: SEE: Self-Efficacy for Exercise Scale, GDS: Geriatric Depression Scale-15, LSNS:
Lubben Social Network Scale-6.
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Description of Muscle Mass and Strength
Skeletal muscle mass (SM) was measured using BIS. The mean score of SM was 17.51
kg (SD = 5.28). Muscle strength was measured by the grip strength (GS) test. The mean score of
GS was 14 kg (SD = 5.91) (Table 4). There was a significant difference in the mean score of SM
between men and women. The mean score of SM for men was 22.27 kg (SD = 6.9) and 15.56 kg
for women (SD = 2.84); t(29) = 3.9, p = .001. There was also a significant difference in the mean
score of GS between men (M = 21.78 kg, SD = 4.32) and women (M = 10.82 kg, SD = 2.50);
t(29) = 8.901, p < .001. The results showed that men had greater SM and GS than women (Table
5).
Table 4
Description of Muscle Mass and Strength (n = 31)
Classification
SM

M
17.51

SD
5.28

GS

14.00

5.91

Note: SM: Total Skeletal Muscle Mass (kg), GS: Grip
Strength (kg).

Table 5
Differences in Muscle Mass and Strength Based on Gender (n = 31)
Male
M
22.27
21.78

Female
M
SD
15.56
2.84
10.82
2.5

SD
6.9
4.32

SM
GS
*p< .05
Note: SM: Total Skeletal Muscle Mass (kg), GS: Grip Strength (kg).

t
3.9*
8.901*

p
=.001*
<.001*

Description of Muscle Function
Gait speed, repeated chair rise, SPPB, TUG and weight corrected jump power were used
to assess muscle function. Mean score of 4-m gait speed was 0.65 m/s (SD = 0.18), repeated
chair rise was 17.28 s (SD = 5.83), SPPB was 6.35 (SD = 2.69), TUG was 18.31 s (SD = 7.58),
74

and weight corrected jump power was 8.56 W/kg (SD = 5.51). Based on the established cut-off
points for gait speed by the European Working Group on Sarcopenia in Older People
(EWGSOP) (Cruz-Jentoft et al., 2010); 24 (77.4%) individuals had slow gait speed. Based on the
established cut-off points for SPPB (Guralnik et al., 2000), 18 (58.1%) individuals had low SPPB
performance and 8 (25.8%) had intermediate SPPB performance. Only 5 (16.1%) individuals had
high performance. The results are detailed in Table 6.
Men generated significantly higher weight corrected jump power than women. The mean
score of weight corrected jump power for men was 12.06 w/kg (SD = 5.97) and 7.29 w/kg for
women (SD = 4.87); t(28) = 2.234, p = .034. Men had numerically higher mean measurements
than women for gait speed 0.67 (SD = 0.18) vs. 0.65 (SD = 0.18) m/s. Men also performed better
than women on repeated chair rise 15.5 (SD = 6.43) vs. 17.9 (SD = 5.69) s and TUG 15.82 (SD =
5.95) vs. 19.21 (SD = 8.01) s. Women had greater mean of SPPB score 6.36 (SD = 2.48) than
men 6.33 (SD = 3.32). However, these differences were not statistically significant (Table 7).
Table 6
Description of Muscle Function
Classification
Chair rise
TUG

M
17.28
18.31

SD
5.83
7.58

n
24
31

Weight corrected jump power

8.56

5.51

30

%

Gait speed
0.65
0.18
31
≤ 0.8 m/s
24
77.4
> 0.8 m/s
7
22.6
SPPB
6.35
2.69
31
0-6
18
58.1
7-9
8
25.8
10-12
5
16.1
Note: Chair rise and Timed Up and Go (TUG) are measured by second (s), Weight corrected jump
power is measured by Watt/kg, Gait speed is measured by meter/second (m/s), Gait speed score > 0.8
m/s = slow gait speed, Gait speed score ≤ 0.8 m/s = fast gait speed, SPPB: Short Physical Performance
Battery.
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Table 7
Differences in Muscle Function Based on Gender
Males (n=8)
M
SD
0.67
0.18
15.5
6.43
6.33
3.32
15.82
5.95
12.06
5.97

Females (n=22)
M
SD
0.65
0.18
17.9
5.69
6.36
2.48
19.21
8.01
7.29
4.87

t
p
Gait speed
.292
.772
Chair rise**
.868
.395
SPPB
.028
.978
TUG
1.089
.286
Weight corrected jump
2.234
.034*
power***
*p< .05, **n=24, ***n=30
Note: Gait speed is measured by meter/second (m/s), Chair rise and Timed Up and Go (TUG) are
measured by second (s), SPPB: Short Physical Performance Battery, Weight corrected jump power is
measured by Watt/kg.

Relationship Between Muscle Outcomes and Self-Efficacy, Depression, and Social Support
Self-efficacy for exercise, depression, and social support were dichotomized. Groups
were created for self-efficacy based on the mean score. Depression and social support were
grouped based on the established cut-off points (Allen & Annells, 2009; Marc et al., 2008;
Lubben et al., 2006). The SM, GS, gait speed, repeated chair rise, SPPB, TUG, and jump power
were examined as continues variables. T-tests were performed to examine the differences in
muscle outcomes (i.e., SM, GS, gait speed, repeated chair rise, SPPB, TUG, jump power) based
on self-efficacy, depression, and social support. No significant differences were found in muscle
outcomes based on self-efficacy (Table 8) and social support (Table 10). There was a significant
difference in chair rise time based on depression (t(22) = 2.597, p = .016). Subjects without
depressive symptoms completed the five repeated chair rises faster than subjects with depressive
symptoms. The mean score for subjects without depressive symptoms was 16.45 (SD = 5.34) and
for subjects with depressive symptoms was 26.45 (SD = 0.47) (Table 9).
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Table 8
Differences in Muscle Outcomes Based on the Self-Efficacy
High self-efficacy
M
SD
18.10
5.13
14.94
5.91
0.69
0.18
15.70
5.88
6.5
2.89
17.35
5.43
9.90
5.87

Low self-efficacy
M
SD
16.87
5.55
13.00
5.94
0.61
0.17
19.49
5.26
5.93
2.49
19.39
9.57
7.22
4.97

t
p
SM
.639
.528
GS
.909
.371
Gait speed
1.303
.203
Chair rise*
1.623
.119
SPPB
.841
.407
TUG
.730
.471
Weight corrected
1.35
.188
jump power**
N=31, *n=24, **n=30
Note: SM: Total Skeletal Muscle Mass (kg), GS: Grip Strength (kg), Gait speed is measured by
meter/second (m/s), Chair rise and Timed Up and Go (TUG) are measured by second (s); SPPB: Short
Physical Performance Battery, Weight corrected jump power power is measured by Watt/kg.
Table 9
Differences in Muscle Outcomes Based on Depressive Symptoms
Not depressed
M
SD
19.22
2.50
14.19
6.00
0.67
0.18
16.45
5.34
6.56
2.79
17.59
7.74
8.86
5.70

Depressed
M
SD
17.25
5.56
12.75
5.91
0.53
0.10
26.45
0.47
5.00
1.41
22.98
4.63
6.61
4.16

t
.689
.447
1.460
2.597
1.082
1.343
.755

p
.496
.658
.155
.016*
.288
.190
.456

SM
GS
Gait speed
Chair rise**
SPPB
TUG
Weight corrected
jump power***
*p< .05, N=31, **n=24, ***n=30
Note: SM: Total Skeletal Muscle Mass (kg), GS: Grip Strength (kg), Gait speed is measured by
meter/second (m/s), Chair rise and Timed Up and Go (TUG) are measured by second (s); SPPB: Short
Physical Performance Battery, Weight corrected jump power is measured by Watt/kg..
Table 10
Differences in Muscle Outcomes Based on Social Support

SM
GS
Gait speed
Chair rise*
SPPB
TUG
Weight corrected
jump power**
N=31, *n=24, **n=30

Not socially isolated
M
SD
18.42
5.20
14.33
6.53
0.7
0.20
16.60
5.44
7.0
2.63
19.00
8.24
9.89
4.30

Socially isolated
M
SD
15.60
5.22
13.30
4.57
0.63
0.17
17.70
6.20
6.05
2.73
16.92
6.18
7.90
6.02
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t
1.415
.449
1.055
.442
.919
.703
1.044

p
.168
.657
.300
.663
.366
.488
.307

Note: SM: Total Skeletal Muscle Mass (kg), GS: Grip Strength (kg), Gait speed is measured by
meter/second (m/s), Chair rise and Timed Up and Go (TUG) are measured by second (s); SPPB: Short
Physical Performance Battery, Weight corrected jump power is measured by Watt/kg.

Graphical Presentation of the Differences
Figure 5 graphically presents the mean scores of muscle mass, strength, and function
based on the dichotomized groups of self-efficacy, depression, and social support. The figure
suggests that there is a trend for subjects with higher self-efficacy scoring better on all
measurements than the subjects with lower self-efficacy (Figure 5-A). There is also a trend for
subjects without depressive symptoms scoring better on all measurements than the subjects with
depressive symptoms. The figure suggests that there is a trend for subjects with strong social
support scoring better on all measurements (except TUG test) than the subjects with weak social
support.

Mean Score

25
20
15
10
5
0

Muscle
Mass (kg)

Grip
Strength
(kg)

Gait Speed SPPB Score
(m/s)*

High self-efficacy

Weight
Corrected
Jump Power
(Watt/kg)

Chair Rise
(s)**

Low self-efficacy

*Gait speed was scaled by a factor of 10 for the graph.
**Lower scores in chair rise and TUG tests indicate better performance.
(A)
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TUG (s)**

Mean Score

30
25
20
15
10
5
0

Muscle
Mass (kg)

Grip
Gait Speed SPPB Score Weight
Strength
(m/s)*
Corrected
(kg)
Jump
Power
(Watt/kg)
Not depressed

Chair Rise TUG (s)**
(s)**

Depressed

*Gait speed was scaled by a factor of 10 for the graph.
**Lower scores in chair rise and TUG tests indicate better performance.

Mean Score

(B)

20
18
16
14
12
10
8
6
4
2
0

Muscle
Mass (kg)

Grip
Strength
(kg)

Gait Speed SPPB Score Weight
(m/s)*
Corrected
Jump
Power
(Watt/kg)
Not isolated

Chair Rise TUG (s)**
(s)**

Isolated

*Gait speed was scaled by a factor of 10 for the graph.
**Lower scores in chair rise and TUG tests indicate better performance.
(C)
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Figure 5. Graphical Presentation of the Differences in Muscle Outcomes Based on the IVs. Selfefficacy (A), Depression (B), and Social support (C).
Convergent Validity of Muscle Mechanography
Convergent validity of MM was evaluated by examining the relationship between weight
corrected jump power and grip strength, gait speed, chair rise, SPPB, and TUG tests. Pearson's
product moment correlation coefficients were significant with each measure demonstrating

convergent validity. Weight corrected jump power was significantly and positively correlated with
GS, gait speed, and SPPB (r = .542, .716, and .777, respectively; p < .01). Weight corrected jump
power was significantly and negatively correlated with chair rise and TUG (r = -.538 and -.638,

respectively; p < .01). The results are detailed in Table 11.
Table 11
Correlation Coefficient Values Between Weight Corrected Jump Power, Muscle Mass, and Traditional
Muscle Function Tests
Measure
1
2
3
4
5
6
n
1. SM
31
2. GS
.562**
31
3. Gait speed
.056
.172
31
4. Chair rise
-.113
-.213
-.652**
24
5. SPPB
-.123
.115
.787**
-.726**
31
6. TUG
-.106
-.403*
-.728**
.606**
-.633**
31
7. Weight corrected jump
.262
.542**
.716**
-.538**
.777**
-.638**
30
power
*p< .05, ** p<.01
Note: SM: Total Skeletal Muscle Mass (kg), GS: Grip Strength (kg), Gait speed is measured by
meter/second (m/s), Chair rise is measured by second (s), SPPB: Short Physical Performance Battery,
TUG: Timed Up and Go and is measured by second (s), Weight corrected jump power is measured by
Watt/kg.

Additional Findings
Description of Muscle Strength Based on EWGSOP
Participants were grouped into high and low grip strength based on the cut-off points
established by the EWGSOP; the cut-off point for men is < 30 kg and for women < 20 kg (Cruz-
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Jentoft et al., 2010). Eighty-nine percent of men (n=8) had low GS and only one man (11%) had
high GS. All of the women (100%) had low GS (Table 12).
Table 12
Description of Muscle Strength (n = 31)
n
Measure
GS
Male
<30 kg
≥30 kg
Female
<20 kg
≥20 kg

%

31
8
1

89
11

22
0

100
0

M

SD

14
21.78

5.91
4.32

10.82

2.5

Note: GS: Grip Strength (kg).

Differences in Muscle Mass, Strength, and Function Based on the Incidence of Fall

An independent-samples t-test was conducted to compare mean scores of SM, GS, gait
speed, chair rise, SPPB, TUG, and weight corrected jump power between individuals who had an
incidence of fall in the past year and those who did not had an incidence of fall. A significant
difference in the mean score of GS between individuals who did not had an incidence of fall (M
= 15.67 kg, SD = 6.57) and individuals who had an incidence of fall (M = 11.7 kg, SD = 4.03);
t(29) = 2.081, p = .047. The results are detailed in Table 13.
Table 13
Differences in Fall Incidence Based on Muscle Mass, Strength, and Function
_____Falls___
M
SD
16.47
4.79
11.7
4.03
0.67
0.23
15.52
5.90
6.92
2.84
19.1
10.02
7.64
5.09

___No Falls___
M
SD
18.25
5.63
15.67
6.57
5.94
2.6
18.53
5.65
5.94
2.58
17.69
5.28
9.27
5.87

SM
GS
Gait speed
Chair rise**
SPPB
TUG
Weight corrected jump
power***
*p< .05, N = 31, **n=24, n=30***
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t
0.925
2.081
0.34
1.263
0.999
0.499
0.793

p
.363
.047*
.738
.225
.326
.622
.434

Note: SM: Total Skeletal Muscle Mass (kg), GS: Grip Strength (kg).

Discussion
Little is known about the characteristics of muscle function and the association between
cognitive and psychosocial factors and sarcopenia among older adults, particularly those who
live in RCACs. This study described the muscle outcomes of older adults living in one RCAC
and examined the relationship between self-efficacy for exercise, depression, and social support
and muscle outcomes, including muscle mass, strength, and function. This study showed that the
participants had poor muscle mass, strength, and function. Values of muscle outcomes were
numerically lower in comparison with the values observed in most of other studies (Dietzel,
Gast, Heine, Felsenberg, & Armbrecht, 2013; Tsubaki, Kubo, Kobayashi, Jigami, & Takahashi,
2009; Siglinsky et al., 2015). This is might due to fact that this study included frail and very old
adults. The variability of inclusion and exclusion criteria across studies may also have an
important impact on the findings. For instance, several studies included young individuals and
excluded individuals with walking aids, those were unable to climb a standard staircase or unable
to walk 800 m unaided, and those with any impairment of activities of daily living (Dietzel et al.,
2013; Tsubaki et al., 2009; Siglinsky et al., 2015). Accordingly, it is not surprising that the
included sample had low muscle mass, strength, and function scores as this study represented a
vulnerable and understudied population.
A sex difference exists for muscle mass, grip strength, and Weight corrected jump power.
Consistent with previously published values among community-dwelling older adults (Janssen,
Heymsfield, Wang, & Ross, 2000; Yorke, Curtis, Shoemaker, & Vangsnes, 2015), men
demonstrated significantly higher mean skeletal muscle mass and hand grip strength than
women. Similar to previous study, the results also showed that men had significantly greater

82

weight corrected jump power compared to women (Siglinsky et al., 2015). Although men
performed slightly better than women on gait speed, chair rise, and TUG tests, women had
slightly higher SPPB score than men. However, these differences were not statistically
significant. These results are parallel to the available conflicting data regarding sex differences
and physical function tests among community-dwelling older adults (Cooper et al., 2011; Fragala
et al., 2012, Siglinsky et al., 2015).
While the study did not demonstrate significant associations between self-efficacy for
exercise and muscle outcomes, the results showed a trend for individuals with high self-efficacy
to have better scores on all muscle mass, strength, and function measurements than those with
low self-efficacy. This trend is similar to results from a previous study that found an association
between self-efficacy and physical function in older adults (Cooper, Huisman, Kuh, & Deeg,
2011). Self-efficacy is a main determinant of exercise and physical activity behaviors (McAuley
et al., 2006), which both are among the most effective interventions to combat sarcopenia and
functional limitations in older adults (Pillard, et al., 2011; Keysor, 2003; Morley, 2012). Despite
the suggested protective effect of physical activity on muscle outcomes, physical activity
behaviors and the practicality of exercise among older adults are remain questionable (Pillard et
al., 2011). This is due to the different characteristics of older adults, including different levels of
self-efficacy and outcome expectations as well as the physical, mental, and environmental
obstacles. These barriers are considered a challenge for researchers and clinicians to help older
adults to engage in or to increase physical activity or exercise (Lee, Arthur, & Avis, 2008).
Addressing these aspects may maximize the effect of physical activity or exercise on muscle
outcomes and prevent the onset or progression of sarcopenia among older adults.
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Depressive symptoms were only significantly associated with poor performance on chair
rise test. Besides, the results showed that individuals without depressive symptoms had greater
muscle mass and strength, higher jump power, and better scores on the muscle function tests.
Few previous studies have examined the association between depression and sarcopenia. Hsu
and colleagues conducted a study among older men living in a retirement community and
reported that older adults with depressive symptoms were significantly lower in muscle mass,
strength, and function and had more physical dependence than those without depressive
symptoms (Hsu et al., 2014). Kim and colleagues found similar results and reported a lower
skeletal muscle mass in participants with depressive symptoms (Kim et al., 2011). Nevertheless,
the latest report from Byeon and colleagues did not identify an association between depressive
symptoms and muscle mass, strength, and function (Byeon et al., 2016). Although the
association between sarcopenia and depression appeared inconsistent from the data of the latest
observational studies, the findings of this study added to the growing evidence that depression
can be a risk factor for sarcopenia.
This study did not find significant associations between social support and muscle mass,
strength, and function. However, the findings showed that individuals with strong social support
system had greater muscle mass and strength and performed better on the muscle function tests
(except for TUG test) than those who were classified as socially isolated. These findings are
congruent with previous study that found a significant association between poor social support
and low grip strength (Lamarca et al., 2013), which is a major component of sarcopenia (Fielding
et al., 2011). Research indicated that strong social support is a protective factor in physical
function incapacity, as well as it impacts the level of physical activity and physical health in
older adults (Golden, Conroy, & Lawlor, 2009; Seeman, & Chen, 2002; Gallant, 2003; Wallace
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et al., 2015; Yeom et al., 2008; Resnick, Orwig, Magaziner, & Wynne, 2002; Molloy, Dixon,
Hamer, & Sniehotta, 2010). These findings suggest that social support may be a countermeasure
against the adverse impact of physical inactivity on muscle outcomes, including muscle mass,
strength, and function.
The study also examined the convergent validity of MM relative to the traditional muscle
function and strength tests (i.e., gait speed, chair rise, SPPB, grip strength). MM can quantitively
measure the muscle function parameters including muscle power. The two-leg countermovement
jump test is the most widely used test to assess muscle power (i.e., weight corrected jump power).
The main findings in this study demonstrated convergent validity across all the included
measures of muscle function and strength in this study. Weight corrected jump power was
significantly and positively correlated with GS, gait speed, and SPPB (r = .542, .716, and .777,
respectively; p < .01). Weight corrected jump power was also significantly and negatively
correlated with chair rise (r = -.538 and -.638, respectively; p < .01).
The findings from this study are congruent with results from previous studies that have
compared weight corrected jump power with traditional muscle function and strength tests
(Rittweger et al., 2004; Siglinsky et al., 2015). Siglinsky and colleagues reported a correlation
between weight corrected jump power and grip strength, as well as between weight corrected jump
power and gait speed, chair rise, and total SPPB score (Siglinsky et al., 2015). Another study

showed high correlation between weight corrected jump power and gait speed, chair rise, and TUG
(Rittweger et al., 2004). However, Rittweger and colleagues reported higher associations than
those found in this study (Rittweger et al., 2004). This might be related to the fact that they
recruited healthy individuals. Overall, these findings are consistent with the results from this
study that weight corrected jump power correlates with traditional muscle function tests.
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Previous research revealed that weight corrected jump power was best correlated with age
and it is possible that MM may be superior to traditional tests at quantifying muscle function in
older adults because of its higher correlation with age and good correlation with traditional
muscle function tests and measured lean mass (Siglinsky et al., 2015). These results add to the
clinical validity of MM and could potentially lead to greater sensitivity to change when
monitoring exercise interventions in older adults. MM can be also useful in obtaining precise
measures of muscle function and benchmarks for functional data among older adults.
Limitations
The study has several limitations including study design, sample size and methods.
Causality cannot be inferred when descriptive-correlational study designs are used. A small
convenience sample from one geographic region was utilized for this study so the findings may
not be generalizable. The small sample size and inferential analyses used may have caused
limited statistical power and led to a Type II error. In addition, there was a lack of control for all
potentially confounding variables. Although pain was examined as a confounding variable, many
other potentially confounding variables in this study were not controlled for and therefore the
generalizability is limited and the results should be viewed with caution. Individuals with endstage organ disease, cognitive impairment, recent injury or surgery that limits ability to move
around, and those who were unable to stand without assistance were excluded. This limits
generalizability to a broader population and the findings should be viewed with caution.
Another limitation is the use of muscle function tests (i.e., SPPB, TUG) presents some
drawbacks mainly due to dichotomous (yes/no) determinations and being prone to human errors
as the results depend on the times taken by individual examiners. Furthermore, although BIS is
inexpensive, noninvasive, and well correlate with MRI and DXA predictions, the use of BIS to
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assess muscle mass has a limitation. Due to the common problem of dehydration in older adult
patients, BIS underestimates fat tissue, resulting in artificially high fat-free mass values. In
addition, although self-efficacy, depression, and social support were measured using validated
scoring systems, the results may not be robust since they are limited to only one time
measurement. Finally, the convergent validity of MM was tested in a homogeneous small group
of older adults living in one RCAC and the results must be reviewed with caution.
Implications and Recommendation for Future Research
The findings from this study have important implications for the identification of
sarcopenia and for nursing practice. The findings show that RCACs residents have poor muscle
outcomes, including muscle mass, strength, and function. This vulnerable population should be
the target of assessment and prevention strategies to attenuate the frequently reported declines in
physical function and muscle outcomes. In addition, the study supports the evidence that
sarcopenia is not only related to the ageing processes; there are several modifiable factors that
may be important in the onset and progression of sarcopenia. Findings from the current study
suggest that self-efficacy, depression, and social support may be modifiable factors associated
with poor muscle outcomes. This may emphasize the importance of health promotion earlier in
life and prevention planning to prevent sarcopenia and maintain better muscle mass, strength,
and function.
Physical activity and exercise are among the most beneficial interventions for preventing
sarcopenia and ameliorating muscle outcomes (Bruyère et al., 2016; Cruz-Jentoft et al., 2010;
Pillard et al., 2011). Improving physical activity and exercise behaviors can be achieved through
alleviating depressive symptoms and enhancing self-efficacy and social support (Resnick et al.,
2002). This suggests interventions to improve physical activity and exercise behaviors among
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older adults should incorporate depression management and social support to strengthen selfefficacy and outcome expectations related to physical activity and exercise. Improving
depressive symptoms also minimizes the negative impact of depression on muscle outcomes in
older adults (Pillard et al., 2011; Schaap, Pluijm, Deeg, & Visser, 2006).
Nurses should play a major role in identifying those with poor muscle outcomes and
improving physical activity and exercise behavior by providing frequent expert support and
implementing self-efficacy-based interventions. Nurses should also employ new technology such
as MM to predict the onset of physical function decline and evaluate the potential effect of
nursing therapeutic interventions on muscle outcomes.
Finally, future longitudinal studies with large sample sizes are required to confirm the
association between the studied variables and to examine other potential lifestyle behaviors that
might contribute to sarcopenia and its reversibility. Such studies provide a rationale for the
development and evaluation of effective, feasible, transferable and sustainable interventions
implemented in RCAC settings. Finally, future research is needed to provide evidence about the
validity of MM and its ability to identify small changes in older adults with a wide range of
performance, as well as to examine whether MM is associated with geriatric outcomes such as
sarcopenia, falls, and fractures. Such evidence supports the sensitivity of this methodology to
intervention-induced changes in muscle function and the possibility of using MM in the clinical
and research evaluation of sarcopenia among older adults.
Conclusion
Sarcopenia is major health problem among the aging population worldwide. This study is
only one of a few to evaluate the relationship between selected cognitive and psychosocial
factors and sarcopenia among older adults living in RCACs. The study suggests that RCACs
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have poor muscle mass, strength, and function. The findings support the hypothesis that
depressive symptoms are associated with poor muscle function. The study also shows that the
decline in muscle mass, strength, and function is seen more frequently in individuals with low
self-efficacy level and poor social support. In addition, this study provides a new evidence about
MM as a new technology to quantitively assess muscular function in older adults, potentially
making this a valuable research tool.
Chapter Summary
This chapter reported the design, methods, sample, and setting of the study. The findings
about self-efficacy for exercise, depression, social support, and muscle characteristics of RCACs
residents, as well as the findings on the associations between the variables were presented.
Limitations, implications, and recommendations for future research were discussed. The findings
of this cross-sectional descriptive correlational study filled gaps in knowledge and contributed to
the literature on risk factors for sarcopenia in older adults living in RCACs, and provided
information about MM as a novel method to evaluate muscle function in older adults.
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CHAPTER 5
Chapter Introduction
This chapter is focused on discussing the findings of the study. A discussion of how the
specific findings are consistent with the adapted theoretical framework, and other research
findings are presented. The limitations of the study and implications for nursing practice, health
policy and education are discussed. Recommendations for future research and a concluding
statement are presented.
Synthesis of Findings
Sarcopenia is a geriatric syndrome characterized by a reduction in muscle mass, strength,
and function. This syndrome is highly prevalent and associated with functional decline and loss
of independence in older adults. Understanding the etiology and risk factors of sarcopenia is an
essential step towards the development of new methods for clinical diagnosis, new insights into
the underlying mechanisms, and ultimately to the development of effective interventions for
sarcopenia prevention and management. The findings of this study indicate that older adults
living in RCACs have lower values of muscle mass, strength, and function in comparison with
other values observed in many other studies (Dietzel et al., 2013; Siglinsky et al., 2015; Tsubaki
et al., 2009). This indicates that this group of older adults may be at greater risk for negative
health consequences than community dwelling older adults, such as fall, fractures, and being
placed in more restricted living environment including nursing homes.
Consistent with other literature, findings from this study shows a trend for individuals
with high self-efficacy, without depressive symptoms, and with strong social support to present
greater muscle mass, strength, and function (Hsu et al., 2014; Kim et al., 2011; Lamarca et al.,
2013). While there is no research to date that examines d the association between self-efficacy
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for exercise and sarcopenia, other studies found that self-efficacy is a key predictor for physical
activity and exercise, both of which countermeasure functional decline and poor muscle
outcomes (Keysor, 2003; McAuley et al., 2006; Pillard, et al., 2011). Several studies also
demonstrate relationship between depressive symptoms and social support and muscle outcomes
(Hsu et al., 2014; Kim et al., 2011; Lamarca et al., 2013). These findings highlight the
importance of further exploring the examined factors and addressing them in future interventions
to prevent, maintain, and improve muscle outcomes and functional capacity among older adults,
particularly RCACs residents.
In addition, the development of interventions to mitigate sarcopenia and functional
decline requires sensitive and reproducible testing methodologies. Similar to other studies, the
current study provides new evidence about the validity of MM as a novel method to quantitively
assess muscle function parameters in older adults. MM is found to be safe, valid, and sensitive
method with greater ability to detect small changes in muscle function among older adults in
comparison to the traditional muscle function tests such as gait speed and SPPB (Buehring et al.,
2015; Siglinsky et al., 2015; Taani et al., 2017). Using such technology with good reproducibility
and sensitivity could be useful in assessing for sarcopenia, evaluating the effectiveness of
nursing intervention, and extending the nursing science.
Implications for Nursing Theory
Findings from the study show that older adults without depressive symptoms and with
high self-efficacy and social support have greater muscle mass, strength, and function (although
self-efficacy and social support were not significant). These findings are consistent with the
adapted Individual and Family Self-Management Theory (IFSMT) framework (Ryan & Sawin,
2009) which suggests that context factors (e.g., depression and social support) and the self-
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management process (e.g., self-efficacy) may contribute to better self-management behaviors
(physical activity, exercise, and healthy eating habits), and lead to improved health outcomes
(better muscle mass, strength, and function). The findings from this study suggest that addressing
the examined risk factors could be a helpful intervention for improving muscle outcomes among
older adult living in RCACs.
The IFSMT could be used to provide theory-informed nursing interventions to improve
muscle outcomes and prevent sarcopenia. Individual and family-centered interventions impact
self-management behaviors addressing either the context or the self-management process. While
interventions focused on the contextual factors can reduce risk or foster conditions that support
self-management, interventions aimed at the self-management process can enhance knowledge
and beliefs and increase the use of self-regulation behaviors. The findings from this study
suggest that future research should focus on interventions to improve engaging in physical
activity and exercise programs, managing depression, and developing a strong social network.
These factors may play a role in RCACs residents’ attitudes influencing their healthy behaviors
including physical activity, exercise, and eating habits and ultimately their muscle outcomes.
Incorporating the concepts and assumptions of the IFSMT helped examine potential risk
factors for sarcopenia from a nursing perspective. Nonetheless, the adapted theoretical
framework used to guide this study is not yet comprehensive or final. The author suggests
considering the adapted theoretical framework as a foundation for future nursing research.
Nurses are encouraged to validate the findings of this study and generate empirical evidence on
the relationship between the studied variables utilizing theory-testing approach. Continued use
and testing of the IFSMT could result in expanding nursing knowledge related to selfmanagement in older adults with sarcopenia and functional decline, as well as revealing concepts
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essential to self-management and determining what concepts are applicable for sarcopenia
among older adults.
Implications for Education, Clinical Practice, and Policy
Implications for Nursing Education
Evidence from previous research revealed that providing care for older adults by
healthcare professionals prepared in geriatrics leads to improvements in health outcomes,
including better physical, functional, and psychosocial well-being without an increase in
healthcare costs (Kovner, Mezey, & Harrington, 2002). Such improvement in health outcomes
may also reduce cost. Therefore, increasing the geriatric content in undergraduate nursing
curriculum could be a helpful strategy to raise awareness among nurses about chronic conditions
in older adults and provide quality nursing care for older adults. Geriatric certifications and
education programs should be offered to nurses to provide them with knowledge and skills
required to assess and manage chronic conditions including sarcopenia and functional loss and to
provide the highest quality care possible for their patients. More research is needed to determine
if these educational initiatives actually improve patient outcomes and reduce cost.
The role of the nurse in disease prevention continues to be of utmost importance. Selfmanagement is a crucial aspect to quality living and successful prevention and management of
chronic conditions. The American Association of Colleges of Nursing (AACN) created the
Essentials of Baccalaureate Education for Professional Nursing Practice document to disclose the
important curricular elements and framework for developing the undergraduate nursing
curriculum for the 21st century (AACN, 2008). The document emphasized the importance of
integrating disease prevention and health behavior change theories into nursing courses.
Following these recommendations, nursing courses should be modified regularly to reflect the
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current evidence-based self-management practice. The findings from this study can be used as an
example to educate nursing students about the IFSMT, implications and ramifications of poor
muscle outcomes, possible risk factors for sarcopenia, and how to promote self-management
behaviors among their patients.
Implications for Clinical Practice
Nurses have a broad scope of practice that plays a significant role in improving patients'
knowledge, behavior change, and health outcomes. Nurses are likely to encounter older adults
with sarcopenia and functional decline in hospitals, nursing homes, assisted-living facilities, and
in their own homes. Nurses are expected to develop holistic care plans to prevent sarcopenia and
improve physical function and overall well-being of older adults. However, research shows that
the routine assessment for sarcopenia is lacking and sarcopenia is commonly underdiagnosed and
undertreated (Giuliani et al., 2008; Iolascon et al., 2014; Roberts et al., 2013; Zacker, 2006).
Assessment for sarcopenia and targeting older adults at high risk may be an important
first step to prevent and manage functional decline (Beaudart et al., 2016; Fielding et al., 2011).
Nurses have a significant role in identifying patients who are at risk for sarcopenia and
functional decline, implementing nursing preventive measures, and referring them to specialists
in the field (Hunt, Chapa, Hess, Swanick, & Hovanec, 2014; Zacker, 2006). This study provides
information about risk factors for sarcopenia and encourage nurses to incorporate methods for
screening such as gait speed and grip strength. The Red Flag and SARC-F questionnaires could
also be useful to quickly and easily screen older adults for sarcopenia and functional decline
during a standard health care (Beaudart et al., 2016; Cruz-Jentoft et al., 2014; Fielding et al.,
2011). Integrating sophisticated methods such as MM in the clinical setting may be helpful to
assess muscle function and detect those at risk for sarcopenia.
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Patient-centered interventions such as motivational interviewing and collaborative goal
setting were not examined in this study but may be helpful modalities to improve healthy
behaviors. Motivational interviewing and collaborative goal setting may encourage patients to
determine what changes are necessary - such as engaging in physical activity, improving
nutritional intake, managing depression, and improving social support network - and how they
can be achieved (Britt, Hudson, & Blampied, 2004; Handley et al., 2006). Nurses should also
identify both individual and contextual health risk factors that hinder the capacity of older adults
to promote their health behaviors. In addition, hospitalization leads to sarcopenia among older
adults due to an increased inflammatory burden, malnutrition, and bed rest-related muscle disuse
(Welch, Hassan-Smith, Greig, Lord, & Jackson, 2017). Nurses must take a lead role in
prevention of sarcopenia and functional decline in hospitalized older adults through identifying
patients at risk, mobility assessments, initiating exercises, managing malnutrition, and early
mobilization. These practices may reduce the length of stay, hours needed to provide care, and
adverse outcomes related to poor muscle outcomes and loss of functional capacity.
Implications for Health Policy
Preventing and managing sarcopenia require policy solutions and a wide range of
interrelated programs and actions from both the public and private sectors. Using results from
this study and other research on sarcopenia to raise awareness about risk factors for sarcopenia,
its impact on health and well-being, and the importance of healthy lifestyles is a crucial step to
prevent sarcopenia and ensure good muscle outcomes among older adults. Because the most
effective approach to prevent sarcopenia is to promote physical activity, exercise, and proper
nutrition (Cruz-Jentoft et al., 2010; Morley, 2012; Rom, Kaisari, Aizenbud, & Reznick, 2012),
factors including the self-management behaviors in older adults’ population and the lack of
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resources for exercise programs and appropriate nutrition should be a major concern for policy
makers. Public policy should focus on increasing accessibility to public exercise facilities at little
or no cost; implementing therapeutic foods supplementation solutions to reverse undernutrition;
and providing health promotion and mental health counseling services (Bruyère et al., 2016;
Rom et al., 2012).
Stakeholders from public health authorities, healthcare organizations, academia, research
centers, consumers, and aging associations across the country should begin a national dialogue to
discuss the importance of preventing sarcopenia and functional decline in older adults.
Stakeholders should make an effort to secure funding and resources for future research, as
sarcopenia is still relatively a new area of research. Supporting research in this area is crucial to
better understand the etiology of sarcopenia and functional decline, establish standardized
methodology for clinical assessment, and develop new intervention strategies. Furthermore, new
policies are needed to tackle sarcopenia and functional decline upstream and to shift from
reactive repair to proactive prevention paradigm (Mazières et al., 2017). These policies should
include implementing a comprehensive care model for prevention of sarcopenia and functional
decline in the clinical settings and long-term care facilities and offering interventions that are
multidisciplinary, integrated and goal-oriented at the physical, social, and psychological domains
of functional decline.
Limitations
Several limitations should be considered while interpreting the findings from this study.
A cross-sectional descriptive correlational design was used, and therefore the results cannot be
used to make causal claims among relationships of sarcopenia and the hypothesized associated
factors. The study was focused on a small convenience sample from one RCAC and individuals
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with end-stage organ disease, recent injury or surgery, cognitive impairment, and those who were
unable to stand without assistance were excluded. Therefore, the findings should not be
generalizable to nursing home residents or healthy community-dwelling older adults and should
be viewed with caution. The small sample size and statistical analysis techniques used in this
study may have caused limited statistical power and led to a Type II error
Although pain was examined as a confounding variable, many other potentially
confounding variables including current medical condition, severity of illness, and comorbidities
were not controlled for. Thus, the generalizability is limited and the results should be viewed
with caution. The study also has some measurement limitations. First, using the traditional
muscle function tests (i.e., SPPB, TUG) presents some shortfalls mainly due to dichotomous
(yes/no) determinations and being prone to human errors. Second, the use of BIS for muscle
mass assessment has a limitation due to the dehydration problems usually observed in older
adults, which may result in an underestimation of the fat tissue and an overestimation of fat-free
mass. However, BIA is inexpensive, easy to use, reproducible, and considered as a portable
alternative to DXA and MRI. Third, measuring self-efficacy, depression, and social support is
limited to only one time measurement and future studies could use repeated measures for more
robust findings. Finally, the convergent validity of MM was tested in a homogeneous small
group of older adults living in one RCAC and the results must be interpreted with caution.
Recommendation for Research
Understanding the risk factors for sarcopenia and functional decline in RCACs residents
has implications for future nursing research that could bridge the gap between research-generated
evidence and nursing care. The findings from this study show a trend for individuals with high
self-efficacy, without depressive symptoms, and with strong social support to present greater
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muscle mass, strength, and function. Future longitudinal studies with large sample sizes are
required to confirm the association between the studied variables and to examine other potential
lifestyle behaviors that might contribute to sarcopenia and its reversibility.
While self-management interventions are commonly complex with multiple components,
the feasibility of these interventions should be investigated, particularly among RCACs
residents. Such interventions could improve self-management behaviors and physical function
and prevent sarcopenia in older adults. Testing the effect of variety of exercise programs, such as
group-based exercise and vibration exercise, on physical function and muscle outcomes is also
recommended. Measurement methods such MM can be used to evaluate the effectiveness of
nursing interventions on physical function and muscle outcomes among older adults. Although
the available results from several studies demonstrate the safety, practicality, and validity of
MM; it’s valuable to conduct future research to confirm these findings and to examine whether
MM is associated with geriatric outcomes such as sarcopenia, falls, and fractures.
The recruitment process of the population of older adults, particularly RACAs residents
can be lengthy and exhausting. In the original study, the author collaborated with social workers,
physical therapists, and registered nurses who worked within the facility to recruit the greatest
possible number of subjects and to ensure successful recruitment of the most representative
sample of subjects. Another recommendation is to recruit from multiple facilities to reach the
target sample size and to ensure sample representativeness. In addition, several strategies were
used in the original study to reduce burden on the participants, including administering the
questionnaire by interview, assessing whether the older adult is fatigued and wants to finish the
questionnaires or muscle function tests after a one hour break or on another day. Both strategies
were found to be effective in reducing the burden on the participants.
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Conclusion
Sarcopenia, the decline in muscle mass, strength, and function, is associated with
functional loss and disability among older adults. The findings show that RCACs residents have
poor muscle outcomes, which may affect their everyday functions and make them at high risk for
falls and fractures. The poor muscle outcomes are also seen more often in those with depressive
symptoms and low self-efficacy and social support. These contextual and self-management
process-related factors may have important roles in the development of sarcopenia. The study
also provides evidence about the validity of MM as a tool to quantitively assess muscle function
in older adults. Such tools can also be used in research setting to assess the effect of nursing
intervention on muscle outcomes.
Chapter Summary
The current study revealed that older adults living in RCACs have low muscle outcomes,
and these poor outcomes are more prevalent in individuals with depressive symptoms and with
low-self-efficacy and social support. Nurses has the responsibility to take a lead role in the
prevention of sarcopenia and functional decline in older adults through individual-centered care,
education, and motivation. Nurse educators are also encouraged to improve the quality of
nursing education by integrating geriatric content to meet the health needs of the growing
population of older adults. Moreover, since chronic health conditions are highly prevalent among
older adults such sarcopenia and functional loss, there is a necessity to design and develop
nursing intervention to mitigate sarcopenia and improve physical function in older adults. MM
can be integrated in designing and evaluating specific nursing interventions aimed at improving
physical function and muscle outcomes in older adults. In summary, the results of this study
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necessitate a broader examination of the risk factors for sarcopenia, exploring potential
intervention modalities, and employing sophisticated methods in this area of research.

100

References
Administration on Aging. (2012). A profile of older Americans: 2012. Retrieved from
http://www.aoa.gov/Aging_Statistics/Profile/2012/docs/2012profile.pdf
Alexandre, T., Oliveira Duarte, Y. A., Santos, J. L. F., Wong, R., & Lebrão, M. L. (2014).
Prevalence and associated factors of sarcopenia among elderly in Brazil: Findings from
the SABE study. The Journal of Nutrition, Health & Aging, 18, 284-290.
doi:10.1007/s12603-013-0413-0
Allen, J., & Annells, M. (2009). A literature review of the application of the Geriatric Depression
Scale, Depression Anxiety Stress Scales and Post‐traumatic Stress Disorder Checklist to
community nursing cohorts. Journal of Clinical Nursing, 18, 949-959.
American Association of Colleges of Nursing [AACN] (2008). The Essentials of Baccalaureate
Education for Professional Nursing Practice. Retrieved from
http://www.aacn.nche.edu/education-resources/BaccEssentials08.pdf
Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change.
Psychological Review, 84, 191-215.
Barbat-Artigas, S., Rolland, Y., Cesari, M., Abellan van Kan, G., Vellas, B., & AubertinLeheudre, M. (2013). Clinical Relevance of Different Muscle Strength Indexes and
Functional Impairment in Women Aged 75 Years and Older. Journals of Gerontology
Series A: Biomedical Sciences and Medical Sciences, 68, 811-819.
doi:10.1093/gerona/gls254
Bauer, J., Biolo, G., Cederholm, T., Cesari, M., Cruz-Jentoft, A., Morley, J., . . . Boirie, Y.
(2013). Evidence-based recommendations for optimal dietary protein intake in older

101

people: A position paper from the PROT-AGE Study Group. Journal of the American
Medical Directors Association, 14, 542-559. doi:10.1016/j.jamda.2013.05.021
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R.,
... & Lindeman, R. D. (1998). Epidemiology of sarcopenia among the elderly in New
Mexico. American Journal of Epidemiology, 147, 755-763.
Beaudart, C., Buckinx, F., Rabenda, V., Gillain, S., Cavalier, E., Slomian, J., ... & Bruyère, O.
(2014). The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle
power: A systematic review and meta-analysis of randomized controlled trials. The
Journal of Clinical Endocrinology & Metabolism, 99, 4336-4345. doi:10.1210/jc.20141742
Beaudart, C., McCloskey, E., Bruyère, O., Cesari, M., Rolland, Y., Rizzoli, R., ... & Brandi, M.
L. (2016). Sarcopenia in daily practice: assessment and management. BMC Geriatrics,
16(1), 170. doi:10.1186/s12877-016-0349-4
Bernabeu-Mora, R., Medina-Mirapeix, F., Llamazares-Herrán, E., García-Guillamón, G.,
Giménez-Giménez, L. M., & Sánchez-Nieto, J. M. (2015). The short physical
performance battery is a discriminative tool for identifying patients with COPD at risk of
disability. International Journal of Chronic Obstructive Pulmonary Disease, 10, 2619–
2626. doi:10.2147/COPD.S94377
Berry, S. D., & Miller, R. R. (2008). Falls: Epidemiology, pathophysiology, and relationship to
fracture. Current Osteoporosis Reports, 6, 149-154. doi:10.1007/s11914-008-0026-4
Binkley, T.L. & Specker, B.L. (2008). Muscle-bone relationships in the lower leg of healthy prepubertal females and males. Journal of Musculoskeletal & Neuronal Interactions, 8, 239–
243.

102

Bohannon, R.W. (2015). Muscle strength: Clinical and prognostic value of hand-grip
dynamometry. Current Opinion in Clinical Nutrition and Metabolic Care, 18, 465–470.
doi:10.1097/MCO.0000000000000202
Bohannon, R. W., & Schaubert, K. L. (2005). Test–retest reliability of grip-strength measures
obtained over a 12-week interval from community-dwelling elders. Journal of Hand
Therapy, 18, 426-428. doi:10.1197/j.jht.2005.07.003
Brady, & Straight. (2014). Muscle capacity and physical function in older women: What are the
impacts of resistance training? Journal of Sport and Health Science, 3, 179-188.
doi:10.1016/j.jshs.2014.04.002
Brady, A., Straight, C., & Evans, E. (2014). Body composition, muscle capacity, and physical
function in older adults: An integrated conceptual model. Journal of Aging and Physical
Activity, 22, 441-452. doi:10.1123/japa.2013-0009
Britt, E., Hudson, S. M., & Blampied, N. M. (2004). Motivational interviewing in health settings:
A review. Patient Education and Counseling, 53, 147-155.
Bruyère, O., Beaudart, C., Locquet, M., Buckinx, F., Petermans, J., & Reginster, J. Y. (2016).
Sarcopenia as a public health problem. European Geriatric Medicine, 7, 272-275.
doi:10.1016/j.eurger.2015.12.002
Buehring, B., Krueger, D., & Binkley, N. (2010). Jumping mechanography: A potential tool for
sarcopenia evaluation in older individuals. Journal of Clinical Densitometry, 13, 283291. doi:10.1016/j.jocd.2010.04.002
Buehring, B., Krueger, D., Fidler, E., Gangnon, R., Heiderscheit, B., & Binkley, N. (2015).
Reproducibility of jumping mechanography and traditional measures of physical and

103

muscle function in older adults. Osteoporosis International, 26, 819-825.
doi:10.1007/s00198-014-2983-z
Byeon, C. H., Kang, K. Y., Kang, S. H., Kim, H. K., & Bae, E. J. (2016). Sarcopenia is not
associated with depression in Korean adults: Results from the 2010–2011 Korean
National Health and Nutrition Examination Survey. Korean Journal of Family Medicine,
37, 37-43. doi:10.4082/kjfm.2016.37.1.37
Campbell, T. M., & Vallis, L. A. (2014). Predicting fat-free mass index and sarcopenia in
assisted-living older adults. AGE, 36, 9674. doi:10.1007/s11357-014-9674-8
Castillo, E. M., Goodman-Gruen, D., Kritz-Silverstein, D., Morton, D. J., Wingard, D. L., &
Barrett-Connor, E. (2003). Sarcopenia in elderly men and women: The Rancho Bernardo
study. American Journal of Preventive Medicine, 25, 226-231. doi:10.1016/S07493797(03)00197-1
Cawthon, P.M., Fullman, R.L., Marshall, L., Mackey, D.C., Fink, H.A., Cauley, J.A. & Ensrud,
K.E. (2008). Physical performance and risk of hip fractures in older men. Journal of Bone
and Mineral Research, 23, 1037–1044. doi:10.1359/jbmr.080227
Ceria, C. D., Masaki, K. H., Rodriguez, B. L., Chen, R., Yano, K., & Curb, J. D. (2001). The
relationship of psychosocial factors to total mortality among older Japanese‐American
men: The Honolulu Heart Program. Journal of the American Geriatrics Society, 49, 725731. doi:10.1046/j.1532-5415.2001.49148.x
Cesari, M., Penninx, B. W., Pahor, M., Lauretani, F., Corsi, A. M., Williams, G. R., ... &
Ferrucci, L. (2004). Inflammatory markers and physical performance in older persons:
The InCHIANTI study. The Journals of Gerontology Series A: Biological Sciences and
Medical Sciences, 59(3), M242-M248.

104

Caserotti, P., Aagaard, P., Simonsen, E. & Puggaard, L. (2001). Contraction-specific differences
in maximal muscle power during stretch-shortening cycle movements in elderly males
and females. European Journal of Applied Physiology, 84, 206–212.
doi:10.1007/s004210170006
Chen, S. Y., & Wang, H. H. (2007). The relationship between physical function, knowledge of
disease, social support and self-care behavior in patients with rheumatoid arthritis.
Journal of Nursing Research, 15, 183-192.
Chen, X., & Silverstein, M. (2000). Intergenerational social support and the psychological wellbeing of older parents in China. Research on Aging, 22, 43-65.
doi:10.1177/0164027500221003
Clark, B. C., & Manini, T. M. (2010). Functional consequences of sarcopenia and dynapenia in
the elderly. Current Opinion in Clinical Nutrition and Metabolic Care, 13, 271-276.
doi:10.1097/MCO.0b013e328337819e
Cobb, S. (1976). Social support as a moderator of life stress. Psychosomatic Medicine, 38, 300314.
Cooper, R., Hardy, R., Sayer, A. A., Ben-Shlomo, Y., Birnie, K., Cooper, C., ... & McNeill, G.
(2011). Age and gender differences in physical capability levels from mid-life onwards:
The harmonisation and meta-analysis of data from eight UK cohort studies. PloS one,
6(11), e27899. doi:10.1371/journal.pone.0027899
Cooper, R., Huisman, M., Kuh, D., & Deeg, D. J. (2011). Do positive psychological
characteristics modify the associations of physical performance with functional decline
and institutionalization? Findings from the longitudinal aging study Amsterdam. Journals

105

of Gerontology Series B: Psychological Sciences and Social Sciences, 66(4), 468-477.
doi:10.1093/geronb/gbr049
Cramm, J. M., Hartgerink, J. M., De Vreede, P. L., Bakker, T. J., Steyerberg, E. W.,
Mackenbach, J. P., & Nieboer, A. P. (2012). The relationship between older adults’ selfmanagement abilities, well-being and depression. European Journal of Ageing, 9, 353360. doi:10.1007/s10433-012-0237-5
Cruz-Jentoft, A. J., Landi, F., Schneider, S. M., Zúñiga, C., Arai, H., Boirie, Y., ... & Cederholm,
T. (2014). Prevalence of and interventions for sarcopenia in ageing adults: A systematic
review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age and
Ageing, 43, 748-759. doi:10.1093/ageing/afu115
Cruz-Jentoft, A. J., Landi, F., Topinkova, E., & Michel, J. P. (2010). Understanding sarcopenia
as a geriatric syndrome. Current Opinion in Clinical Nutrition & Metabolic Care, 13, 17. doi:10.1097/MCO.0b013e328333c1c1
Dietzel, R., Felsenberg, D., & Armbrecht, G. (2015). Mechanography performance tests and
their association with sarcopenia, falls and impairment in the activities of daily living: A
pilot cross-sectional study in 293 older adults. Journal of Musculoskeletal & Neuronal
Interactions, 15, 249-256.
Dietzel, R., Gast, U., Heine, T., Felsenberg, D., & Armbrecht, G. (2013). Cross-sectional
assessment of neuromuscular function using mechanography in women and men aged 2085 years. J Musculoskelet Neuronal Interact, 13(3), 312-319.
Dorfman, R. A., Lubben, J. E., Mayer-Oakes, A., Atchison, K., Schweitzer, S. O., De Jong, F. J.,
& Matthias, R. E. (1995). Screening for depression among a well elderly population.
Social Work, 40, 295-304.

106

Ferrucci, L., Guralnik, J. M., Studenski, S., Fried, L. P., Cutler, G. B., & Walston, J. D. (2004).
Designing randomized, controlled trials aimed at preventing or delaying functional
decline and disability in frail, older persons: A consensus report. Journal of the American
Geriatrics Society, 52, 625-634. doi:10.1111/j.1532-5415.2004.52174.x
Fielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., . . . Zamboni,
M. (2011). Sarcopenia: An undiagnosed condition in older adults. Current consensus
definition: Prevalence, etiology, and consequences. International working group on
sarcopenia. Journal of the American Medical Directors Association, 12, 249-256.
doi:10.1016/j.jamda.2011.01.003
Figueiredo, C. P., Domiciano, D. S., Lopes, J. B., Caparbo, V. F., Scazufca, M., Bonfá, E., &
Pereira, R. M. R. (2014). Prevalence of sarcopenia and associated risk factors by two
diagnostic criteria in community-dwelling older men: The São Paulo Ageing & Health
Study (SPAH). Osteoporosis International, 25, 589-596. doi:10.1007/s00198-013-2455-x
Fiske, A., Wetherell, J. L., & Gatz, M. (2009). Depression in older adults. Annual Review of
Clinical Psychology, 5, 363-389. doi:10.1146/annurev.clinpsy.032408.153621
Fragala, M. S., Clark, M. H., Walsh, S. J., Kleppinger, A., Judge, J. O., Kuchel, G. A., & Kenny,
A. M. (2012). Gender differences in anthropometric predictors of physical performance
in older adults. Gender Medicine, 9(6), 445-456. doi:10.1016/j.genm.2012.10.004
Freire, A. N., Guerra, R. O., Alvarado, B., Guralnik, J. M., & Zunzunegui, M. V. (2012).
Validity and reliability of the short physical performance battery in two diverse older
adult populations in Quebec and Brazil. Journal of Aging and Health, 24, 863-878.
doi:10.1177/0898264312438551

107

Fricke, O., Weidler, J., Tutlewski, B. & Schoenau, E. (2006). Mechanography—A new device
for the assessment of muscle function in pediatrics. Pediatric Research, 59, 46–49.
doi:10.1203/01.pdr.0000191580.07644.1c
Gallant, M. P. (2003). The influence of social support on chronic illness self-management: A
review and directions for research. Health Education & Behavior, 30, 170-195.
doi:10.1177/1090198102251030
Gariballa, S., & Alessa, A. (2013). Sarcopenia: Prevalence and prognostic significance in
hospitalized patients. Clinical Nutrition, 32, 772-776. doi:10.1016/j.clnu.2013.01.010
Gianoudis, J., Bailey, C. A., & Daly, R. M. (2014). Associations between sedentary behaviour
and body composition, muscle function and sarcopenia in community-dwelling older
adults. Osteoporosis International, 26, 571-579. doi:10.1007/s00198-014-2895-y
Gibson, K., Day, L., Hill, K. D., Jolley, D., Newstead, S., Cicuttini, F., ... & Flicker, L. (2010).
Screening for pre-clinical disability in different residential settings. BMC Geriatrics, 10,
52. doi:10.1186/1471-2318-10-52
Giuliani, C. A., Gruber-Baldini, A. L., Park, N. S., Schrodt, L. A., Rokoske, F., Sloane, P. D., &
Zimmerman, S. (2008). Physical performance characteristics of assisted living residents
and risk for adverse health outcomes. The Gerontologist, 48, 203-212.
doi:10.1093/geront/48.2.203
Goisser, S., Kemmler, W., Porzel, S., Volkert, D., Sieber, C. C., Bollheimer, L. C., & Freiberger,
E. (2015). Sarcopenic obesity and complex interventions with nutrition and exercise in
community-dwelling older persons–A narrative review. Clinical Interventions in Aging,
10, 1267-1282. doi:10.2147/CIA.S82454

108

Golden, J., Conroy, R. M., & Lawlor, B. A. (2009). Social support network structure in older
people: Underlying dimensions and association with psychological and physical health.
Psychology, Health & Medicine, 14(3), 280-290. doi:10.1080/13548500902730135
Gómez, J. F., Curcio, C. L., Alvarado, B., Zunzunegui, M. V., & Guralnik, J. (2013). Validity
and reliability of the Short Physical Performance Battery (SPPB): A pilot study on
mobility in the Colombian Andes. Colombia Medica, 44(3), 165-171.
Grimby, G., & Saltin, B. (1983). The ageing muscle. Clinical Physiology, 3, 209-218.
doi:10.1111/j.1475-097X.1983.tb00704.x
Gudivaka, R., Schoeller, D., Spiegel, D., & Kushner, R. (1994). Effect of body position,
electrode placement dans time on prediction of total body water by multifrequency
bioelectrical impedance analysis. Age & Nutrition, 5, 111-117.
Guralnik, J. M., Ferrucci, L., Pieper, C. F., Leveille, S. G., Markides, K. S., Ostir, G. V., ... &
Wallace, R. B. (2000). Lower extremity function and subsequent disability consistency
across studies, predictive models, and value of gait speed alone compared with the Short
Physical Performance Battery. The Journals of Gerontology Series A: Biological
Sciences and Medical Sciences, 55(4), M221-M231.
Guralnik, J. M., Ferrucci, L., Simonsick, E. M., Salive, M. E., & Wallace, R. B. (1995). Lowerextremity function in persons over the age of 70 years as a predictor of subsequent
disability. New England Journal of Medicine, 332(9), 556-562.
doi:10.1056/NEJM199503023320902
Guralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., ... &
Wallace, R. B. (1994). A short physical performance battery assessing lower extremity

109

function: Association with self-reported disability and prediction of mortality and nursing
home admission. Journal of Gerontology, 49(2), M85-M94.
Han, P., Kang, L., Guo, Q., Wang, J., Zhang, W., Shen, S., ... & Shi, Z. (2016). Prevalence and
factors associated with sarcopenia in suburb-dwelling older Chinese using the Asian
Working Group for Sarcopenia Definition. The Journals of Gerontology Series A:
Biological Sciences and Medical Sciences, 71, 529-535. doi:10.1093/gerona/glv108
Handley, M., MacGregor, K., Schillinger, D., Sharifi, C., Wong, S., & Bodenheimer, T. (2006).
Using action plans to help primary care patients adopt healthy behaviors: A descriptive
study. Journal of the American Board of Family Medicine, 19, 224-231.
Hardcastle, S.A., Gregson, C.L., Rittweger, J., Crabtree, N., Ward, K. & Tobias, J.H. (2014).
Jump power and force have distinct associations with cortical bone parameters: Findings
from a population enriched by individuals with high bone mass. Journal of Clinical
Endocrinology & Metabolism, 99, 266–275. doi:10.1210/jc.2013-2837
Henwood, T. R., Keogh, J. W., Reid, N., Jordan, W., & Senior, H. E. (2014). Assessing
sarcopenic prevalence and risk factors in residential aged care: Methodology and
feasibility. Journal of Cachexia, Sarcopenia and Muscle, 5, 229-236.
doi:10.1007/s13539-014-0144-z
Herr, K. A., Spratt, K., Mobily, P. R., & Richardson, G. (2004). Pain intensity assessment in
older adults: Use of experimental pain to compare psychometric properties and usability
of selected pain scales with younger adults. The Clinical Journal of Pain, 20, 207-219.
Hirani, V., Blyth, F., Naganathan, V., Le Couteur, D. G., Seibel, M. J., Waite, L. M., ... &
Cumming, R. G. (2015). Sarcopenia is associated with incident disability,
institutionalization, and mortality in community-dwelling older men: The Concord Health

110

and Ageing in Men Project. Journal of the American Medical Directors Association, 16,
607-613. doi:10.1016/j.jamda.2015.02.006
Hsu, Y. H., Liang, C. K., Chou, M. Y., Liao, M. C., Lin, Y. T., Chen, L. K., & Lo, Y. K. (2014).
Association of cognitive impairment, depressive symptoms and sarcopenia among
healthy older men in the veterans retirement community in southern Taiwan: A cross‐
sectional study. Geriatrics & Gerontology International, 14(S1), 102-108.
doi:10.1111/ggi.12221
Hunt, D., Chapa, D., Hess, B., Swanick, K., & Hovanec, A. (2014). The importance of resistance
training in the treatment of sarcopenia. Journal of Nursing Education and Practice, 5(3),
39-43. doi:10.5430/jnep.v5n3p39
Iolascon, G., Di Pietro, G., Gimigliano, F., Mauro, G. L., Moretti, A., Giamattei, M. T., ... &
Brandi, M. L. (2014). Physical exercise and sarcopenia in older people: position paper of
the Italian Society of Orthopaedics and Medicine (OrtoMed). Clinical Cases in Mineral
and Bone Metabolism, 11(3), 215-221.
Ireland, A., Degens, H., Ganse, B., Maden-Wilkinson, T., Wilks, D. & Rittweger, J. (2015).
Greater tibial bone strength in male tennis players than controls in the absence of greater
muscle output. Journal of Orthopaedic Translation, 3, 142–151.
doi:10.1016/j.jot.2015.04.001
Janssen, I. (2010). Evolution of sarcopenia research. Applied Physiology, Nutrition, and
Meabolism, 35, 707-712. doi:10.1139/H10-067
Janssen, I., Heymsfield, S. B., Baumgartner, R. N., & Ross, R. (2000). Estimation of skeletal
muscle mass by bioelectrical impedance analysis. Journal of Applied Physiology, 89(2),
465-471.

111

Janssen, I., Heymsfield, S. B., & Ross, R. (2002). Low relative skeletal muscle mass (sarcopenia)
in older persons is associated with functional impairment and physical disability. Journal
of the American Geriatrics Society, 50, 889-896. doi:10.1046/j.1532-5415.2002.50216.x
Janssen, I., Heymsfield, S. B., Wang, Z., & Ross, R. (2000). Skeletal muscle mass and
distribution in 468 men and women aged 18–88 yr. Journal of Applied Physiology, 89(1),
81-88.
Jensen, M. P., & McFarland, C. A. (1993). Increasing the reliability and validity of pain intensity
measurement in chronic pain patients. Pain, 55, 195-203.
Janssen, I., Shepard, D. S., Katzmarzyk, P. T., & Roubenoff, R. (2004). The healthcare costs of
sarcopenia in the United States. Journal of the American Geriatrics Society, 52, 80-85.
doi:10.1111/j.1532-5415.2004.52014.x
Jensen, M.D., Ryan, D.H., Apovian, C.M, Ard, J.D., Comuzzie, A.G., Donato,K..A, Hu, F.B.,
Hubbard, V.S., Jakicic, J.M., Kushner, R.F., Loria, C.M., Millen, B.E., Nonas, C.A., PiSunyer, F.X., Stevens, J., Stevens, V.J., Wadden, T.A., Wolfe, B.M., & Yanovski, S,Z.
(2013). AHA/ACC/TOS guideline for the management of overweight and obesity in
adults: A report of the American College of Cardiology/American Heart Association
Task Force on Practice Guidelines and The Obesity Society. Circulation, 129, S102–
S138.
Kamel, H. K. (2003). Sarcopenia and aging. Nutrition Reviews, 61, 157-167.
doi:10.1301/nr.2003.may.157-167
Kaysen, G. A., Zhu, F., Sarkar, S., Heymsfield, S. B., Wong, J., Kaitwatcharachai, C., ... &
Levin, N. W. (2005). Estimation of total-body and limb muscle mass in hemodialysis

112

patients by using multifrequency bioimpedance spectroscopy. The American Journal of
Clinical Nutrition, 82, 988-995.
Kerse, N., Butler, M., Robinson, E., & Todd, M. (2004). Fall prevention in residential care: A
cluster, randomized, controlled trial. Journal of the American Geriatrics Society, 52, 524531. doi:10.1111/j.1532-5415.2004.52157.x
Keysor, J. J. (2003). Does late-life physical activity or exercise prevent or minimize
disablement?: A critical review of the scientific evidence. American Journal of
Preventive Medicine, 25(3), 129-136. doi.org/10.1016/S0749-3797(03)00176-4
Kim, H., Kim, S., Eun, C. R., Seo, J. A., Cho, H. J., Kim, S. G., . . . Kim, N. H. (2011).
Depression is associated with sarcopenia, not central obesity, in elderly Korean men.
Journal of the American Geriatrics Society, 59, 2062-2068. doi:10.1111/j.15325415.2011.03664.x
Kovach, C. R. (2013). Assessing pain and unmet need in patients with advanced dementia: The
role of the serial trial intervention (STI). Handbook of Pain and Palliative Care (pp. 131144). New York, NY: Springer.
Kovner, C. T., Mezey, M., & Harrington, C. (2002). Who cares for older adults? Workforce
implications of an aging society. Health Affairs, 21, 78-89. doi:10.1377/hlthaff.21.5.78
Lamarca, F., Kamimura, M., Rodrigues, J., Fetter, R., Bigogno, F., Carrero, J., Avesani,. C.
(2013). Sarcopenia and dynapenia are associated with worse quality of life in elderly HD
patients. Journal of Renal Nutrition, 23(2), 152. doi:10.1053/j.jrn.2013.01.013
Landi, F., Abbatecola, A. M., Provinciali, M., Corsonello, A., Bustacchini, S., Manigrasso, L., ...
& Lattanzio, F. (2010). Moving against frailty: Does physical activity matter?.
Biogerontology, 11, 537-545. doi:10.1007/s10522-010-9296-1

113

Landi, F., Liperoti, R., Fusco, D., Mastropaolo, S., Quattrociocchi, D., Proia, A., ... & Onder, G.
(2012). Prevalence and risk factors of sarcopenia among nursing home older
residents. The Journals of Gerontology Series A: Biological Sciences and Medical
Sciences, 67, 48-55. doi:10.1093/gerona/glr035
Lau, E. M., Lynn, H. S., Woo, J. W., Kwok, T. C., & Melton, L. J. (2005). Prevalence of and risk
factors for sarcopenia in elderly Chinese men and women. The Journals of Gerontology
Series A: Biological Sciences and Medical Sciences, 60, 213-216.
doi:10.1093/gerona/60.2.213
Lee, L. L., Arthur, A., & Avis, M. (2008). Using self-efficacy theory to develop interventions
that help older people overcome psychological barriers to physical activity: A discussion
paper. International Journal of Nursing Studies, 45(11), 1690-1699.
doi:10.1016/j.ijnurstu.2008.02.012
Lee, J. S., Auyeung, T. W., Kwok, T., Lau, E. M., Leung, P. C., & Woo, J. (2007). Associated
factors and health impact of sarcopenia in older Chinese men and women: A crosssectional study. Gerontology, 53, 404-410. doi:10.1159/000107355
Leong, D.P., Teo, K.K., Rangarajan, S., Lopez-Jaramillo, P., Avezum, A. Jr. , Orlandini, A. &
Yusuf, S. (2015). Prognostic value of grip strength: Findings from the Prospective Urban
Rural Epidemiology (PURE) study. The Lancet, 386, 266–273. doi:10.1016/S01406736(14)62000-6
Lubben, J., Blozik, E., Gillmann, G., Iliffe, S., von Renteln Kruse, W., Beck, J. C., & Stuck, A.
E. (2006). Performance of an abbreviated version of the Lubben Social Network Scale
among three European community-dwelling older adult populations. The
Gerontologist, 46, 503-513.

114

Marc, L. G., Raue, P. J., & Bruce, M. L. (2008). Screening performance of the Geriatric
Depression Scale (GDS-15) in a diverse elderly home care population. American Journal
of Geriatric Psychiatry 16, 914-921.
Marek, K., Stetzer, F., Ryan, P., Bub, L., Adams, S., Schidt, A., . . . O’Brien, A.-M. (2013).
Nurse care coordination and technology effects on health status of frail older adults via
enhanced self-management of medication: randomized clinical trial to test efficacy.
Nursing Research, 62, 269-278. doi:10.1097/NNR.0b013e318298aa55
Martins, L. C. A., Bôas, P. F. V., & McLellan, K. P. (2016). Sarcopenia prevalence and
associated factors in elderly people assisted by primary health care, São Paulo, Brazil: A
cross-sectional study sarcopenia prevalence and in elderly. Journal of Aging Research &
Clinical Practice, 5, 162-166. doi:10.14283/jarcp.2016.107
Matheson, L.A., Duffy, S., Maroof, A., Gibbons, R., Duffy, C. & Roth, J. (2013). Intra- and
inter-rater reliability of jumping mechanography muscle function assessments. Journal of
Musculoskeletal & Neuronal Interactions, 13, 480–486.
Mathiowetz, V. (2002). Comparison of Rolyan and Jamar dynamometers for measuring grip
strength. Occupational Therapy International, 9(3), 201-209. doi:10.1002/oti.165
Mazières, C. L., Morley, J. E., Levy, C., Agenes, F., Barbagallo, M., Cesari, M., ... & Izquierdo,
M. (2017). Prevention of functional decline by reframing the role of nursing homes?.
Journal of the American Medical Directors Association, 18(2), 105-110.
doi:10.1016/j.jamda.2016.11.019
McAuley, E., Szabo, A., Gothe, N., & Olson, E. A. (2011). Self-efficacy: Implications for
physical activity, function, and functional limitations in older adults. American Journal of
Lifestyle Medicine, 5, 361-369. doi:10.1177/1559827610392704

115

Michaelis, I., Kwiet, A., Gast, U., Boshof, A., Antvorskov, T., Jung, T. & Felsenberg, D. (2008).
Decline of specific peak jumping power with age in master runners. Journal of
Musculoskeletal & Neuronal Interactions, 8, 64–70.
Mijnarends, D. M., Schols, J. M., Meijers, J. M., Tan, F. E., Verlaan, S., Luiking, Y. C., ... &
Halfens, R. J. (2015). Instruments to assess sarcopenia and physical frailty in older
people living in a community (care) setting: Similarities and discrepancies. Journal of the
American Medical Directors Association, 16, 301-308. doi:10.1016/j.jamda.2014.11.011
Minneci, C., Mello, A., Mossello, E., Baldasseroni, S., Macchi, L., Cipolletti, S., . . . Di Bari, M.
(2015). Comparative study of four physical performance measures as predictors of death,
incident disability, and falls in unselected older persons: The Insufficienza Cardiaca negli
Anziani Residenti a Dicomano Study. Journal of the American Geriatrics Society, 63,
136-141. doi:10.1111/jgs.13195
Mistry, R., Rosansky, J., McGuire, J., McDermott, C., & Jarvik, L. (2001). Social isolation
predicts re‐hospitalization in a group of older American veterans enrolled in the
UPBEAT Program. International Journal of Geriatric Psychiatry, 16, 950-959.
doi:10.1002/gps.447
Molloy, G. J., Dixon, D., Hamer, M., & Sniehotta, F. F. (2010). Social support and regular
physical activity: Does planning mediate this link?. British Journal of Health Psychology,
15(4), 859-870. doi:10.1348/135910710X490406
Montero-Odasso, M., Schapira, M., Soriano, E.R., Varela, M., Kaplan, R., Camera, L.A. &
Mayorga, L.M. (2005). Gait velocity as a single predictor of adverse events in healthy
seniors aged 75 years and older. Journals of Gerontology. Series A, Biological Sciences
and Medical Sciences, 60, 1304–1309. doi:10.1093/gerona/60.10.1304

116

Mor-Barak, M. E., Miller, L. S., & Syme, L. S. (1991). Social networks, life events, and health
of the poor, frail elderly: A longitudinal study of the buffering versus the direct effect.
Family & Community Health, 14(2), 1-13.
Morley, J. E. (2012). Sarcopenia in the elderly. Family Practice, 29(1), i44-i48.
doi:10.1093/fampra/cmr063
Morley, J. E., Anker, S. D., & Haehling, S. (2014). Prevalence, incidence, and clinical impact of
sarcopenia: Facts, numbers, and epidemiology—update 2014. Journal of Cachexia,
Sarcopenia and Muscle, 5(4), 253-259. doi:10.1007/s13539-014-0161-y
Morley, J. E., Argiles, J. M., Evans, W. J., Bhasin, S., Cella, D., Deutz, N. E., ... & KalantarZadeh, K. (2010). Nutritional recommendations for the management of
sarcopenia. Journal of the American Medical Directors Association, 11, 391-396.
doi:10.1016/j.jamda.2010.04.014
Muir, S. W., & Montero‐Odasso, M. (2011). Effect of vitamin D supplementation on muscle
strength, gait and balance in older adults: A systematic review and meta‐analysis. Journal
of the American Geriatrics Society, 59, 2291-2300. doi:10.1111/j.15325415.2011.03733.x
Murphy, R., Ip, E., Zhang, Q., Boudreau, R., Cawthon, P., Newman, A., . . . Harris, T. (2013).
Transition to sarcopenia and determinants of transitions in older adults: A populationbased study. Journals of Gerontology Series A: Biomedical Sciences and Medical
Sciences, 69, 751-758. doi:10.1093/gerona/glt131
National Institute of Nursing Research. (2011). Bringing science to life (NIH Publication No. 117783). Retrieved from https://www.ninr.nih.gov/sites/default/files/ninr-strategic-plan2011.pdf

117

Newman, A. B., Kupelian, V., Visser, M., Simonsick, E., Goodpaster, B., Kritchevsky, S. B., ...
& Harris, T. B. (2006). Strength, but not muscle mass, is associated with mortality in the
health, aging and body composition study cohort. The Journals of Gerontology Series A:
Biological Sciences and Medical Sciences, 61, 72-77. doi:10.1093/gerona/61.1.72
Pagotto, V., & Silveira, E. (2014). Methods, diagnostic criteria, cutoff points, and prevalence of
sarcopenia among older people. The Scientific World Journal, 2014, 1-11.
doi:10.1155/2014/231312
Pillard, F., Laoudj-Chenivesse, D., Carnac, G., Mercier, J., Rami, J., Rivière, D., & Rolland, Y.
(2011). Physical activity and sarcopenia. Clinics in Geriatric Medicine, 27(3), 449-470.
doi:10.1016/j.cger.2011.03.009
Podsiadlo, D., & Richardson, S. (1991). The timed “Up & Go”: A test of basic functional
mobility for frail elderly persons. Journal of the American Geriatrics Society, 39(2), 142148.
Pojednic, R.M., Clark, D.J., Patten, C., Reid, K., Phillips, E.M. & Fielding, R.A. (2012). The
specific contributions of force and velocity to muscle power in older adults. Experimental
Gerontology, 47, 608–613. doi:10.1016/j.exger.2012.05.010
Polit, D.E., & Beck, C.T. (2012). Nursing research: Generating and assessing evidence for
nursing practice (9th Ed.). Philadelphia, PA: Lippincott Williams & Wilkins
Potts, M. K., Hurwicz, M. L., Goldstein, M. S., & Berkanovic, E. (1992). Social support, healthpromotive beliefs, and preventive health behaviors among the elderly. Journal of Applied
Gerontology, 11, 425–441.
Puthoff, M.L. (2008). Outcome measures in cardiopulmonary physical therapy: Short physical
performance battery. Cardiopulmonary Physical Therapy Journal, 19, 17–22.

118

Rantalainen, T., Nikander, R., Heinonen, A., Multanen, J., Häkkinen, A., Jämsä, T. & Sievänen,
H. (2010). Neuromuscular performance and body mass as indices of bone loading in
premenopausal and postmenopausal women. Bone, 46, 964–969.
doi:10.1016/j.bone.2010.01.002
Rantalainen, T., Sievänen, H., Linnamo, V., Hoffrén, M., Ishikawa, M., Kyröläinen, H. &
Heinonen, A. (2009). Bone rigidity to neuromuscular performance ratio in young and
elderly men. Bone, 45, 956–963. doi:10.1016/j.bone.2009.07.014
Resnick, B., & Jenkins, L. (2000). Testing the Reliability and Validity of the Self-Efficacy for
Exercise Scale. Nursing Research, 49, 154–159.
Resnick, B., Orwig, D., Magaziner, J., & Wynne, C. (2002). The effect of social support on
exercise behavior in older adults. Clinical Nursing Research, 11(1), 52-70.
doi:10.1177/105477380201100105
Rittweger, J., Schiessl, H., Felsenberg, D., & Runge, M. (2004). Reproducibility of the jumping
mechanography as a test of mechanical power output in physically competent adult and
elderly subjects. Journal of the American Geriatrics Society, 52, 128-131.
doi:10.1111/j.1532-5415.2004.52022.x
Roberts, H., Syddall, H., Sparkes, J., Ritchie, J., Butchart, J., Kerr, A., . . . Sayer, A. (2013). Grip
strength and its determinants among older people in different healthcare settings. Age and
Ageing, 43, 241-246. doi:10.1093/ageing/aft118
Rom, O., Kaisari, S., Aizenbud, D., & Reznick, A. Z. (2012). Lifestyle and sarcopenia-etiology,
prevention, and treatment. Rambam Maimonides Medical Journal, 3(4), e0024.
doi:10.5041/RMMJ.10091.

119

Roshanaei-Moghaddam, B., Katon, W. J., & Russo, J. (2009). The longitudinal effects of
depression on physical activity. General Hospital Psychiatry, 31(4), 306-315.
doi:10.1016/j.genhosppsych.2009.04.002
Runge, M. & Hunter, G. (2006). Determinants of musculoskeletal frailty and the risk of falls in
old age. Journal of Musculoskeletal and Neuronal Interactions, 6, 167–173.
Runge, M., Rittweger, J., Russo, C.R., Schiessl, H. & Felsenberg, D. (2004). Is muscle power
output a key factor in the age-related decline in physical performance? A comparison of
muscle cross section, chair-rising test and jumping power. Clinical Physiology and
Functional Imaging, 24, 335–340. doi:10.1111/j.1475-097X.2004.00567.x
Ryan, P., Maierle, D., Csuka, M. E., Thomson, A., & Szabo, A. (2013). Computer-based
intervention to enhance self-management of calcium and vitamin D intake in women.
Western Journal of Nursing Research, 35, 986-1010. doi:10.1177/0193945913483369
Ryan, P., & Sawin, K. J. (2009). The individual and family self-management theory: Background
and perspectives on context, process, and outcomes. Nursing Outlook, 57, 217-225.
doi:10.1016/j.outlook.2008.10.004
Ryan, P., & Sawin, K. (2013). The individual and family self-management theory. Retrieved
from http://www4.uwm.edu/nursing/research/self-management.cfm.
Santos, V. R. D., Christofaro, D. G. D., Gomes, I. C., Agostinete, R. R., Freitas Júnior, I. F., &
Gobbo, L. A. (2015). Factors associated with sarcopenia in subjects aged 80 years and
over. Revista de Nutrição, 28, 319-326. doi:10.1590/1415-52732015000300008
Schaap, L. A., Pluijm, S. M., Deeg, D. J., & Visser, M. (2006). Inflammatory markers and loss of
muscle mass (sarcopenia) and strength. The American Journal of Medicine, 119(6),
526.e9–526.e17. doi:10.1016/j.amjmed.2005.10.049

120

Schoene, D., Wu, S. M. S., Mikolaizak, A. S., Menant, J. C., Smith, S. T., Delbaere, K., & Lord,
S. R. (2013). Discriminative ability and predictive validity of the timed Up and Go test in
identifying older people who fall: Systematic review and meta‐analysis. Journal of the
American Geriatrics Society, 61(2), 202-208. doi:10.1111/jgs.12106
Scott, D., Blizzard, L., Fell, J., & Jones, G. (2012). Prospective study of self‐reported pain,
radiographic osteoarthritis, sarcopenia progression, and falls risk in community‐dwelling
older adults. Arthritis Care & Research, 64, 30-37. doi:10.1002/acr.20545
Seeman, T., & Chen, X. (2002). Risk and protective factors for physical functioning in older
adults with and without chronic conditions: MacArthur Studies of Successful Aging. The
Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 57(3),
S135-S144. doi:10.1093/geronb/57.3.S135
Senior, H. E., Henwood, T. R., Beller, E. M., Mitchell, G. K., & Keogh, J. W. (2015). Prevalence
and risk factors of sarcopenia among adults living in nursing homes. Maturitas, 82, 418–
423. doi:10.1016/j.maturitas.2015.08.006
Sheikh, II, Yesavage, J. A. (1986). Geriatric Depression Scale (GDS): Recent evidence and
development of a shorter version. Clinical Gerontologist, 5(1), 165-173.
Siglinsky, E., Krueger, D., Ward, R. E., Caserotti, P., Strotmeyer, E. S., Harris, T. B., ... &
Buehring, B. (2015). Effect of age and sex on jumping mechanography and other
measures of muscle mass and function. Journal of Musculoskeletal & Neuronal
Interactions, 15(4), 301-308.

121

Singh, H., Kim, D., Kim, E., Bemben, M.G., Anderson, M., Seo, D. & Bemben, D.A. (2014).
Jump test performance and sarcopenia status in men and women, 55 to 75 years of
age. Journal of Geriatric Physical Therapy, 37, 76–82.
doi:10.1519/JPT.0b013e3182a51b11
Studenski, S., Perera, S., Patel, K., Rosano, C., Faulkner, K., Inzitari, M. & Guralnik, J. (2011).
Gait speed and survival in older adults. Journal of the American Medical
Association, 305, 50–58. doi:10.1001/jama.2010.1923
Sun, G., French, C. R., Martin, G. R., Younghusband, B., Green, R. C., Xie, Y. G., ... & Zhang,
H. (2005). Comparison of multifrequency bioelectrical impedance analysis with dualenergy X-ray absorptiometry for assessment of percentage body fat in a large, healthy
population. The American Journal of Clinical Nutrition, 81, 74-78.
Taani, M. H., Kovach, C. R., Buehring, B. (2017). Muscle mechanography: A novel method to
measure muscle function in older adults. Research in Gerontological Nursing, 10(1) 1724. doi:10.3928/19404921-20161209-03
Tasar, P. T., Sahin, S., Karaman, E., Ulusoy, M. G., Duman, S., Berdeli, A., & Akcicek, F.
(2015). Prevalence and risk factors of sarcopenia in elderly nursing home residents.
European Geriatric Medicine, 6, 214-219. doi:10.1016/j.eurger.2015.03.002
Treffel, L., Dmitrieva, L., Gauquelin-Koch, G., Custaud, M.A., Blanc, S., Gharib, C. & Millet,
C. (2016). Craniomandibular system and postural balance after 3-day dry
immersion. PLoS One, 11, 1–16. doi:10.1371/journal.pone.0150052
Tsubaki, A., Kubo, M., Kobayashi, R., Jigami, H., Sugawara, K. & Takahashi, H.E. (2016).
Maximum power during vertical jump and isometric knee extension torque alter mobility

122

performance: A cross-sectional study of healthy individuals. Physical Medicine and
Rehabilitation, 8(1), 19–27. doi:10.1016/j.pmrj.2015.04.012
Tsubaki, A., Kubo, M., Kobayashi, R., Jigami, H., & Takahashi, H. E. (2009). Normative values
for maximum power during motor function assessment of jumping among physically
active Japanese. J Musculoskelet Neuronal Interact, 9(4), 263-267.
Veilleux, L. & Rauch, F. (2010). Reproducibility of jumping mechanography in healthy children
and adults. Journal of Musculoskeletal & Neuronal Interactions, 10, 256–266.
Verbrugge, L. M., & Jette, A. M. (1994). The disablement process. Social Science & Medicine,
38(1), 1-14. doi:10.1016/0277-9536(94)90294-1
Volpato, S., Bianchi, L., Cherubini, A., Landi, F., Maggio, M., Savino, E., . . . Ferrucci, L.
(2014). Prevalence and clinical correlates of sarcopenia in community-dwelling older
people: Application of the EWGSOP definition and diagnostic algorithm. Journals of
Gerontology Series A: Biomedical Sciences and Medical Sciences, 69, 438-446.
doi:10.1093/gerona/glt149
Wallace, L. M., Theou, O., Pena, F., Rockwood, K., & Andrew, M. K. (2015). Social
vulnerability as a predictor of mortality and disability: Cross-country differences in the
survey of health, aging, and retirement in Europe (SHARE). Aging Clinical and
Experimental Research, 27, 365-372. doi:10.1007/s40520-014-0271-6
Walston, J., Hadley, E. C., Ferrucci, L., Guralnik, J. M., Newman, A. B., Studenski, S. A., ... &
Fried, L. P. (2006). Research agenda for frailty in older adults: Toward a better
understanding of physiology and etiology: Summary from the American Geriatrics
Society/National Institute on Aging Research Conference on Frailty in Older Adults.
Journal of the American Geriatrics Society, 54, 991-1001.

123

Warren, M., Ganley, K. J., & Pohl, P. S. (2016). The association between social participation and
lower extremity muscle strength, balance, and gait speed in US adults. Preventive
Medicine Reports, 4, 142–147. doi:10.1016/j.pmedr.2016.06.005
Welch, C., Hassan-Smith, Z. K., Greig, C. A., Lord, J. M., & Jackson, T. A. (2017). Acute
sarcopenia secondary to hospitalisation-An emerging condition affecting older adults.
Aging and Disease, 8(6), 1-14. doi:10.14336/AD.2017.0315
Williamson, A., & Hoggart, B. (2005). Pain: A review of three commonly used pain rating
scales. Journal of Clinical Nursing, 14, 798-804. doi:10.1111/j.1365-2702.2005.01121.x
Yalcin, A., Aras, S., Atmis, V., Cengiz, O. K., Varli, M., Cinar, E., & Atli, T. (2015). Sarcopenia
prevalence and factors associated with sarcopenia in older people living in a nursing
home in Ankara Turkey. Geriatrics & Gerontology International, 16, 903-910.
doi:10.1111/ggi.12570
Yamada, Y., Watanabe, Y., Ikenaga, M., Yokoyama, K., Yoshida, T., Morimoto, T., & Kimura,
M. (2013). Comparison of single-or multifrequency bioelectrical impedance analysis and
spectroscopy for assessment of appendicular skeletal muscle in the elderly. Journal of
Applied Physiology, 115, 812-818. doi: 10.1152/japplphysiol.00010.2013
Yeom, H. A., Fleury, J., & Keller, C. (2008). Risk factors for mobility limitation in communitydwelling older adults: A social ecological perspective. Geriatric Nursing, 29, 133-140.
doi:10.1016/j.gerinurse.2007.07.002
Yorke, A. M., Curtis, A. B., Shoemaker, M., & Vangsnes, E. (2015). Grip strength values
stratified by age, gender, and chronic disease status in adults aged 50 years and older.
Journal of Geriatric Physical Therapy, 38(3), 115-121.
doi:10.1519/JPT.0000000000000037

124

Yu, R., Wong, M., Leung, J., Lee, J., Auyeung, T. W., & Woo, J. (2014). Incidence,
reversibility, risk factors and the protective effect of high body mass index against
sarcopenia in community‐dwelling older Chinese adults. Geriatrics & Gerontology
International, 14(S1), 15-28. doi:10.1111/ggi.12220
Zacker, R. J. (2006). Health-related implications and management of sarcopenia: This agerelated deterioration in functionality is, to some extent, preventable. furthermore,
encouraging patients to adopt healthy eating and exercise habits can even reverse some of
the effects. JAAPA-Journal of the American Academy of Physicians Assistants, 19(10),
24-29. doi:10.1097/01720610-200610000-00008
Zimmerman, S., Sloane, P. D., Eckert, J. K., Gruber-Baldini, A. L., Morgan, L. A., Hebel, J. R.,
... & Chen, C. K. (2005). How good is assisted living? Findings and implications from an
outcomes study. The Journals of Gerontology Series B: Psychological Sciences and
Social Sciences, 60, S195-S204.

125

APPENDICES
Appendix A: Studies Addressing the Risk Factors for Sarcopenia in Older Adults
Author,
Year
Alexandre
et al.
(2014)

Purpose

Examine the prevalence
and factors associated with
sarcopenia in community
dwelling older adults

Design, Sample
Size, Age
Correlational,
cross-sectional
n = 1149
≥ 60 years

126
Byeon et al. Examine the relationship
(2016)
between sarcopenia and
depression in community
dwelling older adults by
age group and obesity
status

Castillo et
al. (2003)

Examine the prevalence
and factors associated with
sarcopenia in communitydwelling older adults

Correlational,
cross-sectional
n = 7,364
Age was
categorized into
three groups (20
- 39, 40 - 59,
and ≥ 60 years)
Correlational,
cross-sectional
n = 1700
65-98 year-old

Measure

Outcome Measure

The Mini Mental State Exam
(MMSE), the International
Physical Activity Questionnaire
(IPAQ), Geriatric Depression
Scale (GDS), Mini-Nutritional
Assessment (MNA), skeletal
muscle mass index using the
Lee equation, handgrip
strength, and gait speed

Cognitive impairment (OR 2.68,
95% CI 1.23–5.84), lower income
(OR 2.57, 95% CI 1.06–6.20),
smoking (OR 2.00, 95% CI 1.11–
3.63), undernutrition (OR 11.54,
95% CI 3.45–38.59) and risk for
undernutrition (OR 3.15, 95% CI
2.03–4.89) were factors
associated with sarcopenia

Body Max Index (BMI),
depressive symptoms, and
appendicular skeletal muscle
mass via Dual Energy X-ray
Absorptiometry (DXA)

No significant associations
between sarcopenia and
depression among all age groups

Medical conditions, medication
use, Bioimpedance
Spectroscopy (BIS), grip
strength, alcohol intake,
smoking status, physical
activity level, and BMI

Lack of physical activity and
current smoking are risk factors
for sarcopenia

Author,
Year

Purpose

Figueiredo
et al.
(2014)

Analyze the prevalence of
sarcopenia and associated
risk factors in communitydwelling older adults

Design, Sample
Size, Age
Correlational,
cross-sectional

Measure

Outcome Measure

Lifestyle, race, medical history,
BMI, DXA

BMI (OR 0.45, 95% CI 0.36–
0.57), black race (OR 0.27, 95%
CI 0.08–0.88), current smoking
(OR 3.44, 95% CI 1.18–9.96),
physical activity (OR 0.28, 95%
CI 0.08–0.95), and total femur
bone mineral density (OR 0.019,
95% CI 0.0003–0.98) were risk
factors for sarcopenia
Depression symptoms and lower
serum albumin concentration
were associated factors for
sarcopenia

n = 399
Mean age = 74.2
years

Gariballa &
Alessa
(2013)

127
Gianoudis
et al.
(2014)

Identify the clinical
determinants and
prognostic significance of
sarcopenia
in a cohort of hospitalized
acutely ill older patients

Correlational,
cross-sectional

Examine the relationship
between total sitting and
TV viewing time on
sarcopenia in communitydwelling older adults

Correlational,
cross-sectional

n = 432
≥ 65 years

n = 162
60 – 86 years

Han et al.
(2016)

Examine the prevalence
and factors associated with
sarcopenia in communitydwelling older adults

Correlational,
cross-sectional
n = 1,069

Medical conditions, history of
chronic illnesses, smoking
status, alcohol and drug intake,
nutritional status, Barthel Index
of Activities of Daily Living,
muscle strength-hand grip, and
muscle mass measured by midarm muscle circumference
Three repetition maximum
testing 30 s sit-to-stand, four
square step test, the timed-upand-go (TUG) test, timed stair
climb test, and total sitting and
TV viewing time via
questionnaire

Overall sitting time 1+hr/day the
risk of sarcopenia increased by 33
% (OR 1.33, 95% CI 1.05, 1.68)

Medical conditions, educational Presence of sarcopenia was
level, smoking and drinking
inversely associated with BMI for
habits, history of falls, physical both sexes. Diabetes in males
(OR 5.04, 95% CI 1.70–14.89),

Author,
Year

Purpose

Design, Sample
Size, Age
≥ 60 years

Hsu et al.
(2014)
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Kim et al.
(2011)

Evaluate the association of
cognitive impairment,
depressive mood and
sarcopenia among older
men living in the veterans
retirement community

Correlational,
cross-sectional

Examine the relationship
between depression and
various components of
body composition,
including fat and muscle,
in community-dwelling
older adults

Correlational,
cross-sectional

Measure

activity level, GDS, BIS, gait
speed, and grip strength

ADL, gait speed, handgrip
strength, BMI, BIA, MMSE,
and GDS

n = 353
≥ 65 years

n = 836
≥ 60 years

GDS, abdominal visceral fat
area and subcutaneous fat area
via Computed Tomography
(CT), appendicular skeletal
muscle mass via DXA

Outcome Measure

diabetes in females (OR 2.36,
95% CI 1.06–5.25), daily
consumption of alcohol (OR
10.60, 95% CI 1.75–64.24),
peptic ulcer in female (OR 5.58,
95% CI 2.13–14.59) were
associated risk factors for
sarcopenia
Sarcopenia was associated with
cognitive impairment (OR 3.03,
95% CI 1.63–5.65) and
depressive symptoms (OR 2.25,
95% CI 1.03–4.89)
Older adults with sarcopenia
were significantly lower in BMI
compared to those who did not
have sarcopenia
Depression was associated with
low BMI and sarcopenia. The
risk of depression was lower with
higher appendicular skeletal
muscle mass (OR 0.49; 95% CI
0.29–0.85) and lower with higher
BMI (OR 0.70, 95% CI 0.51–
0.96). Depression was negatively
associated with BMI in women
(OR 0.73; 95% CI 0.56–0.95)

Author,
Year

Purpose

Landi et al.
(2012)

Evaluate the prevalence of
sarcopenia and its
association with functional
and clinical status in
nursing home residents

Design, Sample
Size, Age
Correlational,
cross-sectional
n = 122

Measure

Outcome Measure

ADL via Minimum Data Set
assessment form for the nursing
Home (MDS-NH), cognitive
performance, BMI, gait speed,
hand grip strength, and BIS

Cerebrovascular disease (OR
5.16, 95% CI
1.03–25.87), osteoarthritis (OR
7.24, 95% CI 2.02–25.95) were
associated risk factors for
sarcopenia. Risk of sarcopenia
negatively associated with BMI
>21kg/m2 (OR 0.76, 95% CI
0.64-0.90), physical activity
1+hr/day (OR 0.40, 95% CI 0.120.98)

medical conditions, DXA,
alcohol consumption, smoking
status, regular exercise, and
BMI

BMI < 18.5 was a significant risk
factor for
sarcopenia in men (OR 39.1, 95%
CI
11.3–134.6) and women (OR 9.7,
95% CI 2.8–33.8)
Sarcopenia was associated with
cigarette smoking (OR -0.19,
95% CI -0.31, -0.07), chronic
illnesses (diabetes, hypertension,
heart disease, COPD),
underweight (OR -1.28, 95% CI 1.47, -1.29), and physical
inactivity (OR -0.27, 95% CI 0.37, -0.17)

≥ 70 years
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Lau et al.
(2005)

Lee et al.
(2007)

Martins,
Bôas,

Evaluate the prevalence of
and risk factors for
sarcopenia in communitydwelling older adults

Examine the association
between sarcopenia and
common chronic illnesses,
lifestyle factors,
psychosocial well-being
and physical performance
in community-dwelling
older adults

Identify the prevalence of

Correlational,
cross-sectional
n = 527
≥ 70 years
Correlational,
cross-sectional
n = 4000

Medical illnesses, smoking
status, alcohol consumption,
Physical activity scale of the
elderly (PASE), GDS, grip
strength, timed chair-stands,
gait speed, and DXA

≥ 65 years

Correlational,
cross-sectional

Socioeconomic and
demographic status,

Retirement (OR 2.165, CI:95%
CI 1.037 - 4.250) and smoking

Author,
Year
McLellan
(2016)

Murphy et
al. (2013)

Purpose

sarcopenia and its
association with
anthropometric and
socioeconomic factors in
older adult patients assisted
by primary health care
Examine the time course of
sarcopenia and to
explore potential
determinants of transition
between stages of
sarcopenia in communitydwelling older adults

Design, Sample
Size, Age

n = 136

Measure

Outcome Measure
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anthropometric profile was
assessed, BIS, grip strength,
and dietary intake

(OR 9.435, 95% CI 1.228 72.499) were risk factors for
sarcopenia

DXA, gait speed, grip strength,
BMI, physical activity level,
pain, smoking status

History of pain (OR 1.18, 95% CI
1.01–1.39) and higher BMI (OR
1.30, 95% CI 1.25–1.36) were
predictive of transition from
normal state into sarcopenic state

Education level, chronic
noncommunicable diseases,
ethnicity, BMI, and DXA

Nutritional status (OR 5.14, 95%
CI 1.94-13.57) was associated
with sarcopenia

BIA, grip strength, gait speed,
Short Physical Performance
Battery (SPPB), MNA, GDS,
MMSE, and IPAQ

BMI (OR = 0.80, 95% CI 0.65–
0.97), low physical performance
(OR 0.83, 95% CI 0.69–1.00),
nutritional status (OR 0.19, 95%
CI 0.05–0.68) and sitting time

≥ 60 years

Correlational,
retrospective,
longitudinal
study (9-year
follow-up)
n = 2928
70 - 79 years

Santos et
al. (2015)

Analyze whether
sarcopenia is associated
with sociodemographic
factors and chronic
noncommunicable diseases
in community-dwelling
older adults

Senior et al. Evaluate the prevalence
(2015)
and risk factors of
sarcopenia among nursing
home residents

Correlational,
cross-sectional
n = 120
80 – 95 years

Correlational,
cross-sectional
n = 102
≥ 60 years

Author,
Year

Purpose

Design, Sample
Size, Age

Measure

Outcome Measure

(OR 1.18, 95% CI 1.00–1.39)
were risk factors for sarcopenia
Tasar et al.
(2015)

Investigate the prevalence
of sarcopenia and its
influencing factors in the
local elderly nursing home
residents

Correlational,
cross-sectional
n = 211

Smoking and alcohol intake
status, medications use, number
and types of chronic diseases,
upper arm circumferences,
BMI, SPPB, and BIS

Malnutrition (OR 0.533, 95% CI
0.292–0.974) and current
smoking (OR 2.289, 95% CI
1.063–4.929) were risk factors
for sarcopenia

BIA, gait speed, smoking habit,
education level, physical
activity, nutritional status,
comorbidities, Center for
Epidemiologic Studies
Depression scale, MMSE, and
blood sample

Lower insulin-like growth factor
I (OR 3.89, 95% CI 1.03–14.1)
and low bioavailable testosterone
(OR 2.67, 95% CI 1.31–5.44)
were associated with sarcopenia.
A decreased probability of being
sarcopenic was detected for
individuals with higher level of
education
(OR 0.85, 95% CI 0.74–0.98).
Nutritional intake, physical
activity, and level of comorbidity
were not associated with
sarcopenia

Barthel Index of Activities of
Daily Living, MMSE, MNA,
BMI, handgrip strength, gait
speed, BIS

BMI was associated with
sarcopenia (OR 2.91, 95% CI
1.18-7.16)

≥ 65 years
Volpato et
al. (2014)
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Estimate the prevalence
and clinical correlates of
sarcopenia in communitydwelling older adults

Correlational,
cross-sectional
n = 730
≥ 65 years

Yalcin et
al. (2015)

Evaluate the prevalence of
sarcopenia and associated
factors with sarcopenia
among nursing home
residents

Correlational,
cross-sectional
n = 141

Author,
Year

Yu et al.
(2014)

Purpose

Examined the incidence
and the reversibility of
sarcopenia and their
associated factors over a 4year period in communitydwelling older adults

Design, Sample
Size, Age
≥ 65 years
Correlational,
cohort,
longitudinal
study (4-year
follow-up)
n = 4000
≥ 65 years

- P < 0.05 is statistically significant

Measure

Medical conditions, dietary
intake, education level,
physical activity level, DXA,
grip strength, and gait speed

Outcome Measure

Stroke (OR 2.56, 95% CI 1.32–
4.95), Instrumental ADL
impairment (OR 2.12, 95% CI
1.49–3.02), COPD (OR 1.84,
95% CI 1.02–3.31), BMI (OR
0.66, 95% CI 0.62–0.70),
physical activity (OR 0.995, 95%
CI 0.991–0.999) were risk factors
for sarcopenia
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Appendix B: Short Physical Performance Battery (SPPB) Instructions

Read the instructions that are in bold and italic aloud.
This is a physical performance test that has three main components:
assessment of balance, gait speed and chair rise time.

an

General Notes:
If a patient is not able to complete a test, record the reason, stop the balance tests,
and move on.
All tests are done with eyes open. Patients can move their arms to stabilize, but can
not grab onto any objects or people.
Walking aids are not permitted during the balance tests.
1. BALANCE TESTS
The patient must be able to stand unassisted without the use of a cane or walker. You may help
the patient to get up.
Now let’s begin the evaluation. I would now like you to try to move your body in
different movements. I will first describe and show each movement to you. Then
I’d like you to try to do it. If you cannot do a particular movement, or if you feel it
would be unsafe to try to do it, tell me and we’ll move on to the next one. Let me
emphasize that I do not want you to try to do any exercise that you feel might be
unsafe.
Do you have any questions before we begin?
A. Side-by-Side Stand
1. Now I will show you the first movement.
2. (Demonstrate) I want you to try to stand with your feet together, side-by-side, for
about 10 seconds.
3. You may use your arms, bend your knees, or move your body to maintain your
balance, but try
not to move your feet. Try to hold this position until I tell you to stop.
4. When the patient has his/her feet together, ask “Are you ready?”
5. Then let go and begin timing as you say, “Ready, begin.”
6. Stop the stopwatch and say “Stop” after 10 seconds or when the patient steps out of
position or grabs your arm.
7. If patient is unable to hold the position for 10 seconds, record result and move on.

B. Semi-Tandem Stand
1. Now I will show you the second movement.
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2. (Demonstrate) Now I want you to try to stand with the side of the heel of one foot
touching the big toe of the other foot for about 10 seconds. You may put either
foot in front, whichever is more
comfortable for you.
3. You may use your arms, bend your knees, or move your body to maintain your
balance, but try
not to move your feet. Try to hold this position until I tell you to stop.
4. When the patient has his/her feet together, ask “Are you ready?”
5. Then let go and begin timing as you say “Ready, begin.”
6. Stop the stopwatch and say “Stop” after 10 seconds or when the patient steps out of
position or grabs your arm.
7. If patient is unable to hold the position for 10 seconds, record result and go to the gait
speed test.
C. Tandem Stand
1. Now I will show you the third movement.
2. (Demonstrate) Now I want you to try to stand with the heel of one foot in front of
and touching the toes of the other foot for about 10 seconds. You may put either
foot in front, whichever is more comfortable
for you.
3. You may use your arms, bend your knees, or move your body to maintain your
balance, but try not
to move your feet. Try to hold this position until I tell you to stop.
4. Supply just enough support to the patient’s arm to prevent loss of balance.
5. When the patient has his/her feet together, ask “Are you ready?”
6. Then let go and begin timing as you say, “Ready, begin.”
7. Stop the stopwatch and say “Stop” after 10 seconds or when the patient steps out of
position or grabs your arm.
2. GAIT SPEED TEST
Now I am going to observe how you normally walk. If you use a cane or other
walking aid and you feel you need it to walk a short distance, then you may use it.
A. First Gait Speed Test
1. This is our walking course. I want you to walk to the other end of the course at
your usual speed, just as if you were walking down the street to go to the store.
2. Demonstrate the walk for the patient.
3. Walk all the way past the other end of the tape before you stop. Do you feel this
would be safe?
4. Have the patient stand with both feet touching the starting line.
5. When I want you to start, I will say: “Ready, begin.” When the patient acknowledges
this instruction say: “Ready, begin.”
6. Press the start/stop button to start the stopwatch as the patient begins walking.
7. Stop timing when one of the patient’s feet is completely across the end line.
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B. Second Gait Speed Test
1. Now I want you to repeat the walk. Remember to walk at your usual pace, and go
all the way past the other end of the course.
2. Have the patient stand with both feet touching the starting line.
3. When I want you to start, I will say: “Ready, begin.” When the patient acknowledges
this instruction say: “Ready, begin.”
4. Press the start/stop button to start the stopwatch as the patient begins walking.
5. Walk behind and to the side of the patient.
6. Stop timing when one of the patient’s feet is completely across the end line.
3. CHAIR STAND TEST
A. Single Chair Stand
1. Let’s do the last movement test. Do you think it would be safe for you to try to
stand up from a chair without using your arms?
2. This test measures the strength in your legs.
3. (Demonstrate and explain the procedure.) First, fold your arms across your chest
and sit so that your feet are on the floor; then stand up keeping your arms folded
across your chest.
4. Please stand up keeping your arms folded across your chest. Are you ready?
Stand. (Record result).
5. If patient cannot rise without using arms, say “Okay, try to stand up using your arms.
Are you ready? Stand.” This is the end of their test. Record result and go to the scoring
page.
B. Repeated Chair Stands
1. Do you think it would be safe for you to try to stand up from a chair five times
without using your arms?
2.

Please stand up straight as QUICKLY as you can five times, without stopping in
between. After standing up each time, sit down and then stand up again. Keep
your arms folded across your chest. I’ll be timing you with a stopwatch.
Remember, if you cannot complete this test or if you feel it would be unsafe to do
so tell me and we will quit.

3. When the patient is properly seated, say: “Are you ready? Stand” and begin timing.
4. Count out loud as the patient arises each time, up to five times.
5. Stop if patient becomes tired or short of breath during repeated chair stands.
6. Stop the stopwatch when he/she has straightened up completely for the fifth time.
7. Also stop:
• If patient uses his/her arms
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• After 1 minute, if patient has not completed rises
• At your discretion, if concerned for patient’s safety
8. If the patient stops and appears to be fatigued before completing the five stands, confirm
this by asking “Can you continue?”
9. If patient says “Yes,” continue timing. If patient says “No,” stop the stopwatch.
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Appendix C: Timed Up & Go Test (TUG) Instructions
Directions:
The timed “Up and Go” test measures, in seconds, the time taken by an individual to stand up
from a standard arm chair (approximate seat height of 46 cm [18in], arm height 65 cm [25.6 in]),
walk a distance of 3 meters (118 inches, approximately 10 feet), turn, walk back to the chair,
and sit down. The subject wears their regular footwear and uses their customary walking aid
(none, cane, walker). No physical assistance is given. They start with their back against the
chair, their arms resting on the armrests, and their walking aid at hand. They are instructed that,
on the word “go” they are to get up and walk at your normal pace to a line on the floor 3 meters
away, turn, return to the chair and sit down again. The subject walks through the test once
before being timed in order to become familiar with the test. Either a stopwatch or a wristwatch
with a second hand can be used to time the trial.
Instructions to the patient:
“When I say ‘go’ I want you to stand up and walk to the line, turn and then walk back to the chair
and sit down again. Walk at your normal pace.”

Scoring:
Time for ‘Up and Go’ test _________sec.
Unstable on turning?
Walking aid used?

Type of aid: ___________
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Appendix D: Self-Efficacy for Exercise Scale

How confident are you right now that you could exercise 3 times per week for 20 minutes
if:
Not

Very

Confident

Confident

1. You were worried the exercise would cause further pain

0 1 2 3 4 5 6 7 8 9 10

2. You were bored by the program or activity

0 1 2 3 4 5 6 7 8 9 10

3. You were not sure exactly what exercises to do

0 1 2 3 4 5 6 7 8 9 10

4. You had to exercise alone

0 1 2 3 4 5 6 7 8 9 10

5. You did not enjoy it

0 1 2 3 4 5 6 7 8 9 10

6. You were too busy with other activities

0 1 2 3 4 5 6 7 8 9 10

7. You felt tired during or after exercise

0 1 2 3 4 5 6 7 8 9 10

8. You felt stressed

0 1 2 3 4 5 6 7 8 9 10

9. You felt depressed

0 1 2 3 4 5 6 7 8 9 10

10. You were afraid the exercise would make you fall

0 1 2 3 4 5 6 7 8 9 10

11. You felt pain when exercising

0 1 2 3 4 5 6 7 8 9 10
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Appendix E: Geriatric Depression Scale

Instructions:

Circle the answer that best describes how you felt
over the past week.
1.

Are you basically satisfied with your life?

yes

no

2.

Have you dropped many of your activities and
interests?

yes

no

3.

Do you feel that your life is empty?

yes

no

4.

Do you often get bored?

yes

no

5.

Are you in good spirits most of the time?

yes

no

6.

Are you afraid that something bad is going to
happen to you?

yes

no

7.

Do you feel happy most of the time?

yes

no

8.

Do you often feel helpless?

yes

no

9.

Do you prefer to stay at home, rather than going out
and doing things?

yes

no

10. Do you feel that you have more problems with
memory than most?

yes

no

11. Do you think it is wonderful to be alive now?

yes

no

12. Do you feel worthless the way you are now?

yes

no

13. Do you feel full of energy?

yes

no

14. Do you feel that your situation is hopeless?

yes

no

15. Do you think that most people are better off than
you are?

yes

no

Total Score
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Appendix F: Lubben Social Network Scale-6 (LSNS-6)
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Appendix G: Numeric Pain Rating (NPR) Scale
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Appendix I: Data Analysis Plan
Research
questions/Hypotheses
Descriptive Questions
1. What are the selfefficacy for exercise,
depression, and social
support of older adults
living in RCACs?
2. What are the muscle
mass, strength, and
function of older adults
living in RCACs?

Hypotheses
1. Participants with high
self-efficacy for exercise
will have greater muscle
mass, strength, and
function than those with
low self-efficacy for
exercise

Unit of
Analysis

Variable

Measurement
tool

Level of
Measurement

Statistical Test

Resident
subject

-Self-efficacy for
exercise
-Depression
-Social support

-SEE
-GDS-15
-LSNS-6

All ordinal

Descriptive
(Frequency,
mean, SD,
range)

Resident
subject

-Muscle mass
-Muscle strength
-Muscle function

-Muscle mass
-Grip strength
-Gait speed
-Chair rise
-SPPB
-TUG
-Jump power

All ordinal

Descriptive
(Frequency,
mean, SD,
range)

Resident
subject

IV:
-Self-efficacy for
exercise
DVs:
-Muscle mass
-Muscle strength
-Muscle function

All ordinal

t-test

All ordinal

t-test

All ordinal

t-test

2. Participants without
depressive symptoms
will have greater muscle
mass, strength, and
function than those with
depressive symptoms

Resident
subject

3.Participants with high
social support will have
greater muscle mass,
strength, and function
than those with low
social support

Resident
subject

IV:
-Depression
DVs:
-Muscle mass
-Muscle strength
-Muscle function

IV:
-Social support
DVs:
-Muscle mass
-Muscle strength
-Muscle function
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-SEE

-Muscle mass
-Grip strength
-Gait speed
-Chair rise
-SPPB
-TUG
- Jump power
-GDS-15
-Muscle mass
-Grip strength
-Gait speed
-Chair rise
-SPPB
-TUG
- Jump power
-LSNS-6
-Muscle mass
-Grip strength
-Gait speed
-Chair rise

4. Weight corrected jump
power obtained by MM
correlates well with other
traditional muscle
function and strength
tests, including SPPB,
TUG, and grip strength.

Resident
subject

-Muscle function
-Muscle strength
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-SPPB
-TUG
- Jump power
-Grip strength
-Gait speed
-Chair rise
-SPPB
-TUG
- Jump power

All ordinal

Correlation
Coefficient
Values
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